var title_f25_37_26192="Cavitary TB";
var content_f25_37_26192=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75393&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75393&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cavitary tuberculosis in an adolescent male",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 316px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cavitary tuberculosis in an adolescent male. There is infiltrate and a cavity along the horizontal fissure on the right. Note the absence of hilar adenopathy, which is typical of so-called reactivation or adult-type tuberculosis in adolescents.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey R Starke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26192=[""].join("\n");
var outline_f25_37_26192=null;
var title_f25_37_26193="Contents: Pediatric endocrinology";
var content_f25_37_26193=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?17/55/18302\">",
"       Pediatrics",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric endocrinology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric endocrinology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Adrenal disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/8/40071\">",
"           Adrenal hyperandrogenism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/46/28391\">",
"           Adrenal steroid biosynthesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/38/27238\">",
"           Causes and clinical manifestations of central adrenal insufficiency in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/52/23369\">",
"           Causes and clinical manifestations of primary adrenal insufficiency in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/55/26489\">",
"           Causes and pathophysiology of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/5/22618\">",
"           Clinical features, diagnosis, and management of von Hippel-Lindau disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/32/15878\">",
"           Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/54/17255\">",
"           Diagnosis of adrenal insufficiency in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/9/24726\">",
"           Diagnosis of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/49/11034\">",
"           Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/6/19560\">",
"           Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/1/9240\">",
"           Metabolism of adrenal steroids",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/42/9896\">",
"           Pathogenesis of autoimmune adrenal insufficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/14/38121\">",
"           Pheochromocytoma in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/22/31078\">",
"           Treatment of adrenal insufficiency in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/0/31754\">",
"           Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/51/35641\">",
"           Uncommon causes of congenital adrenal hyperplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/7/12408\">",
"           Unusual causes of adrenal insufficiency",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Diabetes mellitus and hypoglycemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/43/31414\">",
"           Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/60/29641\">",
"           Blood glucose self-monitoring in management of adults with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/37/16983\">",
"           Cerebral edema in children with diabetic ketoacidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/33/14874\">",
"           Classification of diabetes mellitus and genetic diabetic syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/32/41480\">",
"           Clinical features and diagnosis of diabetic ketoacidosis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/28/34249\">",
"           Comorbidities and complications of type 2 diabetes mellitus in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/29/40410\">",
"           Complications and screening in children and adolescents with type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/54/38758\">",
"           Diagnosis of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/59/40889\">",
"           Epidemiology, presentation, and diagnosis of type 1 diabetes mellitus in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/25/4506\">",
"           Epidemiology, presentation, and diagnosis of type 2 diabetes mellitus in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/45/11993\">",
"           Estimation of blood glucose control in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/57/28567\">",
"           Insulin resistance: Definition and clinical spectrum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/30/36329\">",
"           Management of type 2 diabetes mellitus in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/42/23210\">",
"           Pathogenesis of type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/31/36346\">",
"           Pathogenesis of type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/21/32087\">",
"           Prediction of type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/5/13401\">",
"           Prevention of type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/6/21606\">",
"           Self-management education for the child with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/7/1142\">",
"           Special situations in children and adolescents with type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/11/32954\">",
"           The metabolic syndrome (insulin resistance syndrome or syndrome X)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/28/7626\">",
"           Treatment and complications of diabetic ketoacidosis in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Disorders of divalent ions and bone",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/27/4538\">",
"           Bone problems in childhood cancer patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/50/36646\">",
"           Clinical manifestations of hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/21/9562\">",
"           Drugs that affect bone metabolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/37/28248\">",
"           Etiology and treatment of calcipenic rickets in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/24/35209\">",
"           Etiology of hypocalcemia in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/45/21209\">",
"           Hereditary hypophosphatemic rickets and tumor-induced osteomalacia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/15/9462\">",
"           Metabolism of vitamin D",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/23/26999\">",
"           Neonatal hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/5/34906\">",
"           Normal skeletal development and regulation of bone formation and resorption",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/21/26967\">",
"           Overview of rickets in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/8/23685\">",
"           Relation between total and ionized serum calcium concentration",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Disorders of glucose homeostasis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/0/8201\">",
"           Approach to hypoglycemia in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/40/16010\">",
"           Etiology of hypoglycemia in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/48/44809\">",
"           Infant of a diabetic mother",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/9/40090\">",
"           Management of type 1 diabetes mellitus in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/16/17673\">",
"           Neonatal hypoglycemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/49/3866\">",
"           Pathogenesis, clinical features, and diagnosis of persistent hyperinsulinemic hypoglycemia of infancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/0/12295\">",
"           Treatment and complications of persistent hyperinsulinemic hypoglycemia of infancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Growth disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/18/10537\">",
"           Causes of short stature",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/5/82\">",
"           Diagnosis of growth hormone deficiency in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/60/18376\">",
"           Diagnostic approach to short stature",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/7/7286\">",
"           Endocrine surveillance in childhood cancer survivors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/55/31607\">",
"           Growth failure after childhood cancer: Role of growth hormone deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/19/39223\">",
"           Growth failure after childhood cancer: Role of hypothyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/22/39270\">",
"           Growth hormone insensitivity syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/58/23463\">",
"           Growth hormone treatment during the transition period",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/37/3672\">",
"           Growth hormone treatment for children born small for gestational age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/52/18248\">",
"           Growth hormone treatment for idiopathic short stature",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/15/9462\">",
"           Metabolism of vitamin D",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/9/13464\">",
"           Pituitary gigantism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/53/10073\">",
"           The child with tall stature or abnormally rapid growth",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/0/14345\">",
"           Treatment of growth hormone deficiency in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gynecologic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/13/39130\">",
"           Clinical features and diagnosis of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/23/25975\">",
"           Definition and evaluation of abnormal uterine bleeding in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/9/34970\">",
"           Definition, pathogenesis, and etiology of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/8/11402\">",
"           Diagnosis and treatment of endometriosis in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/57/11160\">",
"           Differential diagnosis and approach to the adolescent with abnormal uterine bleeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/7/17529\">",
"           Management of abnormal uterine bleeding in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/34/21033\">",
"           Ovarian cysts and neoplasms in infants, children, and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/25/31125\">",
"           Primary dysmenorrhea in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/46/24297\">",
"           Treatment of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypogonadism",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/42/33449\">",
"           Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/5/22616\">",
"           Clinical manifestations and pathogenesis of disorders of the androgen receptor",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/44/17096\">",
"           Diagnosis and treatment of disorders of the androgen receptor",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/7/7286\">",
"           Endocrine surveillance in childhood cancer survivors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/63/14329\">",
"           Management of Turner syndrome (gonadal dysgenesis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/14/7401\">",
"           Pubertal development and gonadal function in survivors of childhood cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/44/17098\">",
"           Undescended testes (cryptorchidism) in children and adolescents",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypothalamic and pituitary disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/16/38151\">",
"           ACTH deficiency in survivors of childhood cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/3/30776\">",
"           Causes and clinical manifestations of acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/35/21048\">",
"           Clinical manifestations and causes of central diabetes insipidus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/60/24520\">",
"           Craniopharyngioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/7/7286\">",
"           Endocrine surveillance in childhood cancer survivors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/55/31607\">",
"           Growth failure after childhood cancer: Role of growth hormone deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/30/25059\">",
"           Hypothalamic-pituitary axis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/46/7913\">",
"           Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/9/13464\">",
"           Pituitary gigantism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/31/505\">",
"           Treatment of central diabetes insipidus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/34/6691\">",
"           Urine output in diabetes insipidus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neonatal endocrinology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/48/44809\">",
"           Infant of a diabetic mother",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/21/20823\">",
"           Large for gestational age newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/59/37816\">",
"           Neonatal hyperglycemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/23/26999\">",
"           Neonatal hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/16/17673\">",
"           Neonatal hypoglycemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/46/15081\">",
"           Treatment and prognosis of congenital hypothyroidism",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/47/24312\">",
"           Diagnosis of polyuria and diabetes insipidus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/57/28567\">",
"           Insulin resistance: Definition and clinical spectrum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/49/17174\">",
"           Multiple endocrine neoplasia type 1: Definition and genetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/44/17098\">",
"           Undescended testes (cryptorchidism) in children and adolescents",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Physiology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/3/31800\">",
"           Male reproductive physiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/19/40246\">",
"           Measurement of ACTH, CRH, and other hypothalamic and pituitary peptides",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/47/40696\">",
"           Thyroid physiology and screening in preterm infants",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Puberty and adrenarche",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/13/39130\">",
"           Clinical features and diagnosis of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/5/19546\">",
"           Definition, etiology, and evaluation of precocious puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/9/34970\">",
"           Definition, pathogenesis, and etiology of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/57/22424\">",
"           Diagnosis and treatment of delayed puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/7/7286\">",
"           Endocrine surveillance in childhood cancer survivors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/16/28935\">",
"           Epidemiology and pathogenesis of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/2/2089\">",
"           Etiology, diagnosis, and treatment of primary amenorrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/56/34697\">",
"           Etiology, diagnosis, and treatment of secondary amenorrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/48/23302\">",
"           Normal adrenarche",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/25/1434\">",
"           Normal puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/2/27685\">",
"           Physiology of the normal menstrual cycle",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/62/21481\">",
"           Premature adrenarche",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/14/7401\">",
"           Pubertal development and gonadal function in survivors of childhood cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/0/12\">",
"           Steroid hormone metabolism in polycystic ovary syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/46/24297\">",
"           Treatment of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/49/4889\">",
"           Treatment of precocious puberty",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Sexuality",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/13/42201\">",
"           Contraception: Overview of issues specific to adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/5/19546\">",
"           Definition, etiology, and evaluation of precocious puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/32/31236\">",
"           Diagnosis and management of gestational hyperandrogenism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/9/6294\">",
"           Epidemiology and pathogenesis of gynecomastia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/16/28935\">",
"           Epidemiology and pathogenesis of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/59/24506\">",
"           Evaluation of the infant with ambiguous genitalia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/3/31800\">",
"           Male reproductive physiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/47/35577\">",
"           Management of the infant with ambiguous genitalia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/16/41220\">",
"           Normal sexual differentiation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/45/30423\">",
"           Steroid 5-alpha-reductase 2 deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/0/12\">",
"           Steroid hormone metabolism in polycystic ovary syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/49/4889\">",
"           Treatment of precocious puberty",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Thyroid disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/22/21865\">",
"           Acquired hypothyroidism in childhood and adolescence",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/39/2682\">",
"           Clinical features and detection of congenital hypothyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/29/7641\">",
"           Clinical manifestations and diagnosis of hyperthyroidism in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/45/24280\">",
"           Congenital and acquired goiter in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/7/7286\">",
"           Endocrine surveillance in childhood cancer survivors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/6/97\">",
"           Evaluation and management of neonatal Graves' disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/19/39223\">",
"           Growth failure after childhood cancer: Role of hypothyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/59/39864\">",
"           Iodine deficiency disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/33/3608\">",
"           Laboratory assessment of thyroid function",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/51/43830\">",
"           Overview of thyroiditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/30/40425\">",
"           Pathogenesis of Graves' disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/11/27833\">",
"           Pathogenesis of Hashimoto's thyroiditis (chronic autoimmune thyroiditis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/49/1818\">",
"           Radiation-induced thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/37/1626\">",
"           Reduced sensitivity to thyroid hormone",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/8/16518\">",
"           Resistance to thyrotropin and thyrotropin-releasing hormone",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/4/10312\">",
"           Suppurative thyroiditis in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/16/25864\">",
"           Thyroglossal duct cysts and ectopic thyroid",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/41/23191\">",
"           Thyroid nodules and cancer in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/47/40696\">",
"           Thyroid physiology and screening in preterm infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/51/25400\">",
"           Treatment and prognosis of Graves' disease in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/46/15081\">",
"           Treatment and prognosis of congenital hypothyroidism",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-CD03A2F23B-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f25_37_26193=[""].join("\n");
var outline_f25_37_26193=null;
var title_f25_37_26194="Patient information: Bulimia nervosa (The Basics)";
var content_f25_37_26194=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"15\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16566\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/63/7154\">",
"         Person having an ECG",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?25/16/25858\">",
"         Patient information: Anorexia nervosa (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/57/12179\">",
"         Patient information: Depression (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?31/32/32257\">",
"         Patient information: Generalized anxiety disorder (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/6/24675\">",
"         Patient information: Medicines for depression (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?13/6/13413\">",
"         Patient information: Depression in adolescents (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?19/41/20116\">",
"         Patient information: Depression in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Bulimia nervosa (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/bulimia-nervosa-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H30116820\">",
"      <span class=\"h1\">",
"       What is bulimia nervosa?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Bulimia nervosa is an eating disorder in which people have episodes of overeating (called &ldquo;binges&rdquo;). After overeating, people then use unhealthy behaviors to rid their bodies of the food and avoid gaining weight (called &ldquo;purges&rdquo;).",
"     </p>",
"     <p>",
"      Bulimia nervosa is more common in women than men. It usually begins in the teen or early adult years.",
"     </p>",
"     <p>",
"      Many people with bulimia nervosa are a normal weight for their height. Because their weight appears normal, other people might not know that they have an eating disorder. But it&rsquo;s important for people to get treatment, because bulimia nervosa can cause serious problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30116835\">",
"      <span class=\"h1\">",
"       What are the symptoms of bulimia nervosa?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People with bulimia nervosa:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Binge at least 2 times a week &ndash; During binges, people eat a much larger amount of food than normal. When they overeat, they usually feel out of control, guilty, afraid, or ashamed.",
"       </li>",
"       <li>",
"        Purge after they eat &ndash; To avoid gaining weight after overeating, people:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Make themselves vomit",
"       </li>",
"       <li>",
"        Exercise too much",
"       </li>",
"       <li>",
"        Use medicines to make themselves vomit, urinate, or have bowel movements",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Think about their weight and body shape much more than usual &ndash; They think they are overweight, even if they are a normal weight.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30116850\">",
"      <span class=\"h1\">",
"       Is there a test for bulimia nervosa?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No. There is no test. But your doctor or nurse should be able to tell if you have it by doing an exam and talking with you about your eating habits, behaviors, and thoughts.",
"     </p>",
"     <p>",
"      Your doctor or nurse will do tests to check your health, because bulimia nervosa can lead to many health problems. You will probably have:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Blood tests",
"       </li>",
"       <li>",
"        Urine tests",
"       </li>",
"       <li>",
"        An ECG &ndash; An ECG measures the electrical activity in your heart and records your heart rate and rhythm (",
"        <a class=\"graphic graphic_figure graphicRef53145 \" href=\"UTD.htm?6/63/7154\">",
"         figure 1",
"        </a>",
"        ).",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30116865\">",
"      <span class=\"h1\">",
"       What problems can bulimia nervosa cause?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Bulimia nervosa can cause different kinds of health problems. That&rsquo;s because people vomit too often or use certain medicines too much. These health problems can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Dehydration &ndash; This is when the body loses too much water. It can make people feel thirsty, tired, dizzy, or confused, and have dark yellow urine.",
"       </li>",
"       <li>",
"        Feeling very tired",
"       </li>",
"       <li>",
"        Irregular menstrual periods (in women)",
"       </li>",
"       <li>",
"        Belly pain, bloating, and trouble having bowel movements",
"       </li>",
"       <li>",
"        Damage to the esophagus (the tube that connects the mouth to the stomach)",
"       </li>",
"       <li>",
"        Damage to the teeth, gums, or cheeks",
"       </li>",
"       <li>",
"        Heart problems",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      People with bulimia nervosa can also have:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Depression &ndash; This is when people feel very sad most of the time. Some depressed people think about hurting themselves. If you are thinking of hurting yourself, call your doctor or nurse right away or go to the hospital.",
"       </li>",
"       <li>",
"        Anxiety &ndash; This is when people worry a lot or think about certain things over and over.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30116880\">",
"      <span class=\"h1\">",
"       How is bulimia nervosa treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment for bulimia nervosa involves:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Talk therapy &ndash; Different kinds of talk therapy can be helpful, including:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Working one-on-one with a therapist",
"       </li>",
"       <li>",
"        Group therapy &ndash; You can join a group for people with eating disorders.",
"       </li>",
"       <li>",
"        Family therapy &ndash; You and your family can work with a therapist.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Medicines &ndash; Some medicines that treat depression can also help treat bulimia nervosa.",
"       </li>",
"       <li>",
"        A healthy eating plan &ndash; You can work with a dietitian (food expert) to make a healthy eating plan. If you are underweight or overweight, the dietitian can make a meal plan to help you get to a healthy weight.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Most people with bulimia nervosa can be treated at home, but some need to be treated in the hospital. It depends on the person&rsquo;s weight, symptoms, and health problems. Treatment for bulimia nervosa can be hard work, and it can take a long time. A complete recovery can take years.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30116895\">",
"      <span class=\"h1\">",
"       What happens after treatment?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Many people get better with treatment. But people with bulimia nervosa often &ldquo;relapse.&rdquo; This is when their symptoms and unhealthy eating patterns return.",
"     </p>",
"     <p>",
"      To help prevent a relapse, you can follow your treatment plan and keep talking to your therapist. If you start to have symptoms again, let your family, therapist, or doctor know as soon as possible so that you can get help.",
"     </p>",
"     <p>",
"      <strong>",
"       MORE ON THIS TOPIC",
"      </strong>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/16/25858?source=see_link\">",
"       Patient information: Anorexia nervosa (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/32/32257?source=see_link\">",
"       Patient information: Generalized anxiety disorder (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/57/12179?source=see_link\">",
"       Patient information: Depression (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/6/24675?source=see_link\">",
"       Patient information: Medicines for depression (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/6/13413?source=see_link\">",
"       Patient information: Depression in adolescents (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=see_link\">",
"       Patient information: Depression in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?25/37/26194?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16566 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-B2407C6BAC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26194=[""].join("\n");
var outline_f25_37_26194=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30116820\">",
"      What is bulimia nervosa?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30116835\">",
"      What are the symptoms of bulimia nervosa?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30116850\">",
"      Is there a test for bulimia nervosa?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30116865\">",
"      What problems can bulimia nervosa cause?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30116880\">",
"      How is bulimia nervosa treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30116895\">",
"      What happens after treatment?",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16566\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/63/7154\">",
"      Person having an ECG",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/16/25858?source=related_link\">",
"      Patient information: Anorexia nervosa (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/57/12179?source=related_link\">",
"      Patient information: Depression (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/6/13413?source=related_link\">",
"      Patient information: Depression in adolescents (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=related_link\">",
"      Patient information: Depression in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/32/32257?source=related_link\">",
"      Patient information: Generalized anxiety disorder (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/6/24675?source=related_link\">",
"      Patient information: Medicines for depression (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_37_26195="Nystatin and triamcinolone: Drug information";
var content_f25_37_26195=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Nystatin and triamcinolone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?32/0/32771?source=see_link\">",
"    see \"Nystatin and triamcinolone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F202905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antifungal Agent, Topical;",
"     </li>",
"     <li>",
"      Corticosteroid, Topical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F202894\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Cutaneous",
"      <i>",
"       Candida",
"      </i>",
"      :",
"     </b>",
"     Topical: Apply sparingly to affected area(s) twice daily. Therapy should be discontinued when control is achieved or if symptoms persist for &gt;25 days of therapy.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F202901\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F202895\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F202884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream: Nystatin 100,000 units and triamcinolone acetonide 0.1% (15 g, 30 g, 60 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment: Nystatin 100,000 units and triamcinolone acetonide 0.1% (15 g, 30 g, 60 g)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F202872\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F202887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     External use only; do not use on open or weeping wounds; do not use with occlusive dressings.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F202886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of cutaneous candidiasis",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F202903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Acne, allergic dermatitis, dryness, folliculitis, hypertrichosis, hypopigmentation, maceration of the skin, miliaria, perioral dermatitis, skin atrophy, striae",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Burning, irritation, itching",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Increased incidence of secondary infection",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F202890\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to nystatin, triamcinolone, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F202876\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal suppression: Systemic absorption of topical corticosteroids may cause hypercorticism or suppression of hypothalamic-pituitary-adrenal (HPA) axis, particularly in younger children or in patients receiving high doses for prolonged periods. HPA axis suppression may lead to adrenal crisis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dermatitis: Cutaneous hypersensitivity/contact dermatitis to individual ingredients has been reported; instruct patients to seek medical attention.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Infection: Steroids may mask infection or enhance existing infection; prolonged use may result in secondary infections due to immunosuppression.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Kaposi's sarcoma: Prolonged treatment with corticosteroids has been associated with the development of Kaposi's sarcoma (case reports); if noted, discontinuation of therapy should be considered.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Systemic effects: Topical corticosteroids may be absorbed percutaneously. Absorption of topical corticosteroids may cause manifestations of Cushing's syndrome, hyperglycemia, or glycosuria. Absorption is increased by the use of occlusive dressings, application to denuded skin, or application to large surface areas.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Children may absorb proportionally larger amounts of corticosteroids after topical application and may be more prone to systemic effects. HPA axis suppression, intracranial hypertension, and Cushing's syndrome have been reported in children receiving topical corticosteroids. Prolonged use may affect growth velocity; growth should be routinely monitored in pediatric patients.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F202880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aldesleukin: Corticosteroids may diminish the antineoplastic effect of Aldesleukin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticorelin: Corticosteroids may diminish the therapeutic effect of Corticorelin. Specifically, the plasma ACTH response to corticorelin may be blunted by recent or current corticosteroid therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Corticosteroids may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Corticosteroids may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving corticosteroids (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: Corticosteroids may decrease the serum concentration of Telaprevir. Telaprevir may increase the serum concentration of Corticosteroids.  Management: Concurrent use of telaprevir and systemic corticosteroids is not recommended.  When possible, consider alternatives.  If used together, employ extra caution and monitor closely for excessive corticosteroid effects and diminished telaprevir effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F202881\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14287273\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F202897\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F202891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F2524689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Nystatin-Triamcinolone External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100000 unit/g 0.1% (30 g): $159.52",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Ointment",
"     </b>",
"     (Nystatin-Triamcinolone External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100000 unit/g 0.1% (30 g): $159.52",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F15788598\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Urinary free cortisol test, morning plasma cortisol test, and ACTH stimulation test may be used to evaluate HPA axis suppression; signs of infection",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5539904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Fungiderma (TW)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F202875\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Nystatin is an antifungal agent that binds to sterols in fungal cell membrane, changing the cell wall permeability allowing for leakage of cellular contents. Triamcinolone is a synthetic corticosteroid; it decreases inflammation by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability. It suppresses the immune system reducing activity and volume of the lymphatic system. It suppresses adrenal function at high doses.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F202889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Goedert JJ, Vitale F, Lauria C, et al, &ldquo;Risk Factors for Classical Kaposi's Sarcoma,&rdquo;",
"      <i>",
"       J Natl Cancer Inst",
"      </i>",
"      , 2002, 94(22):1712-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/37/26195/abstract-text/12441327/pubmed\" id=\"12441327\" target=\"_blank\">",
"        12441327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9713 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-C7EAEF3114-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26195=[""].join("\n");
var outline_f25_37_26195=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202905\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202894\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202901\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202895\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202884\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202872\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202887\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202886\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202903\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202890\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202876\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299779\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202880\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202881\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14287273\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202897\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202891\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2524689\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15788598\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5539904\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202875\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202889\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9713\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9713|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?32/0/32771?source=related_link\">",
"      Nystatin and triamcinolone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_37_26196="Raltitrexed: Patient drug information";
var content_f25_37_26196=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Raltitrexed: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/1/21525?source=see_link\">",
"     see \"Raltitrexed: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F217007\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Tomudex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10019878\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10019880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2693942",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat colorectal cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691944",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat lung cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10019879\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702848",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to raltitrexed or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703828",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have very bad kidney or liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10019884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2858939",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid driving and doing other tasks or actions that call for you to be alert until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697725",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust during care and for 6 months after care ends.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10019885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth irritation or sores. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698255",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle weakness.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10019887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10019882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10019889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12050 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-AFC96612BD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26196=[""].join("\n");
var outline_f25_37_26196=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217007\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019878\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019880\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019879\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019884\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019885\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019887\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019882\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019889\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/1/21525?source=related_link\">",
"      Raltitrexed: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_37_26197="Gene therapy SCID X";
var content_f25_37_26197=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F57323&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F57323&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    Principles of",
"    <em>",
"     ex vivo",
"    </em>",
"    gene therapy for X-linked severe combined immunodeficiency (SCID-X)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 444px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CD34",
"    <sup>",
"     +",
"    </sup>",
"    cells are incubated",
"    <em>",
"     ex vivo",
"    </em>",
"    with supernatant that contains retrovirus encoding the common cytokine-receptor &gamma;-chain (&gamma;c) gene. Binding of the virus to a cell is followed by viral entry. Viral RNA is retrotranscribed into DNA, which, as a preintegration complex, can recombine with the cell's genome. The &gamma;",
"    <em>",
"     c",
"    </em>",
"    gene can be transcribed, being under the control of the viral long terminal repeat (LTR), which leads to protein synthesis, membrane expression and function.",
"    <div class=\"footnotes\">",
"     mRNA: messenger RNA.",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted by permission from MacMillan Publishers Ltd: Fischer, A, Hacein-Bey, S, Cavazzana-Calvo, M. Gene therapy of severe combined immunodeficiencies. Nature Reviews Immunology 2002; 8:615. Copyright &copy;2002 MacMillan Publishers Ltd.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.nature.com\">",
"      file://www.nature.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26197=[""].join("\n");
var outline_f25_37_26197=null;
var title_f25_37_26198="Approach to liver disease occurring during pregnancy";
var content_f25_37_26198=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to liver disease occurring during pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26198/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26198/contributors\">",
"     Yannick Bacq, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26198/contributors\">",
"     Richard H Lee, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26198/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26198/contributors\">",
"     Keith D Lindor, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26198/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26198/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26198/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26198/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/37/26198/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatobiliary disease occurring in a pregnant woman poses a challenge for the consulting clinician. In a prospective study in Southwest Wales, liver dysfunction was found in 3 percent of deliveries [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26198/abstract/1\">",
"     1",
"    </a>",
"    ]. Hepatic abnormalities occurring during pregnancy require diagnosis in the context of expected physiologic changes. In addition, diagnostic and therapeutic decisions have to consider the health of both the mother and the fetus.",
"   </p>",
"   <p>",
"    The types and presentation of hepatobiliary disease during pregnancy are varied.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are liver diseases that are specific to pregnancy, or multisystem diseases unique to pregnancy, which have significant hepatic manifestations. Examples of the former are intrahepatic cholestasis of pregnancy and acute fatty liver of pregnancy; examples of the latter are hyperemesis gravidarum and preeclampsia, which may be complicated by the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). (See appropriate topic reviews).",
"     </li>",
"     <li>",
"      There are pregnancy-related physiologic changes that may worsen the severity of, or predispose to hepatobiliary diseases that may also occur in nonpregnant women. Examples include cholelithiasis, thrombotic diseases (such as Budd-Chiari syndrome), and hepatitis E virus infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14726?source=see_link\">",
"       \"Intercurrent hepatobiliary disease during pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      There are diseases that are unassociated with pregnancy but can occur during pregnancy (eg, acute viral hepatitis). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14726?source=see_link\">",
"       \"Intercurrent hepatobiliary disease during pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pregnancy can also occur in women with underlying chronic liver disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22777?source=see_link\">",
"       \"Pregnancy in women with pre-existing chronic liver disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These issues are discussed in detail on the appropriate topic reviews. This review will focus on the approach to a pregnant woman who has signs or symptoms of hepatobiliary disease, which are also discussed in a guideline issued by the American College of Gastroenterology (",
"    <a class=\"graphic graphic_table graphicRef72172 \" href=\"UTD.htm?22/53/23387\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26198/abstract/2\">",
"     2",
"    </a>",
"    ]. Three insights are critical to this approach:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An understanding of the physiologic and biochemical changes that occur during normal pregnancy that may have bearing on the pathogenesis and diagnosis of hepatobiliary disease",
"     </li>",
"     <li>",
"      Consideration of the differential diagnosis in patients with suspected hepatobiliary disease",
"     </li>",
"     <li>",
"      An understanding that specific diseases are far more likely in certain trimesters, although there may be exceptions and overlap",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     THE LIVER DURING NORMAL PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy is associated with many normal physiologic changes that must be considered in the diagnosis of hepatobiliary diseases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spider angiomas and palmar erythema, which are classically associated with chronic liver disease, are also common during pregnancy and usually disappear after delivery. It is presumed that the hyperestrogenemia of pregnancy is responsible for these changes as it is in nonpregnant patients with cirrhosis.",
"   </p>",
"   <p>",
"    In late pregnancy, physical examination of the liver is difficult because of the expanding uterus. The liver is forced up further into the chest, and a palpable liver is an abnormal finding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Ultrasound examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The biliary tract is usually normal. Fasting gallbladder volume and residual volume after contraction may be increased.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard and ultrastructural examination of the liver during normal pregnancy reveals no specific abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26198/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Serum proteins and lipids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of hemodilution, serum albumin levels decrease during the first trimester. The decrement becomes more accentuated as the pregnancy advances [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26198/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum total cholesterol and triglyceride concentrations increase markedly during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26198/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. As a result, assessing the patient's lipid profile may be misleading.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Liver tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal pregnancy may affect some liver biochemical tests (",
"    <a class=\"graphic graphic_table graphicRef80006 \" href=\"UTD.htm?10/57/11163\">",
"     table 2",
"    </a>",
"    ). The changes in laboratory values during pregnancy are illustrated by one study, which compared liver function tests in 103 pregnant women with matched controls who were not taking oral contraceptives [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26198/abstract/4\">",
"     4",
"    </a>",
"    ]. An understanding of these changes may be important in the assessment of liver disease in pregnancy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      As noted above, serum albumin was significantly lower in all trimesters due to hemodilution.",
"     </li>",
"     <li>",
"      Serum alkaline phosphatase concentrations were significantly higher (up to two to four times normal) in the third trimester. This is primarily due to placental alkaline phosphatase. Serum gammaglutamyl transpeptidase levels are reduced, and 5'-nucleotidase levels are slightly increased, indicating that the excess alkaline phosphatase is not derived from the liver. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19353?source=see_link\">",
"       \"Enzymatic measures of cholestasis (eg, alkaline phosphatase, 5&rsquo;-nucleotidase, gamma-glutamyl transpeptidase)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Serum alanine aminotransferase levels were slightly higher in the second trimester, but the values were within the normal ranges. There were no differences in serum aspartate aminotransferase levels.",
"     </li>",
"     <li>",
"      Total and free bilirubin concentrations were lower in all three trimesters, while conjugated bilirubin was lower during the second and third trimester. Total bile acid concentrations were not significantly different.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These findings suggest that in normal pregnancy, most liver biochemical tests are either normal or slightly increased or decreased but within the normal range. Thus, an increase in serum aminotransferase, bilirubin, or fasting total bile acid concentrations during pregnancy may be pathologic and should prompt further evaluation. On the other hand, hypoalbuminemia and an elevation in serum alkaline phosphatase may be a normal component of pregnancy and, if within the above ranges, do not usually indicate the presence of liver disease. The prothrombin time is unchanged during pregnancy, and serum fibrinogen increases in late pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PATTERNS OF HEPATOBILIARY DISEASE IN PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cardinal features of hepatobiliary disease can include jaundice, pruritus, abdominal pain, nausea, vomiting, and a variety of liver biochemical test abnormalities. Most are not unique to pregnancy. However, specific patterns that occur during a particular trimester may lead to easy recognition of the underlying disease. As an example, hyperemesis gravidarum, characterized by nausea, vomiting and mild to moderate elevations in serum aminotransferases and bilirubin, typically has its onset in the first trimester. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/15/41207?source=see_link\">",
"     \"Clinical features and evaluation of nausea and vomiting of pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nevertheless, careful evaluation for other disorders that can produce similar symptoms and laboratory abnormalities is prudent. Patients with viral hepatitis, for example, may present with nausea, vomiting, and liver biochemical abnormalities. Furthermore, while specific diseases are typically confined to a particular trimester, exceptions occur. As an example, acute fatty liver of pregnancy usually occurs in the latter part of the third trimester, but can be seen as early as early as 26 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26198/abstract/7\">",
"     7",
"    </a>",
"    ]. In addition, some diseases that occur during the third trimester can also present postpartum, especially preeclampsia or HELLP syndrome.",
"   </p>",
"   <p>",
"    As in the nonpregnant patient, a practical approach for evaluating suspected hepatobiliary disease involves a systematic search for patterns that are characteristic of a particular disease, and judicious diagnostic testing to exclude other causes (",
"    <a class=\"graphic graphic_table graphicRef50080 \" href=\"UTD.htm?38/29/39387\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    When evaluating a pregnant patient with suspected hepatobiliary disease, it is important to ask specific questions about the past medical history, including prior pregnancies. Patients with abnormalities in liver biochemical tests may recall that these were present prior to the pregnancy. Similarly, a history of injection drug use or transfusion provides a risk factor for chronic viral hepatitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ROLE OF A LIVER BIOPSY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A liver biopsy is rarely necessary for the diagnosis of the liver diseases that are specific to pregnancy, such as HELLP syndrome and acute fatty liver of pregnancy. (See appropriate topic reviews). Because it is invasive, a liver biopsy should be performed only when the diagnosis is in doubt and the results could influence treatment or the timing of delivery. One example is a patient who has an atypical presentation of acute fatty liver of pregnancy early in the third trimester. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/38/24166?source=see_link\">",
"     \"Acute fatty liver of pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A percutaneous liver biopsy with ultrasound guidance can be performed safely during pregnancy in patients who otherwise do not have contraindications [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26198/abstract/8\">",
"     8",
"    </a>",
"    ]. If coagulation disorders are present, a transjugular liver biopsy can be performed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29608?source=see_link\">",
"     \"Percutaneous, fine-needle aspiration, and laparoscopic liver biopsy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/37/9814?source=see_link\">",
"     \"Transjugular liver biopsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Clinical scenarios",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following clinical examples demonstrate the approach to diagnosing specific disorders in pregnant women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     A patient with elevated aminotransferases",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 26-year-old woman gravida 3 para 2 currently in her 14th week with a singleton gestation is hospitalized with intractable nausea, vomiting, and dehydration. During her two prior pregnancies, she also had severe nausea and vomiting, which resolved early in the second trimester. Her past medical history is otherwise unremarkable. She has not traveled in the past year, and does not take any medications (including over-the-counter agents and herbal compounds) other than prenatal vitamins and folate. Her physical examination is notable for dry mucus membranes, and a gravid uterus. She has no abdominal pain, and does not have a palpable liver or spleen.",
"   </p>",
"   <p>",
"    Her initial laboratory examination reveals elevations in serum aminotransferases ALT (175",
"    <span class=\"nowrap\">",
"     IU/L),",
"    </span>",
"    AST (122",
"    <span class=\"nowrap\">",
"     IU/L),",
"    </span>",
"    serum total bilirubin (2.1",
"    <span class=\"nowrap\">",
"     mg/dL).",
"    </span>",
"    Amylase and lipase are normal. The albumin is slightly decreased from normal values, but consistent with pregnancy. Liver biochemical tests prior to pregnancy are not available. A right upper quadrant ultrasound is normal. Urinalysis shows elevated ketones. Serology for hepatitis A, B, and C is negative, antinuclear antibodies are absent, and serum protein electrophoresis is normal (making autoimmune hepatitis unlikely). TSH is normal. Obstetrical ultrasound examination demonstrates a normal singleton gestation.",
"   </p>",
"   <p>",
"    The patient is treated with antiemetics and intravenous fluids and improves clinically. Over the next few weeks, her symptoms continue to be present, but remain tolerable and do not require hospitalization. Her serum aminotransferases decline to the low 100s, and serum bilirubin normalizes. At 20 weeks of gestation, her symptoms completely abate, and her liver biochemical tests return to normal.",
"   </p>",
"   <p>",
"    This patient's clinical course and occurrence of symptoms early during pregnancy are consistent with hyperemesis gravidarum. Exclusion of viral or autoimmune hepatitis helps assure that these conditions are not causing or contributing to the liver disease. Elevations in the serum aminotransferases are typically less than 200",
"    <span class=\"nowrap\">",
"     IU/L,",
"    </span>",
"    often with the serum ALT being greater than the serum AST. A right upper quadrant ultrasound demonstrated normal appearing hepatic parenchyma without biliary duct dilation. The patient's history helps to exclude drug toxicity, which may give rise to similar liver biochemical abnormalities. The normal obstetrical ultrasound excludes hydatidiform mole and multiple gestation as causes of her symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/15/41207?source=see_link\">",
"     \"Clinical features and evaluation of nausea and vomiting of pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     A patient with intractable itching",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 23-year-old woman gravida 2 para 1 currently at 35 weeks with a singleton gestation is referred from a dermatologist for intractable itching. The itching is primarily on the palms of her hands and soles of her feet. It is present day and night, and keeps her from sleeping. The patient also had itching during her first pregnancy in which the fetus died in utero in the third trimester. She states no explanation was given for the fetal demise and the pregnancy was otherwise uncomplicated. Autopsy and karyotype of the fetus were normal. She has no known prior history of liver disease or risk factors for viral hepatitis. Her physical examination is notable for numerous skin excoriations related to scratching and a gravid uterus. She has no abdominal pain and a nonpalpable liver or spleen.",
"   </p>",
"   <p>",
"    Laboratory evaluation is notable for elevations of serum aminotransferases, alkaline phosphatase, and total bilirubin (ALT 1201",
"    <span class=\"nowrap\">",
"     IU/L,",
"    </span>",
"    AST 910",
"    <span class=\"nowrap\">",
"     IU/L",
"    </span>",
"    total bilirubin 3.1",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    alkaline phosphatase 400",
"    <span class=\"nowrap\">",
"     IU/L).",
"    </span>",
"    The GGTP is normal, but total serum bile acid concentrations are 10 times normal. Viral hepatitis serologies are negative. A right upper quadrant ultrasound is normal.",
"   </p>",
"   <p>",
"    This patient's clinical presentation is consistent with intrahepatic cholestasis of pregnancy (ICP). Serologic testing excluded viral hepatitis, and the high level of aminotransferases with normal GGTP makes primary biliary cirrhosis unlikely. The absence of abdominal pain, fever, or biliary duct dilation helped exclude choledocholithiasis and cholangitis. The patient's prior history of itching during pregnancy is helpful, since intrahepatic cholestasis of pregnancy tends to recur. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Recurrence in subsequent pregnancies'",
"    </a>",
"    below.) Intrauterine demise during her prior pregnancy may reflect the adverse fetal outcomes associated with this condition and should prompt her clinician to advise increased fetal monitoring with consideration of early delivery. We suggest the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12373?source=see_link\">",
"     ursodeoxycholic acid",
"    </a>",
"    in patients with ICP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4617?source=see_link\">",
"     \"Intrahepatic cholestasis of pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     A patient with preeclampsia",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 23-year-old woman gravida 1 para 0 currently with twin gestations at 32 weeks is hospitalized with hypertension, for which",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/15/28918?source=see_link\">",
"     methyldopa",
"    </a>",
"    had been prescribed earlier in her pregnancy. Despite treatment, she continues to be mildly hypertensive and is developing a progressive rise in serum aminotransferases, which are over 85",
"    <span class=\"nowrap\">",
"     IU/L.",
"    </span>",
"    Hepatitis serology and markers for autoimmune hepatitis are negative. Her platelet count, peripheral blood smear, urinalysis, and right upper quadrant ultrasound are normal.",
"   </p>",
"   <p>",
"    The differential diagnosis in this case includes preeclampsia, toxicity due to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/15/28918?source=see_link\">",
"     methyldopa",
"    </a>",
"    and early acute fatty liver of pregnancy. Considering the above differential diagnosis and the early gestational age, a reasonable approach would be to discontinue the methyldopa, place her on bed rest, control her hypertension with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35544?source=see_link\">",
"     labetalol",
"    </a>",
"    , and administer corticosteroids to promote fetal lung maturity. The patient should be closely monitored in the hospital. Progressive reductions in aminotransferase concentrations would suggest that she either had toxicity due to methyldopa or early preeclampsia controlled by bed rest.",
"   </p>",
"   <p>",
"    After 48 hours, the patient develops proteinuria, progressive thrombocytopenia, worsening hypertension, and a headache; and her serum aminotransferase concentrations continue to rise, suggesting severe preeclampsia or HELLP syndrome. This constellation of findings warrants delivery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/30/17897?source=see_link\">",
"     \"HELLP syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/20/27978?source=see_link\">",
"     \"Preeclampsia: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26373073\">",
"    <span class=\"h3\">",
"     A patient with nausea and vomiting in the third trimester",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 32 year-old woman gravida 1 para 0 with a singleton gestation at 34 weeks of gestation is admitted to the hospital with a three-day history of nausea and vomiting, malaise, and jaundice. Her blood pressure is mildly elevated. Urinalysis shows trace protein, serum aminotransferases range between 200 to 500",
"    <span class=\"nowrap\">",
"     IU/L,",
"    </span>",
"    serum glucose is in the low-normal range. White blood cell count and prothrombin time are elevated. She denies any recent travel. Hepatitis serologies were sent, but are unavailable.",
"   </p>",
"   <p>",
"    The patient most likely has acute fatty liver of pregnancy. The differential diagnoses include HELLP syndrome and atypical preeclampsia, though the coagulopathy and jaundice and clinical symptoms support the diagnosis of acute fatty liver. Treatment would include correction of coagulopathy, monitoring glucose, assessment for encephalopathy, and delivery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/38/24166?source=see_link\">",
"     \"Acute fatty liver of pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/30/17897?source=see_link\">",
"     \"HELLP syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/20/27978?source=see_link\">",
"     \"Preeclampsia: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     RECURRENCE IN SUBSEQUENT PREGNANCIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The expectant mother who has developed an illness during pregnancy will not only have concerns over the well-being of the fetus but, with those diseases that are unique to pregnancy, will want to understand the likelihood of recurrence during subsequent pregnancies. These diseases include hyperemesis gravidarum, intrahepatic cholestasis of pregnancy, acute fatty liver of pregnancy, and preeclampsia which can be complicated by the HELLP syndrome (see appropriate topic reviews).",
"   </p>",
"   <p>",
"    Although it is not possible to predict the risk of recurrence in individual patients, the following general conclusions can be made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intrahepatic cholestasis recurs in 60 to 70 percent of subsequent pregnancies.",
"     </li>",
"     <li>",
"      Acute fatty liver of pregnancy can recur in subsequent pregnancies, even if the search of mutation of HADHA gene coding subunit long-chain 3-hydroxyacyl coenzyme A dehydrogenase (LCHAD) is negative. The frequency of recurrence is unclear.",
"     </li>",
"     <li>",
"      Hyperemesis gravidarum with liver involvement may recur in subsequent pregnancies, but the risk of such liver involvement is unclear.",
"     </li>",
"     <li>",
"      The rate of recurrence varies with the clinical setting in preeclampsia, ranging from 5 to 7 percent in uncomplicated preeclampsia at term in primigravidas to as high as 65 to 75 percent in those with severe preeclampsia, especially if occurring in the second trimester. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13434?source=see_link&amp;anchor=H3#H3\">",
"       \"Management of hypertension in pregnant and postpartum women\", section on 'Preeclampsia'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pregnancy is associated with many normal physiologic changes that must be considered in the diagnosis of hepatobiliary diseases. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'The liver during normal pregnancy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The cardinal features of hepatobiliary disease may include jaundice, pruritus, abdominal pain, nausea, vomiting, and a variety of liver biochemical test abnormalities. Most are not unique to pregnancy. However, specific patterns that occur during a particular trimester may lead to easy recognition of the underlying disease.",
"     </li>",
"     <li>",
"      Hyperemesis gravidarum should be considered in the differential diagnosis of abnormal liver tests presenting in the first trimester. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/15/41207?source=see_link\">",
"       \"Clinical features and evaluation of nausea and vomiting of pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Intrahepatic cholestasis of pregnancy should be considered in patients with pruritus and abnormal liver tests, especially in late pregnancy. Affected pregnancies are at increased risk for prematurity and stillbirth. Treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12373?source=see_link\">",
"       ursodeoxycholic acid",
"      </a>",
"      and early delivery should be considered. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4617?source=see_link\">",
"       \"Intrahepatic cholestasis of pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acute fatty liver of pregnancy, preeclampsia, and HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome should be considered in late pregnancy, especially in the third trimester. Patients with acute fatty liver of pregnancy can develop liver failure. Delivery is the primary treatment. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/38/24166?source=see_link\">",
"       \"Acute fatty liver of pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Viral or drug-induced hepatitis should be considered in any of the trimesters of pregnancy.",
"     </li>",
"     <li>",
"      A practical approach for evaluating suspected hepatobiliary disease involves a systematic search for patterns that are characteristic of a particular disease and judicious diagnostic testing to exclude other causes. Common clinical scenarios are presented above. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical scenarios'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When evaluating a pregnant patient with suspected hepatobiliary disease, it is important to ask specific questions about the past medical history, including prior pregnancies. Patients with abnormalities in liver biochemical tests may recall that these were present prior to the pregnancy.",
"     </li>",
"     <li>",
"      Liver biopsy is rarely necessary for the diagnosis of liver diseases occurring during pregnancy. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Role of a liver biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk of recurrence during subsequent pregnancies is variable. It may not be possible to accurately predict the risk in individual patients. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Recurrence in subsequent pregnancies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H117173799\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the death of Marshall M. Kaplan, MD, who passed away in September 2012. UpToDate wishes to acknowledge Dr. Kaplan's many contributions to our program, in particular, his work on this topic as our Section Editor for Alcoholic and Metabolic Liver Disease.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26198/abstract/1\">",
"      Ch'ng CL, Morgan M, Hainsworth I, Kingham JG. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002; 51:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26198/abstract/2\">",
"      Riely CA. Liver disease in the pregnant patient. American College of Gastroenterology. Am J Gastroenterol 1999; 94:1728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26198/abstract/3\">",
"      ANTIA FP, BHARADWAJ TP, WATSA MC, MASTER J. Liver in normal pregnancy, pre-eclampsia, and eclampsia. Lancet 1958; 2:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26198/abstract/4\">",
"      Bacq Y, Zarka O, Br&eacute;chot JF, et al. Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology 1996; 23:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26198/abstract/5\">",
"      Potter JM, Nestel PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 1979; 133:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26198/abstract/6\">",
"      Brizzi P, Tonolo G, Esposito F, et al. Lipoprotein metabolism during normal pregnancy. Am J Obstet Gynecol 1999; 181:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26198/abstract/7\">",
"      Buytaert IM, Elewaut GP, Van Kets HE. Early occurrence of acute fatty liver in pregnancy. Am J Gastroenterol 1996; 91:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26198/abstract/8\">",
"      Knox TA. Evaluation of abnormal liver function in pregnancy. Semin Perinatol 1998; 22:98.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3563 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-A392849A5D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26198=[""].join("\n");
var outline_f25_37_26198=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      THE LIVER DURING NORMAL PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Ultrasound examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Serum proteins and lipids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Liver tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PATTERNS OF HEPATOBILIARY DISEASE IN PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ROLE OF A LIVER BIOPSY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Clinical scenarios",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - A patient with elevated aminotransferases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - A patient with intractable itching",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - A patient with preeclampsia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26373073\">",
"      - A patient with nausea and vomiting in the third trimester",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      RECURRENCE IN SUBSEQUENT PREGNANCIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H117173799\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/3563\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/3563|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/53/23387\" title=\"table 1\">",
"      ACG guidelines liver disease during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/57/11163\" title=\"table 2\">",
"      Liver test normal pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/29/39387\" title=\"table 3\">",
"      Dx liver disease pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/38/24166?source=related_link\">",
"      Acute fatty liver of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/15/41207?source=related_link\">",
"      Clinical features and evaluation of nausea and vomiting of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19353?source=related_link\">",
"      Enzymatic measures of cholestasis (eg, alkaline phosphatase, 5&rsquo;-nucleotidase, gamma-glutamyl transpeptidase)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/30/17897?source=related_link\">",
"      HELLP syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14726?source=related_link\">",
"      Intercurrent hepatobiliary disease during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4617?source=related_link\">",
"      Intrahepatic cholestasis of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13434?source=related_link\">",
"      Management of hypertension in pregnant and postpartum women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29608?source=related_link\">",
"      Percutaneous, fine-needle aspiration, and laparoscopic liver biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/20/27978?source=related_link\">",
"      Preeclampsia: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22777?source=related_link\">",
"      Pregnancy in women with pre-existing chronic liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/37/9814?source=related_link\">",
"      Transjugular liver biopsy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_37_26199="Systemic therapy for poor performance status patients with advanced non-small cell lung cancer";
var content_f25_37_26199=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Systemic therapy for poor performance status patients with advanced non-small cell lung cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26199/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26199/contributors\">",
"     Rogerio C Lilenbaum, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26199/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26199/contributors\">",
"     James R Jett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26199/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26199/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/37/26199/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 29, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of patients with lung cancer depends upon the cell type (non-small cell lung cancer [NSCLC] versus small cell lung cancer), extent of disease (stage), molecular characteristics, and an assessment of the patient's overall medical condition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/61/13273?source=see_link\">",
"     \"Overview of the initial evaluation, treatment and prognosis of lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with stage I, II, or III NSCLC are generally treated with curative intent using surgery, radiation therapy (RT), or a combined modality approach that incorporates systemic therapy (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ). In contrast, palliative systemic therapy may be appropriate for patients with disseminated (stage IV) disease as well as those who have relapsed following prior definitive treatment.",
"   </p>",
"   <p>",
"    Patients with a borderline or poor performance status (ie, ECOG PS &ge;2 [(",
"    <a class=\"graphic graphic_table graphicRef72901 \" href=\"UTD.htm?9/15/9467\">",
"     table 2",
"    </a>",
"    )] or Karnofsky Performance Status (KPS) &le;70 [(",
"    <a class=\"graphic graphic_table graphicRef58785 \" href=\"UTD.htm?2/11/2236\">",
"     table 3",
"    </a>",
"    )]) comprise about 30 to 40 percent of patients with advanced NSCLC [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/1\">",
"     1",
"    </a>",
"    ]. Such patients have been excluded from most clinical trials and have often been managed with less aggressive systemic therapy or with best supportive care (BSC) alone [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Systemic therapy for poor performance status patients with advanced NSCLC will be reviewed here. Other relevant topics presented separately include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/57/21401?source=see_link\">",
"       \"Overview of the treatment of advanced non-small cell lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/54/34666?source=see_link\">",
"       \"Initial systemic chemotherapy for advanced non-small cell lung cancer without an epidermal growth factor receptor mutation or the ALK fusion oncogene\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31816?source=see_link\">",
"       \"Initial systemic therapy for advanced non-small cell lung cancer with a mutation in the epidermal growth factor receptor\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40440?source=see_link\">",
"       \"Anaplastic lymphoma kinase (ALK) fusion oncogene positive non-small cell lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/34/9768?source=see_link\">",
"       \"Advanced non-small cell lung cancer: Maintenance therapy after initial chemotherapy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36455?source=see_link\">",
"       \"Systemic therapy for advanced non-small cell lung cancer in elderly patients and patients with a poor performance status\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/36/40520?source=see_link\">",
"       \"Second-line therapy for patients with previously treated advanced non-small cell lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H525781721\">",
"    <span class=\"h1\">",
"     CHEMOTHERAPY VERSUS TARGETED THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Historically, cytotoxic chemotherapy has been the primary option for systemic therapy in patients with advanced NSCLC. Contemporary research has led to the development of agents that target specific pathways involved in the pathogenesis of NSCLC. These include small molecules targeting the epidermal growth factor receptor (EGFR) tyrosine kinase (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/12/19654?source=see_link\">",
"     gefitinib",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/13/36056?source=see_link\">",
"     erlotinib",
"    </a>",
"    ) and tumors containing the ALK fusion oncogene (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/58/30631?source=see_link\">",
"     crizotinib",
"    </a>",
"    ). These agents have become the preferred initial treatment for patients with these molecular abnormalities.",
"   </p>",
"   <p>",
"    Whenever possible, therapy should be individualized based upon the molecular and histologic features of the tumor. Patients should have tumor tissue assessed for the presence of a somatic mutation in the epidermal growth factor receptor (EGFR), which confers sensitivity to EGFR tyrosine kinase inhibitors, and for the anaplastic lymphoma kinase (ALK) fusion oncogene, which confers sensitivity to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/58/30631?source=see_link\">",
"     crizotinib",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40440?source=see_link&amp;anchor=H2#H2\">",
"     \"Anaplastic lymphoma kinase (ALK) fusion oncogene positive non-small cell lung cancer\", section on 'Molecular pathogenesis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31816?source=see_link\">",
"     \"Initial systemic therapy for advanced non-small cell lung cancer with a mutation in the epidermal growth factor receptor\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patient management is then dictated by the results of these molecular studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with an EGFR mutation are managed with an EGFR tyrosine kinase inhibitor (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/13/36056?source=see_link\">",
"       erlotinib",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/12/19654?source=see_link\">",
"       gefitinib",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31816?source=see_link\">",
"       \"Initial systemic therapy for advanced non-small cell lung cancer with a mutation in the epidermal growth factor receptor\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Those with an ALK fusion oncogene in their tumor are preferentially treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/58/30631?source=see_link\">",
"       crizotinib",
"      </a>",
"      . (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40440?source=see_link\">",
"       \"Anaplastic lymphoma kinase (ALK) fusion oncogene positive non-small cell lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients without a mutation in EGFR or the ALK fusion oncogene are generally treated with chemotherapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/54/34666?source=see_link\">",
"       \"Initial systemic chemotherapy for advanced non-small cell lung cancer without an epidermal growth factor receptor mutation or the ALK fusion oncogene\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7872498\">",
"    <span class=\"h1\">",
"     POOR PERFORMANCE STATUS PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with a poor performance status (ie, ECOG PS &ge;2 (",
"    <a class=\"graphic graphic_table graphicRef72901 \" href=\"UTD.htm?9/15/9467\">",
"     table 2",
"    </a>",
"    ) or Karnofsky Performance Status (KPS) &le;70 (",
"    <a class=\"graphic graphic_table graphicRef58785 \" href=\"UTD.htm?2/11/2236\">",
"     table 3",
"    </a>",
"    )) comprise about 30 to 40 percent of patients with advanced NSCLC [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/1\">",
"     1",
"    </a>",
"    ]. Impaired performance status may be due to either the NSCLC or to unrelated comorbidity.",
"   </p>",
"   <p>",
"    Older cooperative group studies suggested that poor performance status patients (Eastern Cooperative Oncology Group [ECOG] performance status [PS] &ge;2 or a Karnofsky Performance Status [KPS] &le;70) derived little or no benefit from systemic chemotherapy and had high rates of treatment-related morbidity and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/4\">",
"     4",
"    </a>",
"    ]. However, more recent trials that have focused specifically upon patients with a poor performance status indicate that some patients do benefit from treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/2,5-12\">",
"     2,5-12",
"    </a>",
"    ]. The approach to these patients using cytotoxic chemotherapy has generally focused on single agent therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Trials specifically targeting patients with performance status 2 indicate that some poor performance status patients benefit from an aggressive approach to treatment, using either cytotoxic chemotherapy or targeted therapy if an appropriate somatic mutation is identified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CYTOTOXIC CHEMOTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data from contemporary clinical trials indicate that platinum-based doublet chemotherapy is more effective than single agent therapy in prolonging survival and that this can be achieved without excessive toxicity.",
"   </p>",
"   <p>",
"    The most extensive data on the role of combination versus single agent cytotoxic chemotherapy in poor performance status patients come from a randomized trial in which 205 eligible patients were treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    (500",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    with or without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    (at an AUC of 5) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/13\">",
"     13",
"    </a>",
"    ]. Chemotherapy cycles were repeated every three weeks for four cycles. All patients had stage IIIB or IV disease, were performance status 2, and had received no prior chemotherapy. Approximately one-third of patients were 70 years of age or older. The trial was initially open to all patients with NSCLC but was subsequently amended to exclude those with squamous cell histology; ultimately the trial included 14 patients (7 percent) with squamous histology.",
"   </p>",
"   <p>",
"    Results of the trial were presented at the 2012 American Society of Clinical Oncology (ASCO) meeting based upon a median follow-up of six months:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Overall survival was significantly increased with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/27/36279?source=see_link\">",
"       pemetrexed",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"       carboplatin",
"      </a>",
"      compared with pemetrexed alone (median 9.1 versus 5.6 months, 12 month survival rate 43 versus 18 percent, HR 0.57, 95% CI 0.41-0.79).",
"     </li>",
"     <li>",
"      Progression-free survival was significantly increased (5.9 versus 3.0 months, 18 versus 4 percent at 12 months, HR 0.46).",
"     </li>",
"     <li>",
"      The objective response rate (complete plus partial) was significantly increased (24 versus 11 percent).",
"     </li>",
"     <li>",
"      Grade 3 or 4 hematologic toxicity was increased with the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/27/36279?source=see_link\">",
"       pemetrexed",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"       carboplatin",
"      </a>",
"      combination compared with pemetrexed alone, including anemia (12 versus 4 percent), neutropenia (6 versus 1 percent), and thrombocytopenia (1 versus 0 percent). There were four deaths (3.9 percent) attributed to therapy on the combined modality treatment arm and none on the single agent treatment arm.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Subset analyses from two larger trials also support the benefit of combination rather than single agent chemotherapy. In 123 elderly patients with performance status 2 in a French intergroup trial,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    was superior to single agent chemotherapy (hazard ratios 0.63) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/14\">",
"     14",
"    </a>",
"    ]. Similarly, a subset analysis of 99 patients with performance status 2 in the the CALGB 9730 trial also observed an improvement in overall survival with the combination of carboplatin plus paclitaxel compared with paclitaxel alone (median overall survival 4.7 versus 2.4 months, HR 0.60, 95% CI 0.40-0.91) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional indirect supportive data come from two other trials that were conducted exclusively in poor performance status patients [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/12\">",
"     12",
"    </a>",
"    ]. In one trial, 400 patients were randomly assigned to either standard chemotherapy (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    ) or a combination of carboplatin plus an alternative formulation of paclitaxel [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/10\">",
"     10",
"    </a>",
"    ]. In the other trial, 400 patients were randomly assigned to single agent chemotherapy",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"     gemcitabine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/59/953?source=see_link\">",
"     vinorelbine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/11\">",
"     11",
"    </a>",
"    ]. The identical trial eligibility criteria and simultaneous conduct allowed a secondary analysis comparing single agent versus combination therapy using the standard regimens in 391 poor performance status patients [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Key observations of this analysis included the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Combination chemotherapy resulted in a significantly higher objective response rate than single agent therapy (38 versus 16 percent).",
"     </li>",
"     <li>",
"      Time to progression was significantly increased with combination chemotherapy (4.6 versus 3.5 months). However, the difference in overall survival was not statistically significant (median 8.0 versus 6.6 months, one-year survival 31 versus 26 percent).",
"     </li>",
"     <li>",
"      Toxicity was more severe with the combination regimen, including the incidence of serious or life-threatening adverse events (40 versus 23 percent) and treatment-related deaths (2 versus 0 percent).",
"     </li>",
"     <li>",
"      Multivariate analysis identified four factors that were significantly associated with a worse outcome. These included a serum albumin &le;3.5",
"      <span class=\"nowrap\">",
"       g/dL,",
"      </span>",
"      serum LDH &gt;200 international",
"      <span class=\"nowrap\">",
"       units/L,",
"      </span>",
"      extrathoracic metastases, and the presence of two or more comorbid conditions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H599790950\">",
"    <span class=\"h2\">",
"     Chemotherapy plus bevacizumab",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"     Bevacizumab",
"    </a>",
"    does not currently have a role in the treatment of poor performance status patients. Both of the phase III trials that demonstrated a benefit with bevacizumab were limited to patients with PS 0 or 1 [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. Furthermore, the addition of bevacizumab to chemotherapy in elderly patients was associated with increased toxicity without an overall survival benefit, and there are concerns that excess toxicity in poor performance patients may also counterbalance any increase in antitumor activity. The potential role of bevacizumab in patients with a poor performance status is being investigated in the ToPPS trial, in which patients are randomly assigned to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    , pemetrexed plus bevacizumab, or pemetrexed,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    , plus bevacizumab (NCT00892710) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36455?source=see_link&amp;anchor=H525780428#H525780428\">",
"     \"Systemic therapy for advanced non-small cell lung cancer in elderly patients and patients with a poor performance status\", section on 'Chemotherapy plus bevacizumab'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/54/34666?source=see_link\">",
"     \"Initial systemic chemotherapy for advanced non-small cell lung cancer without an epidermal growth factor receptor mutation or the ALK fusion oncogene\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H599790958\">",
"    <span class=\"h2\">",
"     Guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Older guidelines from the American Society of Clinical Oncology (ASCO) and a European experts panel have recommended single-agent chemotherapy for patients with advanced NSCLC who have a poor performance status (PS 2 or KPS &le;70) for therapy of advanced NSCLC [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. However, our general approach based upon these more recent results is to use platinum-based doublet chemotherapy with a regimen such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    if the treating physician thinks that the doublet therapy will be tolerated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EGFR MUTATION POSITIVE PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidermal growth factor receptor (EGFR) tyrosine kinase (TK) inhibitors (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/13/36056?source=see_link\">",
"     erlotinib",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/12/19654?source=see_link\">",
"     gefitinib",
"    </a>",
"    ) have important activity as initial therapy in patients with advanced NSCLC selected based upon the presence of a somatic mutation in EGFR. (See",
"    <a class=\"local\" href=\"#H525781721\">",
"     'Chemotherapy versus targeted therapy'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31816?source=see_link\">",
"     \"Initial systemic therapy for advanced non-small cell lung cancer with a mutation in the epidermal growth factor receptor\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Single agent EGFR TK inhibitors can have a dramatic benefit in poor performance status patients whose tumors contain a mutation in EGFR [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/19\">",
"     19",
"    </a>",
"    ]. As an example, in a Japanese study, 30 poor performance status patients with previously untreated, advanced NSCLC and an EGFR mutation known to confer sensitivity to TK inhibitors were treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/12/19654?source=see_link\">",
"     gefitinib",
"    </a>",
"    (250",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/20\">",
"     20",
"    </a>",
"    ]. Partial or complete responses were observed in 19 of 29 evaluable patients (66 percent). Among the 22 patients with a performance status &ge;3, 15 (68 percent) improved to a performance status &le;1. The median progression-free survival, median overall survival, and one-year survival rates for the entire cohort were 6.5 months, 18 months, and 63 percent, respectively.",
"   </p>",
"   <p>",
"    EGFR TK inhibitors do not have significant activity in patients without EGFR mutations. Three randomized trials in previously untreated patients with a poor performance status (PS &ge;2) who were not selected based upon EGFR mutation status failed to provide any evidence of benefit from treatment with EGFR TK inhibitors compared with chemotherapy or best supportive care [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26199/abstract/21-23\">",
"     21-23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H272524676\">",
"    <span class=\"h1\">",
"     ALK FUSION ONCOGENE POSITIVE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of the ALK fusion oncogene conferred sensitivity to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/58/30631?source=see_link\">",
"     crizotinib",
"    </a>",
"    , a specific inhibitor of the anaplastic lymphoma kinase (ALK) tyrosine kinase, in phase II studies. Although these studies contained only a limited number of patients with a poor performance status, this approach is preferred for these patients because of the high activity of crizotinib in this setting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40440?source=see_link\">",
"     \"Anaplastic lymphoma kinase (ALK) fusion oncogene positive non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/44/3779?source=see_link\">",
"       \"Patient information: Non-small cell lung cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/22/41314?source=see_link\">",
"       \"Patient information: Non-small cell lung cancer treatment; stage I to III cancer (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?16/63/17396?source=see_link\">",
"       \"Patient information: Non-small cell lung cancer treatment; stage IV cancer (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Poor performance status patients with advanced non-small cell lung cancer (NSCLC) may benefit from systemic treatments that are used in young, good performance status patients. The decision of whether to use systemic antitumor therapy or to provide only best supportive care requires consideration of the patient's overall condition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/57/21401?source=see_link\">",
"     \"Overview of the treatment of advanced non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Whenever possible, therapy should be individualized based upon molecular and histologic features of the tumor. If feasible, patients should have tumor tissue assessed for the presence of a somatic mutation in the epidermal growth factor receptor (EGFR) or the presence of the ALK fusion oncogene, which confer sensitivity to targeted tyrosine kinase (TK) inhibitors. (See",
"      <a class=\"local\" href=\"#H525781721\">",
"       'Chemotherapy versus targeted therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with a poor performance status (Eastern Cooperative Oncology Group PS 2, (",
"      <a class=\"graphic graphic_table graphicRef72901 \" href=\"UTD.htm?9/15/9467\">",
"       table 2",
"      </a>",
"      ), or Karnofsky performance status (KPS) 60 to 70, (",
"      <a class=\"graphic graphic_table graphicRef58785 \" href=\"UTD.htm?2/11/2236\">",
"       table 3",
"      </a>",
"      )), and without a sensitizing molecular abnormality, we recommend cytotoxic chemotherapy rather than targeted therapy (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). We suggest treatment with a platinum-based doublet such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"       carboplatin",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/27/36279?source=see_link\">",
"       pemetrexed",
"      </a>",
"      rather than single agent chemotherapy if the treating physician thinks that a combination regimen will be tolerated (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Single agent chemotherapy remains an option for those not thought to be candidates for doublet chemotherapy. The use of pemetrexed should be restricted to patients with nonsquamous histology. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Cytotoxic chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with a poor performance status (PS &ge;2) and a known sensitivity mutation in the EGFR receptor, we recommend single agent therapy with an EGFR inhibitor (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/13/36056?source=see_link\">",
"       erlotinib",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/12/19654?source=see_link\">",
"       gefitinib",
"      </a>",
"      ) rather than chemotherapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For poor performance status patients whose tumors contain an ALK fusion oncogene, we recommend initial therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/58/30631?source=see_link\">",
"       crizotinib",
"      </a>",
"      rather than chemotherapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H272524676\">",
"       'ALK fusion oncogene positive'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40440?source=see_link&amp;anchor=H11#H11\">",
"       \"Anaplastic lymphoma kinase (ALK) fusion oncogene positive non-small cell lung cancer\", section on 'Crizotinib'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36455?source=see_link&amp;anchor=H272524038#H272524038\">",
"       \"Systemic therapy for advanced non-small cell lung cancer in elderly patients and patients with a poor performance status\", section on 'ALK fusion oncogene'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/1\">",
"      Lilenbaum RC, Cashy J, Hensing TA, et al. Prevalence of poor performance status in lung cancer patients: implications for research. J Thorac Oncol 2008; 3:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/2\">",
"      Azzoli CG, Baker S Jr, Temin S, et al. American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 2009; 27:6251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/3\">",
"      Gridelli C, Ardizzoni A, Le Chevalier T, et al. Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel. Ann Oncol 2004; 15:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/4\">",
"      Sweeney CJ, Zhu J, Sandler AB, et al. Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma . Cancer 2001; 92:2639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/5\">",
"      Langer C, Li S, Schiller J, et al. Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599. J Clin Oncol 2007; 25:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/6\">",
"      Baka S, Ashcroft L, Anderson H, et al. Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status &lt;/= 70) and advanced non-small-cell lung cancer. J Clin Oncol 2005; 23:2136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/7\">",
"      Lilenbaum RC, Herndon JE 2nd, List MA, et al. Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol 2005; 23:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/8\">",
"      Lilenbaum R. Management of advanced non-small-cell lung cancer in patients with a performance status of 2. Clin Lung Cancer 2004; 5:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/9\">",
"      Stinchcombe TE, Choi J, Schell MJ, et al. Carboplatin-based chemotherapy in patients with advanced non-small cell lung cancer and a poor performance status. Lung Cancer 2006; 51:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/10\">",
"      Langer CJ, O'Byrne KJ, Socinski MA, et al. Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-na&iuml;ve advanced non-small cell lung cancer. J Thorac Oncol 2008; 3:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/11\">",
"      O'Brien ME, Socinski MA, Popovich AY, et al. Randomized phase III trial comparing single-agent paclitaxel Poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-na&iuml;ve advanced non-small cell lung cancer. J Thorac Oncol 2008; 3:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/12\">",
"      Lilenbaum R, Villaflor VM, Langer C, et al. Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: prognostic factors and treatment selection based on two large randomized clinical trials. J Thorac Oncol 2009; 4:869.",
"     </a>",
"    </li>",
"    <li>",
"     Lilenbaum R, et al. A randomized phase III trial of single agent pemetrexed (P) versus carboplatin and pemetrexed (CP) in patients with advanced non-small cell lung cancer (NSCLC) and performance status (PS) of 2 (suppl: abstract #7506). J Clin Oncol 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/14\">",
"      Quoix E, Zalcman G, Oster JP, et al. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet 2011; 378:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/15\">",
"      Reck M, von Pawel J, Zatloukal P, et al. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil. J Clin Oncol 2009; 27:1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/16\">",
"      Reck M, von Pawel J, Zatloukal P, et al. Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL). Ann Oncol 2010; 21:1804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/17\">",
"      Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006; 355:2542.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.clinicaltrials.gov/.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/19\">",
"      Langer CJ. The \"lazarus response\" in treatment-naive, poor performance status patients with non-small-cell lung cancer and epidermal growth factor receptor mutation. J Clin Oncol 2009; 27:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/20\">",
"      Inoue A, Kobayashi K, Usui K, et al. First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy. J Clin Oncol 2009; 27:1394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/21\">",
"      Lilenbaum R, Axelrod R, Thomas S, et al. Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2. J Clin Oncol 2008; 26:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/22\">",
"      Goss G, Ferry D, Wierzbicki R, et al. Randomized phase II study of gefitinib compared with placebo in chemotherapy-naive patients with advanced non-small-cell lung cancer and poor performance status. J Clin Oncol 2009; 27:2253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26199/abstract/23\">",
"      Lee SM, Rudd R, Khan I, et al. TOPICAL: Randomized phase III trial of erlotinib compared with placebo in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC) and unsuitable for first-line chemotherapy (abstract #7504). J Clin Oncol 2010.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4612 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-201.77.166.39-5917900B73-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26199=[""].join("\n");
var outline_f25_37_26199=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H525781721\">",
"      CHEMOTHERAPY VERSUS TARGETED THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7872498\">",
"      POOR PERFORMANCE STATUS PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CYTOTOXIC CHEMOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H599790950\">",
"      Chemotherapy plus bevacizumab",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H599790958\">",
"      Guidelines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EGFR MUTATION POSITIVE PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H272524676\">",
"      ALK FUSION ONCOGENE POSITIVE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/4612\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/4612|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/41/37533\" title=\"table 1\">",
"      Lung cancer TMN staging 7th edition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/15/9467\" title=\"table 2\">",
"      ECOG performance scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/11/2236\" title=\"table 3\">",
"      Karnofsky performance status scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/34/9768?source=related_link\">",
"      Advanced non-small cell lung cancer: Maintenance therapy after initial chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40440?source=related_link\">",
"      Anaplastic lymphoma kinase (ALK) fusion oncogene positive non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/54/34666?source=related_link\">",
"      Initial systemic chemotherapy for advanced non-small cell lung cancer without an epidermal growth factor receptor mutation or the ALK fusion oncogene",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31816?source=related_link\">",
"      Initial systemic therapy for advanced non-small cell lung cancer with a mutation in the epidermal growth factor receptor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/61/13273?source=related_link\">",
"      Overview of the initial evaluation, treatment and prognosis of lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/57/21401?source=related_link\">",
"      Overview of the treatment of advanced non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/44/3779?source=related_link\">",
"      Patient information: Non-small cell lung cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/22/41314?source=related_link\">",
"      Patient information: Non-small cell lung cancer treatment; stage I to III cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?16/63/17396?source=related_link\">",
"      Patient information: Non-small cell lung cancer treatment; stage IV cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/36/40520?source=related_link\">",
"      Second-line therapy for patients with previously treated advanced non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36455?source=related_link\">",
"      Systemic therapy for advanced non-small cell lung cancer in elderly patients and patients with a poor performance status",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_37_26200="Treatment and outcome of sepsis in term and late preterm infants";
var content_f25_37_26200=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment and outcome of sepsis in term and late preterm infants",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26200/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26200/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26200/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26200/contributors\">",
"     Leonard E Weisman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26200/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26200/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26200/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/37/26200/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sepsis is an important cause of morbidity and mortality among newborn infants. Although the incidence of sepsis in term and late preterm infants is low, the potential for serious adverse outcomes, including death, is of such great consequence that caregivers should have a low threshold for evaluation and treatment for possible sepsis in any infant, regardless of birth weight or gestational age.",
"   </p>",
"   <p>",
"    The treatment and outcome of sepsis in term and late preterm infants will be reviewed here. The epidemiology, clinical features, diagnosis, and evaluation of sepsis in term and late preterm infants are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6410?source=see_link\">",
"     \"Clinical features and diagnosis of sepsis in term and late preterm infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following terms will be used throughout this discussion on neonatal sepsis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neonatal sepsis is a clinical syndrome in an infant 28 days of life or younger, manifested by systemic signs of infection",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      isolation of a bacterial pathogen from the blood stream [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/1\">",
"       1",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Term infants are those born at a gestational age of 37 weeks or greater",
"     </li>",
"     <li>",
"      Late preterm infants (also called near-term infants) are those born between 34 and 36 completed weeks of gestation [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/2\">",
"       2",
"      </a>",
"      ]&nbsp;(see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/11/22713?source=see_link\">",
"       \"Late preterm infants\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Preterm infants are those born at less than 34 weeks of gestation [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/2\">",
"       2",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Sepsis is classified according to the infant's age at the onset of symptoms: early or late. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H2#H2\">",
"     \"Group B streptococcal infection in neonates and young infants\", section on 'Terminology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early-onset sepsis is defined as the onset of symptoms within the first days of life. There is variability of the age at onset with some experts defining early-onset sepsis as bloodstream infection at &le;72 hours of age [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/3\">",
"       3",
"      </a>",
"      ], and others defining early-onset group B streptococcal (GBS) disease as infection with the onset of symptoms through day six of life [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Late-onset sepsis is defined as the onset of symptoms after the first days of life. Similar to early-onset sepsis, there is variability in its definition, ranging from an onset at &gt;72 hours of life to &ge;7 days of age [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/3,4\">",
"       3,4",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANTIBIOTIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the decision to treat neonatal sepsis with antibiotic therapy is made, the following issues need to be addressed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The choice of antibiotics is dependent upon covering the most likely pathogens. If a pathogen is identified, antibiotic therapy should be modified depending upon the susceptibility of the isolate.",
"     </li>",
"     <li>",
"      The duration of therapy is dependent upon culture results, clinical course, and organism",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Empiric antibiotic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Empiric antibiotic therapy should be initiated for infants with suspected sepsis once the evaluation has been completed. The initial choice of parenteral antimicrobials for suspected sepsis in the term and late preterm neonate is based on the infant's age, likely pathogens, the susceptibility patterns of organisms in a particular nursery, and the presence of an apparent source of infection (eg, skin, joint, or bone involvement). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6410?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical features and diagnosis of sepsis in term and late preterm infants\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Early-onset sepsis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The combination of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"     gentamicin",
"    </a>",
"    is effective in treating most of the common pathogens that cause early-onset sepsis, such as group B Streptococcus (GBS) and Escherichia coli (E. coli) (",
"    <a class=\"graphic graphic_table graphicRef61061 \" href=\"UTD.htm?39/3/39996\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. The empirical regimen for suspected early-onset sepsis in a term or late preterm infant &le;7 days of age consists of ampicillin (150",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose, given every 12 hours) and gentamicin (4",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose, given every 24 hours) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Serum gentamicin levels are not required if renal function is normal and a treatment course of only 48 hours is anticipated [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/7,9\">",
"     7,9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Duration and response to therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A lumbar puncture (LP) should be performed, whenever possible, in all infants with a positive blood culture or in whom",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    is continued for longer than 48 hours without a positive blood culture (presumed sepsis). If treatment is continued longer than 48 hours, and meningitis has been excluded, the ampicillin regimen can be changed to 75",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every 12 hours. If treatment is continued longer than 48 hours, and no LP has been performed (or if the infant has meningitis), the ampicillin dose should be changed to 75",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose, given every six hours. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/47/16121?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment and outcome of bacterial meningitis in the neonate\", section on 'Empirical therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several reports have shown the efficacy of this combination [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a review of all reports of early-onset neonatal bacteremia to the Health Protection Agency (HPA) voluntary surveillance scheme in England and Wales from 2006 to 2008, 94 percent of all isolates were susceptible to the combination of penicillin and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a 10-year review from a single Israeli center, 66 of 73 term or late preterm infants (90 percent) had early-onset sepsis pathogens susceptible to",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      , or both. Among six infants with early-onset S. aureus bacteremia that was not susceptible to ampicillin and gentamicin, there were no complications before or after antibiotic therapy was adjusted based upon antibiotic susceptibility [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An alternative regimen of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    and a third-generation cephalosporin (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"     cefotaxime",
"    </a>",
"    ) is not more effective as the combination of ampicillin and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"     gentamicin",
"    </a>",
"    . In addition, the emergence of cephalosporin-resistant strains (eg, Enterobacter cloacae, Klebsiella, and Serratia species) can occur when cefotaxime is used routinely [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/6,12\">",
"     6,12",
"    </a>",
"    ]. In a study using the Pediatrix database, infants with suspected sepsis who received ampicillin plus cefotaxime compared to those treated with ampicillin plus gentamicin had a 1.5-fold increase in mortality rate (4.2 versus 1.9 percent, adjusted odds ratio 1.5, 95% CI 1.4-1.7) and were less likely to be discharged to home or foster care [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"     Ceftriaxone",
"    </a>",
"    is highly bound to albumin and appears to displace bilirubin [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Although no studies have reported any clinical problem of ceftriaxone displacing free bilirubin, it is currently recommended that ceftriaxone not be used in neonates with a risk for acute bilirubin encephalopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/63/25593?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants\", section on 'Neurologic manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Late-onset sepsis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of antimicrobial-resistant pathogens is low in an infant who is rehospitalized from home for suspected sepsis without an apparent focus. The empirical treatment for suspected late-onset sepsis in term or late preterm infants admitted from the community who are greater than seven days of age, consists of parenteral",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    (75",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose, given every six hours) and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"     gentamicin",
"    </a>",
"    (4",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose, given every 24 hours) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/7\">",
"     7",
"    </a>",
"    ]. The previous mentioned study from the HPA voluntary surveillance scheme in England and Wales demonstrated the efficacy of this antibiotic regimen, as 96 percent of isolates from late onset bacteremia were susceptible to the combination of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/49/34583?source=see_link\">",
"     amoxicillin",
"    </a>",
"    and gentamicin [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/11\">",
"     11",
"    </a>",
"    ]. However, 45 percent of late-onset isolates were coagulase-negative staphylococci. In symptomatic preterm patients, and term infants who have been hospitalized since birth, empiric treatment for coagulase-negative staphylococci bacteremia should include",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    . (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Specific therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    An LP should be performed, whenever possible, in all infants in whom",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    is continued for longer than 48 hours. If treatment is continued longer than 48 hours and meningitis has been excluded, the ampicillin regimen can be changed to 75",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every 12 hours. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/47/16121?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment and outcome of bacterial meningitis in the neonate\", section on 'Empirical therapy'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    In infants who continue to be hospitalized since birth, antimicrobial-resistant organisms must be considered as possible etiologic agents in addition to GBS and E. coli. In these patients,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    (15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose, given every eight hours) is substituted for",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Alternative regimens based upon additional clinical factors include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The addition of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"       cefotaxime",
"      </a>",
"      to the regimen of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      if there is a concern for meningitis. Cefotaxime (50",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per dose) is administered every eight hours, and ampicillin (75",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per dose) every six hours. The gentamicin dose is not altered and remains as 4",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per dose administered every 24 hours.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       Vancomycin",
"      </a>",
"      (15",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per dose, given every eight hours) plus",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"       nafcillin",
"      </a>",
"      should be substituted for",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      if S. aureus infection is suspected. S. aureus is more likely in infants with soft tissue, skin, joint, or bone involvement [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/16\">",
"       16",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/18/37159?source=see_link&amp;anchor=H6#H6\">",
"       \"Treatment of Staphylococcus aureus bacteremia in children\", section on 'Empiric therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If intravascular catheter-related infection is a concern, treatment should be initiated with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       vancomycin",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      to provide empiric coverage for coagulase-negative staphylococci, S. aureus, and gram-negative bacteria",
"     </li>",
"     <li>",
"      If infection is thought to arise from organisms found in the gastrointestinal tract (eg, anaerobic bacteria),",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"       clindamycin",
"      </a>",
"      or another suitable agent should be added to the therapeutic regimen to improve coverage for these pathogens.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Specific therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Empirical antimicrobial therapy is altered based upon the isolation of a pathogen and its pattern of antimicrobial susceptibility. Guidelines for the treatment of the most common causative organisms of neonatal meningitis are provided below and are based upon the recommendations of the American Academy of Pediatrics [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Group B streptococcus &ndash; Group B streptococcus (GBS) is uniformly susceptible to penicillin. Thus, when GBS is identified as the sole causative organism, we recommend that antimicrobial therapy be changed to",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/46/14054?source=see_link\">",
"       penicillin G",
"      </a>",
"      alone (",
"      <a class=\"graphic graphic_table graphicRef71720 \" href=\"UTD.htm?5/19/5436\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef66906 \" href=\"UTD.htm?1/32/1549\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H29#H29\">",
"       \"Group B streptococcal infection in neonates and young infants\", section on 'Definitive therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Escherichia coli &ndash; In patients with Escherichia coli (E. coli) sepsis sensitive to",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      who have improved clinically and in whom meningitis has been excluded, ampicillin monotherapy is administered for a 10- to 14-day course. For patients with ampicillin-resistant E. coli, the choice of definitive therapy includes an aminoglycoside, such as",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      , or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"       cefotaxime",
"      </a>",
"      . However, in our practice, we prefer the use of cefotaxime over gentamicin in patients with ampicillin-resistant E. coli because of the potential ototoxicity and nephrotoxicity associated with gentamicin and the need to monitor gentamicin levels. Although there are limited data on the use of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/24/2439?source=see_link\">",
"       meropenem",
"      </a>",
"      in neonates, it is recommended for the treatment of systemic infections caused by extended-spectrum beta-lactamase producing organisms.",
"     </li>",
"     <li>",
"      Other gram-negative bacilli &ndash; Nonmeningeal infections caused by E. coli, Klebsiella, Proteus, Salmonella, or Shigella can be treated with a single agent, such as",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"       cefotaxime",
"      </a>",
"      , based upon the antimicrobial susceptibility profile. Many experts suggest treatment with both a beta-lactam antimicrobial agent (eg, ampicillin or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/27/28086?source=see_link\">",
"       piperacillin-tazobactam",
"      </a>",
"      ) and an aminoglycoside for bacteremic infections caused by Enterobacter, Serratia, or Pseudomonas. Infections due to extended-spectrum beta-lactamase producing organisms, or those with hyperproduction of beta-lactamases, should be treated with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/24/2439?source=see_link\">",
"       meropenem",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Listeria&nbsp;monocytogenes &ndash; The combination of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      is more effective than ampicillin alone in vitro and in animal models of Listeria infection, and is used for initial therapy. When the infant has improved clinically, consideration can be give to completing a 10- to 14-day course of treatment with ampicillin monotherapy if the infection is mild. Cephalosporins are",
"      <strong>",
"       not",
"      </strong>",
"      active against Listeria monocytogenes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/46/745?source=see_link&amp;anchor=H4#H4\">",
"       \"Treatment, prognosis, and prevention of Listeria monocytogenes infection\", section on 'Antibiotic regimens'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Staphylococcus species &ndash; The directed therapy for infection caused by staphylococci is determined by the sensitivity of the isolate to specific antibiotic agents.",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       Vancomycin",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"       nafcillin",
"      </a>",
"      in combination should be employed initially for S. aureus infection until the susceptibility profile is available. Therapy for methicillin-susceptible S. aureus should be completed with nafcillin. Consideration can be given to completion of therapy with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"       clindamycin",
"      </a>",
"      for susceptible methicillin-resistant, clindamycin-susceptible S. aureus isolates in term infants after resolution of bacteremia. However, clindamycin has bacteriostatic rather than bactericidal activity against S. aureus, and, for more severe infections, therapy should be completed with vancomycin. Coagulase-negative staphylococcal infections usually require treatment with vancomycin. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/18/37159?source=see_link\">",
"       \"Treatment of Staphylococcus aureus bacteremia in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/6/29802?source=see_link&amp;anchor=H24#H24\">",
"       \"Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children\", section on 'Treatment of neonates'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Duration and response to therapy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Positive culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;In neonates with culture proven sepsis, the duration of therapy is generally 10 days [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/1,6,12,17,18\">",
"     1,6,12,17,18",
"    </a>",
"    ]. In most cases, symptomatic infants with proven sepsis improve clinically within 24 to 48 hours. The total white count and ratio of immature to mature neutrophils (referred to as the",
"    <span class=\"nowrap\">",
"     I/T",
"    </span>",
"    ratio) usually are abnormal for the first few days and begin to normalize by 72 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/18\">",
"     18",
"    </a>",
"    ]. Serum C-reactive protein (CRP), a nonspecific acute phase reactant, is a useful laboratory test to monitor the effectiveness of treatment. Serum CRP initially rises within the first 24 to 48 hours and begins to decrease after 48 to 72 hours in responsive infants [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Negative culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;In newborn infants, automated blood culture systems identify 97 percent of pathogens at 24 hours, and 99 percent at 36 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/20\">",
"     20",
"    </a>",
"    ]. Thus, empiric antibiotic therapy should be discontinued in the well-appearing infant after 48 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the unusual circumstance that cultures are negative, and a term infant's clinical condition remains concerning for a systemic infection, antibiotic therapy can be extended until another diagnosis is established to explain the clinical findings or to complete a 10-day course of antibiotics. The use of serial serum CRP measurements can be useful in identifying infants who are more likely to have systemic infection and negative blood culture results [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Follow-up testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;A repeat blood culture after 24 to 48 hours of therapy is obtained to determine the response. Failure to sterilize the bloodstream suggests that the antimicrobial(s) chosen are not active against the infecting pathogen or that there is an unrecognized focus of infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     OTHER THERAPEUTIC CONSIDERATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Supportive care and monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ongoing monitoring of asymptomatic newborn infants with risk factors for infection is important so that early signs and symptoms of sepsis are identified. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6410?source=see_link&amp;anchor=H13#H13\">",
"     \"Clinical features and diagnosis of sepsis in term and late preterm infants\", section on 'Maternal and neonatal risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptomatic infants should be treated in a care setting with full cardiopulmonary monitoring and support, because the clinical course of these infants can deteriorate rapidly. Although there are no data demonstrating the importance of supportive care measures in septic infants, it is generally accepted that adequate oxygenation and perfusion, prevention of hypoglycemia and metabolic acidosis, and maintenance of normal fluid and electrolyte status are critical components of management. Severely ill patients may require ventilatory, volume,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pressor support to maintain adequate oxygenation and perfusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Adjunctive therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of adjunctive immunotherapeutic interventions has been evaluated but has not been shown to conclusively improve the outcome of infants with sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/17,18,21\">",
"     17,18,21",
"    </a>",
"    ]. These therapies include white cell transfusions [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/22\">",
"     22",
"    </a>",
"    ], intravenous immunoglobulin infusions [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/23,24\">",
"     23,24",
"    </a>",
"    ], granulocyte and granulocyte-macrophage colony-stimulating factor administration [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/25\">",
"     25",
"    </a>",
"    ],",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/31/35316?source=see_link\">",
"     pentoxifylline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/26\">",
"     26",
"    </a>",
"    ], and lactoferrin [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/27\">",
"     27",
"    </a>",
"    ]. These interventions should",
"    <strong>",
"     not",
"    </strong>",
"    be routinely administered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary intervention to prevent neonatal sepsis is the use of intrapartum antibiotic prophylaxis (IAP) in mothers with documented group B streptococcal (GBS) colonization, a previous birth of an infant with GBS disease, or GBS bacteriuria during the current pregnancy. Although IAP has resulted in a decrease in the incidence of early-onset GBS invasive neonatal infection, it has not had a similar impact on the rate of late-onset GBS disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H7#H7\">",
"     \"Group B streptococcal infection in neonates and young infants\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    To comprehensively prevent neonatal sepsis, a multi-interventional program needs to be developed that includes effective maternal vaccination, reduction in preterm delivery, and limited exposure of term infants to potential pathogens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to the availability of antibiotics, almost all infants with sepsis died. Outcome data for group B streptococcal (GBS) neonatal sepsis after the introduction of intrapartum antibiotic prophylaxis and the routine use of empirical antibiotic therapy demonstrate an overall fatality rate between 5 and 10 percent. However, mortality is lower in term infants with case fatality rates for early-onset disease, ranging from 2 to 3 percent, and from 1 to 2 percent for late-onset disease.",
"   </p>",
"   <p>",
"    Clinical features associated with mortality in early-onset GBS infection include birth weight less than 2500 g, absolute neutrophil count less than 1500",
"    <span class=\"nowrap\">",
"     cells/mL,",
"    </span>",
"    hypotension, apnea, and pleural effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H37#H37\">",
"     \"Group B streptococcal infection in neonates and young infants\", section on 'Outcome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The mortality rate appears to be higher in neonates with early-onset Escherichia coli (E. coli) sepsis, as illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective review of all the neonatal cases of early-onset Escherichia coli (E. coli) sepsis at a single Spanish center from 1992 to 2002, the mortality rate for term infants was 4 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a retrospective case-control study, cases of E. coli sepsis in infants less than seven days of age were identified in selected counties of California, Georgia, and Connecticut from 1997 to 2001 [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/30\">",
"       30",
"      </a>",
"      ]. The overall case fatality rate was 16 percent. Over two-thirds of the patients were premature, and separate mortality data were not presented for preterm and term infants. Of the 132 E. coli cases, 68 were due to an",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      -resistant species.",
"     </li>",
"     <li>",
"      In a study using prospective data from the National Institute of Child Health and Human Development Neonatal Network of infants born between 2006 and 2009, 16 percent of infants with early-onset sepsis (defined as positive blood or cerebrospinal fluid culture) died [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/5\">",
"       5",
"      </a>",
"      ]. These infants were primarily premature and infected by E. coli. In term infants, 4 of 137 infants with early-onset sepsis (3 percent), 2 of 117 infants from GBS (2 percent), and 2 of 20 infants from E. coli (10 percent) died.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is difficult to ascertain the overall mortality in term and late preterm infants with neonatal sepsis, because there is a subset of septic patients who do not have positive culture results.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a population-based study of 18,299 infants with a birth weight of at least 2000 grams between 1995 and 1996, 4 deaths were reported in 62 infants (6 percent) who met the criteria for proven sepsis with a positive blood culture (n = 22) and probable sepsis based upon clinical evidence (n = 40) [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study based upon the Pediatrix database, the mortality rate of infants (mean gestational age 35 weeks, range 32 to 38 weeks) treated empirically with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      was 1.9 percent. As noted above, the mortality rate was higher (4.2 percent) in those treated with ampicillin and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"       cefotaxime",
"      </a>",
"      (mean gestational age 35 weeks, range 31 to 38 weeks) [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26200/abstract/13\">",
"       13",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Early-onset sepsis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/62/23521?source=see_link\">",
"       \"Patient information: Sepsis in newborn babies (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the incidence of sepsis in term and late preterm infants is low, the potential for serious adverse outcomes, including death, is of such great consequence that caregivers should have a low threshold for evaluation and treatment for possible sepsis in any infant regardless of the birth weight or gestational age.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend initial empirical antibiotic therapy for term and late preterm infants with suspected sepsis that provides broad coverage for the most likely pathogens in this age group (group B streptococcus [GBS] and gram-negative enteric organisms, including Escherichia coli [E. coli]) (",
"      <a class=\"graphic graphic_table graphicRef61061 \" href=\"UTD.htm?39/3/39996\">",
"       table 1",
"      </a>",
"      )&nbsp;(",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The recommended regimen for early-onset sepsis without an apparent focus is",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Early-onset sepsis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The recommended regimens for late-onset sepsis without an apparent focus include",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      in neonates admitted from the community, or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       vancomycin",
"      </a>",
"      and gentamicin in patients who continue to be hospitalized from birth. If intravascular catheter-related infection is a concern, vancomycin and gentamicin should be started. If there is concern of meningitis,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"       cefotaxime",
"      </a>",
"      is added. If an intestinal source for sepsis is suspected,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"       clindamycin",
"      </a>",
"      is added to cover anaerobic organisms. Vancomycin and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"       nafcillin",
"      </a>",
"      should be used in infants with suspected infections due to Staphylococcus aureus. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Late-onset sepsis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/47/16121?source=see_link&amp;anchor=H4#H4\">",
"       \"Treatment and outcome of bacterial meningitis in the neonate\", section on 'Empirical therapy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antibiotic therapy is altered based upon isolation of the causative agent and its antimicrobial susceptibility pattern. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Specific therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The duration of therapy is dependent upon the results of blood culture and clinical course:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In infants with a positive blood culture, we suggest a 10-day course of antibiotic therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Positive culture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In well appearing infants with a negative culture after 48 hours, we suggest that empiric antibiotic therapy be discontinued, as it is likely the infants are not septic (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Negative culture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In infants with negative culture results who continue to have clinical findings consistent with a systemic infection, we suggest that antibiotic therapy be continued until another diagnosis is made that explains the clinical findings, or until a 10-day course of antibiotics is completed (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Negative culture'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most infants with proven sepsis will improve clinically within 24 to 48 hours after appropriate antibiotic treatment is started. The response to antibiotic therapy is assessed by a repeat blood culture 24 to 48 hours after initiation of antibiotic therapy. Failure to sterilize the bloodstream suggests either that the antimicrobial(s) chosen are not active against the infecting pathogen or that there is an unrecognized focus of infection. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Follow-up testing'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Duration and response to therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ongoing monitoring of patients with risk factors for sepsis is important to detect early signs and symptoms that result in prompt evaluation and treatment. Supportive care for symptomatic infants is delivered in an intensive care setting to ensure adequate oxygenation, perfusion, and maintenance of normal fluid and electrolyte balance, especially in severely affected patients. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Supportive care and monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We do",
"      <strong>",
"       NOT",
"      </strong>",
"      suggest the routine use of adjunctive immunotherapy, including white cell blood transfusions, intravenous immunoglobulin infusion, and granulocyte and granulocyte-macrophage colony-stimulating factor administration (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Adjunctive therapies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The mortality of neonatal sepsis in term infants remains low, at or below 5 percent. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Outcome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The primary intervention to prevent neonatal sepsis is the use of intrapartum antibiotic prophylaxis in mothers with documented group B streptococcal (GBS) colonization, a previous birth of an infant with GBS disease or GBS bacteriuria during the current pregnancy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19354?source=see_link\">",
"       \"Chemoprophylaxis for the prevention of neonatal group B streptococcal disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Edwards, MS, Baker, CJ. Sepsis in the Newborn. In: Krugman's Infectious Diseases of Children, 11th ed, Gershon, AA, Hotez, PJ, Katz, SL (Eds), Mosby, Philadelphia 2004, p. 545.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/2\">",
"      Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics 2006; 118:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/3\">",
"      Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008; 121:689.",
"     </a>",
"    </li>",
"    <li>",
"     Committee on Infectious Disease American Academy of Pediatrics. Group B Streptococcal Infections. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th ed, Pickering LK, Baker CJ (Eds), American Academy of Pediatrics, Elk Grove Village 2012. p.680.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/5\">",
"      Stoll BJ, Hansen NI, S&aacute;nchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011; 127:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/6\">",
"      Polin RA, Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012; 129:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/7\">",
"      Rao SC, Ahmed M, Hagan R. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev 2006; :CD005091.",
"     </a>",
"    </li>",
"    <li>",
"     Anderson DM, Eichenwald EC, Chan SW, et al. Guidelines for Acute Care of the Neonate, 17th ed, Baylor College of Medicine, Houston, TX 2009. p.67.",
"    </li>",
"    <li>",
"     Edwards MS, Baker CJ. Bacterial infections in the neonate. In: Principles and Practice of Pediatric Infectious Diseases, 4th ed, Long SS, Pickering LK, Prober CG (Eds), Elsevier Saunders, Philadelphia 2012. p.538.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/10\">",
"      Maayan-Metzger A, Barzilai A, Keller N, Kuint J. Are the \"good old\" antibiotics still appropriate for early-onset neonatal sepsis? A 10 year survey. Isr Med Assoc J 2009; 11:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/11\">",
"      Muller-Pebody B, Johnson AP, Heath PT, et al. Empirical treatment of neonatal sepsis: are the current guidelines adequate? Arch Dis Child Fetal Neonatal Ed 2011; 96:F4.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Red Book: 2009 Report of the Committee on Infectious Diseases, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/13\">",
"      Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006; 117:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/14\">",
"      Gulian JM, Dalmasso C, Gonard V. Interaction of beta-lactam antibiotics on bilirubin-albumin complex: comparison by three methods, total bilirubin, unbound bilirubin and erythrocyte-bound bilirubin. Chemotherapy 1990; 36:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/15\">",
"      Martin E, Fanconi S, K&auml;lin P, et al. Ceftriaxone--bilirubin-albumin interactions in the neonate: an in vivo study. Eur J Pediatr 1993; 152:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/16\">",
"      Fortunov RM, Hulten KG, Hammerman WA, et al. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics 2006; 118:874.",
"     </a>",
"    </li>",
"    <li>",
"     Nizet V, Klein JO. Bacterial sepsis and meningitis. In: Infectious diseases of the Fetus and Newborn Infant, 7th ed, Remington JS, et al (Eds), WB Saunders, Philadelphia 2010. p.222.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/18\">",
"      Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am 2004; 51:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/19\">",
"      Pourcyrous M, Bada HS, Korones SB, et al. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 1993; 92:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/20\">",
"      Garcia-Prats JA, Cooper TR, Schneider VF, et al. Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics 2000; 105:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/21\">",
"      Cohen-Wolkowiez M, Benjamin DK Jr, Capparelli E. Immunotherapy in neonatal sepsis: advances in treatment and prophylaxis. Curr Opin Pediatr 2009; 21:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/22\">",
"      Cairo MS. Neutrophil transfusions in the treatment of neonatal sepsis. Am J Pediatr Hematol Oncol 1989; 11:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/23\">",
"      Ohlsson A, Lacy J. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev 2010; :CD001239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/24\">",
"      INIS Collaborative Group, Brocklehurst P, Farrell B, et al. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med 2011; 365:1201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/25\">",
"      Schibler KR, Osborne KA, Leung LY, et al. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics 1998; 102:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/26\">",
"      Lauterbach R, Pawlik D, Kowalczyk D, et al. Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. Crit Care Med 1999; 27:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/27\">",
"      Mohan P, Abrams SA. Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev 2009; :CD007138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/28\">",
"      Payne NR, Burke BA, Day DL. Correlation of clinical and pathologic findings in early onset neonatal group B streptococcal infection with disease severity and prediction of outcome. Pediatr Infect Dis 1998; 7:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/29\">",
"      Alarcon A, Pe&ntilde;a P, Salas S, et al. Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis. Pediatr Infect Dis J 2004; 23:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/30\">",
"      Schrag SJ, Hadler JL, Arnold KE, et al. Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics 2006; 118:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26200/abstract/31\">",
"      Escobar GJ, Li DK, Armstrong MA, et al. Neonatal sepsis workups in infants &gt;/=2000 grams at birth: A population-based study. Pediatrics 2000; 106:256.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5046 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-813CF6A707-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26200=[""].join("\n");
var outline_f25_37_26200=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANTIBIOTIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Empiric antibiotic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Early-onset sepsis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Late-onset sepsis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Specific therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Duration and response to therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Positive culture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Negative culture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Follow-up testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      OTHER THERAPEUTIC CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Supportive care and monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Adjunctive therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5046\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5046|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/3/39996\" title=\"table 1\">",
"      Bacteria sepsis term infant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/19/5436\" title=\"table 2\">",
"      Early-onset GBS infection rx",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/32/1549\" title=\"table 3\">",
"      Late-onset GBS infection rx",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19354?source=related_link\">",
"      Chemoprophylaxis for the prevention of neonatal group B streptococcal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6410?source=related_link\">",
"      Clinical features and diagnosis of sepsis in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/63/25593?source=related_link\">",
"      Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=related_link\">",
"      Group B streptococcal infection in neonates and young infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/11/22713?source=related_link\">",
"      Late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/62/23521?source=related_link\">",
"      Patient information: Sepsis in newborn babies (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/47/16121?source=related_link\">",
"      Treatment and outcome of bacterial meningitis in the neonate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/18/37159?source=related_link\">",
"      Treatment of Staphylococcus aureus bacteremia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/6/29802?source=related_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/46/745?source=related_link\">",
"      Treatment, prognosis, and prevention of Listeria monocytogenes infection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_37_26201="Classification and clinical features of isolated atrial septal defects in children";
var content_f25_37_26201=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"14\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Classification and clinical features of isolated atrial septal defects in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26201/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26201/contributors\">",
"     G Wesley Vick, III, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26201/contributors\">",
"     Louis I Bezold, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26201/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26201/contributors\">",
"     David R Fulton, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26201/contributors\">",
"     John K Triedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26201/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26201/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/37/26201/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital defects of the atrial septum are common, accounting for approximately 13 percent of congenital heart disorders with a reported birth prevalence of 1.64 per 1,000 live births [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/1\">",
"     1",
"    </a>",
"    ]. An atrial septal defect (ASD) can be isolated or can be associated with other congenital cardiac abnormalities. The sizes of ASDs are variable, and the functional consequences of an ASD are related to the anatomic location of the defect, its size, and the presence or absence of other cardiac anomalies.",
"   </p>",
"   <p>",
"    The classification of ASDs, and the clinical features and evaluation of isolated ASDs in children will be reviewed here. The management and prognosis of children with isolated ASDs are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/1/38936?source=see_link\">",
"     \"Management and outcome of isolated atrial septal defects in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EMBRYOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The septation of the atria begins as early as the fifth week of gestation. The septum primum arises from the superior portion of the common atrium and grows caudally to the endocardial cushions located between the atria and ventricles, eventually closing the orifice (ostium primum) between the atria (",
"    <a class=\"graphic graphic_figure graphicRef77749 \" href=\"UTD.htm?2/6/2153\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A second orifice (the ostium secundum) develops in the septum primum; this orifice is covered by the septum secundum that arises on the right atrial side of the septum primum. The septum secundum grows caudally and covers the ostium secundum. However, the septum secundum does not completely divide the atria; it leaves an oval orifice (the foramen ovale) that is covered (but not sealed) on the left side by the flexible flap of the septum primum (",
"    <a class=\"graphic graphic_figure graphicRef77749 \" href=\"UTD.htm?2/6/2153\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In the fetus, the foramen ovale is held open by the pressure gradient between the right and left atria; the right atrial pressure is higher than that on the left and pushes the flexible septum primum aside, permitting right to left flow of oxygenated blood from the inferior vena cava into the left ventricle. At birth, expansion of the lungs lowers right heart pressures at the same time that systemic vascular resistance rises, causing reversal of the atrial gradient. The septum primum is then held against the septum secundum and the interatrial shunt ceases. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Perinatal physiology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In approximately 70 percent of individuals, the septum primum and septum secundum fuse after birth, creating an intact interatrial septum; the remnant of the foramen ovale in the right atrium is termed the fossa ovalis. However, in a significant proportion of the population, the septae do not fuse. If the foramen ovale is completely covered but not sealed, it is called a \"probe patent\" or simply \"patent\" foramen ovale (PFO), indicating that the foramen can be opened (by a reversal of the interatrial pressure gradient or by an intracardiac catheter). Less commonly, an open communication persists between the atria after septation. Such a communication is called an atrial septal defect (ASD).",
"   </p>",
"   <p>",
"    Developmental defects in partitioning of the left from the right atrium usually result in an isolated ASD. Developmental defects in partitioning of the atria from the ventricles (the embryologic atrioventricular [AV] canal) also often lead to a communication between the right and left atria. Most such AV canal, or endocardial cushion, malformations are associated with major anomalies of the AV valves in addition to an interatrial communication. Defects of the ventricular septum are also commonly present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The various types of ASDs are classified according to their location and the nature of the embryologic defect (",
"    <a class=\"graphic graphic_figure graphicRef52106 \" href=\"UTD.htm?7/36/7748\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Isolated ASDs result from abnormal development of the septa that partition the common atrium of the developing heart into right and left chambers.",
"     </li>",
"     <li>",
"      Atrioventricular (AV) canal defects result primarily from maldevelopment of the partitioning of the AV canal by the endocardial cushions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Isolated ASDs include ASDs at the fossa ovalis (secundum ASD), a defect superior to the fossa ovalis (superior sinus venosus type ASD, superior vena caval defect), a defect inferior to the fossa ovalis (inferior sinus venosus type ASD, inferior vena caval defect), and coronary sinus defects.",
"   </p>",
"   <p>",
"    A patent foramen ovale (PFO) is also a communication between the right and left atria. A PFO is not considered an ASD because no septal tissue is missing. However, an elevation in right atrial pressure can cause right-to-left interatrial shunting through a PFO. Such shunting is associated with a potential risk of paradoxical embolization. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Paradoxical embolization'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/32/3593?source=see_link\">",
"     \"Patent foramen ovale\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Primum ASDs are typically not isolated, but are usually associated with AV valve malformations and sometimes ventricular septal defects. AV canal defects are by definition not isolated and include complete forms, incomplete forms, and common atrium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Secundum defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secundum defects account for approximately 70 percent of all ASDs, and occur twice as often in females as in males [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. Familial recurrent rate has been estimated to be about seven to ten percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. A comprehensive literature review found a median reported incidence of 564 per million live births [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/8\">",
"     8",
"    </a>",
"    ]. However, because patients are commonly undiagnosed in infancy and childhood, the true incidence of secundum atrial septal defect may be substantially higher.",
"   </p>",
"   <p>",
"    They are typically located within the area bordered by the limbus of the fossa ovalis. Multiple defects can be seen if the floor of the fossa ovalis (also known as the valve of foramen ovale) is fenestrated. The defects vary greatly in size, from less than 3 mm to greater than 20 mm.",
"   </p>",
"   <p>",
"    Secundum ASDs may be associated with other ASDs, such as a sinus venosus defect or an ostium primum defect. Some patients with secundum ASD have functional mitral valve prolapse, perhaps related to a change in the left ventricular geometry associated with right ventricular volume overload [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Genetic disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most secundum ASDs occur sporadically, they sometimes occur as part of a congenital syndrome or secondary to a defined genetic defect [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/11\">",
"     11",
"    </a>",
"    ]. The following observations illustrate the range of findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Holt-Oram (heart-hand) syndrome is an autosomal dominant disorder characterized by upper limb defects (often deformities of the radius, carpal bones,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      thumbs) and cardiac septal defects, most commonly a secundum ASD [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]. Cardiac conduction disturbances, including complete heart block, are also common.",
"      <br/>",
"      <br/>",
"      The prevalence of the Holt-Oram syndrome has been estimated to be 0.95 per 100,000 total births; 85 percent of cases are attributed to new mutations [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/12\">",
"       12",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Mutations in the TBX5 gene, which encodes a transcriptional regulatory protein, cause Holt-Oram syndrome in some families [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/14\">",
"       14",
"      </a>",
"      ]. The mutated protein does not interact normally with Gata-4, mutations in which are also responsible for familial ASD [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/15\">",
"       15",
"      </a>",
"      ]. Gata-4 plays an important role in the morphogenesis of the atrioventricular canal and the right ventricle [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/16\">",
"       16",
"      </a>",
"      ].Other families do not demonstrate disease linkage to the TBX5 locus on chromosome 12q2, indicating that Holt-Oram syndrome is genetically heterogeneous [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mutations in the GATA4 gene, which prevent the interaction between its product Gata-4 and TBX5, produce an autosomal dominant disorder characterized by disorder characterized by ASD and, in some patients, other cardiac defects such as ventricular septal defects, atrioventricular septal defects, valvular insufficiency, and pulmonary valve thickening [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mutations in the myosin heavy chain 6 gene (MYH6, also called alpha myosin heavy chain gene), which is expressed at high levels in the developing atria and which affects the binding of the myosin heavy chain to its regulatory light chain, can cause an autosomal dominant disorder characterized by isolated ASD [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/18\">",
"       18",
"      </a>",
"      ]. In an animal model, this mutation prevents formation of the atrial septum without affecting atrial chamber formation. Both the TBX5 mutation causing Holt-Oram syndrome and the above GATA4 mutation reduce the activation of MYH6 [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mutations in the transcription factor NKX2-5 (also called CSX) are responsible for an autosomal dominant disorder characterized by congenital heart disease, most often a secundum ASD, and conduction system disease, but no skeletal defects [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/19,20\">",
"       19,20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a report of three families with familial secundum ASD transmitted as an autosomal dominant trait, one had a locus on chromosome 5p, while no locus was identified in the other two families [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/21\">",
"       21",
"      </a>",
"      ]. Low disease penetrance and variability in expression were noted, and may interfere with recognition of a heritable syndrome. Among 20 family members with the disease haplotype, nine had an ASD, eight had no cardiac defects, and three had other cardiac lesions.",
"     </li>",
"     <li>",
"      Other congenital syndromes in which a secundum ASD may occur include Noonan syndrome, Treacher Collins syndrome, and the thrombocytopenia-absent radii (TAR) syndrome.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Sinus venosus defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sinus venosus ASDs are characterized by malposition of the insertion of the superior or inferior vena cava straddling the atrial septum (",
"    <a class=\"graphic graphic_figure graphicRef52106 \" href=\"UTD.htm?7/36/7748\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/22\">",
"     22",
"    </a>",
"    ]. The interatrial communication is within the mouth of the overriding vein and is outside the area of the fossa ovalis. Sinus venosus defects account for approximately 10 percent of ASDs.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Superior sinus venosus defects (sometimes called superior vena caval defects) are located in the atrial septum immediately caudal to the orifice of the superior vena cava. The right upper lobe and middle lobe pulmonary veins often connect to the junction of the superior vena cava and right atrium, resulting in a partial anomalous pulmonary venous connection [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/23\">",
"       23",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/36/3656?source=see_link&amp;anchor=H7#H7\">",
"       \"Partial anomalous pulmonary venous connection\", section on 'Sinus venosus defects'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inferior sinus venosus defects, also known as inferior vena caval defects, are less common. They are located in the atrial septum immediately cranial to the orifice of the inferior vena cava. Inferior sinus venosus defects are often associated with partial anomalous connection of the right pulmonary veins.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Coronary sinus defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;In coronary sinus ASDs (unroofed coronary sinus), part or the entire common wall between the coronary sinus and the left atrium is absent. Many such patients also have a persistent left superior vena cava.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Patent foramen ovale",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 30 percent of normal adult hearts have a patent foramen ovale (PFO). Defects typically range from 1 to 10 mm in maximal potential diameter [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/24\">",
"     24",
"    </a>",
"    ]. A PFO is not considered an ASD because no septal tissue is missing. As a result, interatrial shunting cannot occur as long as left atrial pressure exceeds right atrial pressure and the flap valve remnant of septum primum of the foramen ovale is competent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/32/3593?source=see_link\">",
"     \"Patent foramen ovale\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A PFO may occur as a familial trait. This possibility was suggested in a study that compared 62 patients under age 60 with an ischemic stroke and 62 matched controls [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/25\">",
"     25",
"    </a>",
"    ]. The prevalence of a PFO in female siblings of patients with a PFO was 77 percent, compared with 25 percent in female siblings of those without a PFO (odds ratio 9.8); there was no such association in men.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Primum defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primum type ASD develops if the septum primum does not fuse with the endocardial cushions, leaving a defect at the base of the interatrial septum that is usually large (",
"    <a class=\"graphic graphic_figure graphicRef52106 \" href=\"UTD.htm?7/36/7748\">",
"     figure 2",
"    </a>",
"    ). Primum ASDs are usually not isolated, typically being associated with anomalies of the AV valves and sometimes defects of the ventricular septum or common AV canal. These disorders are discussed separately. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Associated cardiovascular defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;ASDs are often associated with other congenital cardiac anomalies. Although the associated defects are usually more important than the ASD itself, the ASD may in some cases contribute substantially to the physiology of the condition. As examples, an ASD permits mixing between the pulmonary and systemic circulations in complete transposition of the great arteries while, in tricuspid atresia, the entire cardiac output passes across the ASD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathophysiology of ASDs depends upon the relationship of pulmonary and systemic resistances, the compliance of the right and left ventricles, and the size of the defect.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Perinatal physiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary arterial blood flow in the fetus is limited by high pulmonary vascular resistance. As a result, much of the blood that flows into the right atrium is shunted across the foramen ovale into the left atrium. At birth, left atrial pressure becomes greater than right atrial pressure for several reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The progressive fall in pulmonary vascular resistance that accompanies lung expansion",
"     </li>",
"     <li>",
"      The immediate rise in systemic vascular resistance once the placenta is no longer part of the circulation",
"     </li>",
"     <li>",
"      The substantial increase in pulmonary venous blood flow and consequently pulmonary venous return to the left atrium.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This postpartum change in the atrial pressure relationship causes functional closure of the foramen ovale.",
"   </p>",
"   <p>",
"    The intrauterine physiology is usually not changed by the presence of an ASD. However, the hemodynamic changes after birth do not close the ASD, leading to left-to-right shunting across the defect. Initially, the volume of blood shunted from left to right is small because the right ventricle is still relatively thick-walled and noncompliant. As the right ventricle remodels in response to the decreased pulmonary vascular resistance, its compliance increases, and the mean right atrial pressure decreases. As a result, the left-to-right shunt increases in volume.",
"   </p>",
"   <p>",
"    Transient right-to-left shunting also occurs during the cardiac and respiratory cycles in children with an ASD. At the onset of ventricular contraction, there is a drop in atrial pressure due to atrial relaxation that is more rapid in the left than the right atrium. During inspiration, the decrease in intrathoracic pressure results in an increase in systemic venous return and a decrease in pulmonary venous return, decreasing left atrial pressure and increasing right atrial pressure. Such right-to-left shunting, though transient, can result in mild cyanosis in the neonatal period.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Postnatal physiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;With a small ASD, left atrial pressure is slightly higher than right atrial pressure, resulting in continuous flow of oxygenated blood from the left to the right atrium across the defect (",
"    <a class=\"graphic graphic_figure graphicRef72533 \" href=\"UTD.htm?23/17/23826\">",
"     figure 3",
"    </a>",
"    ). The pressure gradient between the two atria and the amount of shunt flow depend upon the size of the defect and the relative distensibility of the right and left sides of the heart. Left-to-right shunting occurs primarily in late ventricular systole and early diastole, with some augmentation during atrial systole. Even when the right and left atrial pressures are equal, as will be seen with a large defect, left-to-right shunting still occurs because of the greater compliance of the right ventricle compared with the left ventricle.",
"   </p>",
"   <p>",
"    The shunt flow constitutes a \"useless circuit\" through the right atrium, right ventricle, pulmonary circulation, left atrium, and through the defect back to the right atrium. Thus, the volume of blood flow in the pulmonary circulation is greater than that in the systemic circulation. The pulmonary flow to systemic flow ratio",
"    <span class=\"nowrap\">",
"     (Qp/Qs)",
"    </span>",
"    can be as high as 8:1 but, in asymptomatic young adults, is more likely to be in the range of 2:1 to 5:1. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4344?source=see_link\">",
"     \"Pathophysiology of left to right shunts\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The increased flow leads to right-sided dilatation evident on chest radiograph and echocardiographic imaging. Right ventricular function is also occasionally decreased. The main pulmonary arteries dilate and the pulmonary vascularity is increased. These changes may be evident on the chest radiograph, and large vessels in both the lower and upper lobes may be seen.",
"   </p>",
"   <p>",
"    The right-sided volume overload is usually well tolerated for years. Congestive heart failure is unusual before age 30, but substantially increases in prevalence with age. Atrial arrhythmias such as flutter and fibrillation, thought to result from chronic stretching of the atrial muscle, are a common cause of morbidity in older patients with ASD. Occasionally, pulmonary arteriopathy leading to progressive pulmonary hypertension may develop leading to right-to left shunting of blood (ie, Eisenmenger syndrome) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/26\">",
"     26",
"    </a>",
"    ]. The development and progression of pulmonary hypertension depends in part upon the size and duration of the shunt. However, even patients with large shunts of long duration do not always develop pulmonary hypertension, suggesting the influence of other unknown factors. Progressive pulmonary hypertension has been documented in rare patients after closure of the defect despite normal pulmonary hemodynamics at the time of surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/55/6007?source=see_link\">",
"     \"Evaluation and prognosis of Eisenmenger syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Patent foramen ovale",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patent foramen ovale (PFO) is not considered an ASD because no septal tissue is missing. As a result, interatrial shunting cannot occur as long as left atrial pressure exceeds right atrial pressure and the flap valve remnant of septum primum of the foramen ovale is competent.",
"   </p>",
"   <p>",
"    However, an elevation in right atrial pressure can cause right-to-left interatrial shunting through a PFO. Intermittent increases in right atrial pressure occur in normal individuals during early ventricular systole (",
"    <a class=\"graphic graphic_movie graphicRef78654 \" href=\"UTD.htm?12/48/13057\">",
"     movie 1",
"    </a>",
"    ) and with the decreased intrathoracic pressure of inspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/27\">",
"     27",
"    </a>",
"    ]. A persistent, large, fetal Eustachian valve can also direct inferior vena caval blood toward the midportion of the atrial septum, and potentially into the left atrium and systemic circulation throughout the cardiac cycle. In addition, transient right-to-left shunting in patients with a PFO can be induced by the straining and release phases of the Valsalva maneuver.",
"   </p>",
"   <p>",
"    The clinical importance of a PFO lies in its association with paradoxical embolism and stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. Paradoxical embolization occurs when an embolus arising in the systemic venous system or the right atrium crosses the PFO during right-to-left shunting and enters the systemic arterial circulation. This is a rare complication in children. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Paradoxical embolization'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Left-to-right interatrial shunting often occurs in the perinatal period due to transient foramen ovale incompetence. This was illustrated by an echocardiographic study in which 11 of 20 normal term infants had a predominant left-to-right interatrial shunt during ventricular systole, which usually resolved by six days of age [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/30\">",
"     30",
"    </a>",
"    ]. This was thought to result from slight atrial stretching due to transient physiologic extracellular fluid volume expansion combined with a relatively short foramen ovale flap.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following discussion will review the clinical features of ASDs. The natural history of these lesions is discussed elsewhere. Spontaneous closure or a decrease in size is most likely to occur in defects less than 7 to 8 mm in diameter and with younger age at diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/1/38936?source=see_link&amp;anchor=H2#H2\">",
"     \"Management and outcome of isolated atrial septal defects in children\", section on 'Natural history'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The principal features that suggest the presence of an ASD include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fixed splitting of the second heart sound (seen in 90 percent of patients in a study of Japanese schoolchildren [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/31\">",
"       31",
"      </a>",
"      ])",
"     </li>",
"     <li>",
"      A midsystolic pulmonary flow or ejection murmur (seen in 94 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/31\">",
"       31",
"      </a>",
"      ])",
"     </li>",
"     <li>",
"      Right ventricular conduction delay on ECG (seen in 79 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/31\">",
"       31",
"      </a>",
"      ])",
"     </li>",
"     <li>",
"      Enlargement of the right atrium and right ventricle on imaging studies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Echocardiography is warranted in any patient who presents with this combination of findings to confirm the clinical suspicion of an ASD. The findings are discussed in detail below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolated secundum ASDs, as well as most small ASDs of any type, do not cause symptoms in infancy and childhood. The diagnosis is usually made because of a murmur detected incidentally on physical examination. In one series of 481 patients with an ASD who were seen between 1957 and 1976 and who underwent corrective surgery before the age of 40, the defect was discovered on routine examination in 202 (42 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/32\">",
"     32",
"    </a>",
"    ]. However, depending upon the balance between systemic and pulmonary pressures, some newborns have mild cyanosis due to right-to-left shunting across the ASD.",
"   </p>",
"   <p>",
"    Infants with large ASDs may present with heart failure, recurrent respiratory infections, or failure to thrive. Failure to thrive in infants with ASDs may be associated with extracardiac pathology [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. In one series, five of six infants who had secundum ASD repair before one year of age for failure to thrive had other pulmonary",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cardiac disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In many patients with uncorrected moderate to large ASDs, left-to-right shunting increases with age. As a result, the frequency of heart failure accompanied by fluid retention, hepatomegaly, and elevated jugular venous pressure increases with advancing age. Most such patients become symptomatic before age 40. Common symptoms include atrial arrhythmias (the most frequent presenting symptom), exercise intolerance, dyspnea, and fatigue. In the series of 481 patients with an ASD diagnosed before the age of 40, more than half have symptoms of dyspnea and fatigue [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16825?source=see_link\">",
"     \"Pathophysiology and clinical features of atrial septal defects in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;ASDs may be associated with a variety of findings on physical examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Small size for age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants and children with ASDs tend to be small for their age, even in the absence of complicating factors such as heart failure or other cardiac malformations, and many improve following repair. This was illustrated by a study that evaluated asymptomatic children less than nine years of age with an isolated secundum ASD who underwent surgical or transcatheter device closure and had preoperative height or weight Z scores of -1 (16th percentile) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/35\">",
"     35",
"    </a>",
"    ]. After repair, height and weight improved by 0.5 SD in 50 percent in the low height and low weight groups, respectively; these gains occurred sooner than in normal controls matched for size, age, and gender (2.6 versus 5.6 years for weight and 1.7 versus 11.6 years for height).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Precordial palpation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A large left-to-right shunt may result in a precordial bulge due to atrial enlargement. In some patients, atrial enlargement leads to transverse depressions along the sixth and seventh costal cartilages at the site of attachment of the anterior part of the diaphragm, known as Harrison grooves.",
"   </p>",
"   <p>",
"    Patients with large left-to-right shunts also may have a hyperdynamic right ventricular impulse that results in a right ventricular heave. This is most pronounced along the left sternal border and in the subxiphoid area. Patients with pulmonary vascular disease or obstruction to right ventricular outflow have a less dynamic right ventricular impulse, with more of a tapping or thrusting quality.",
"   </p>",
"   <p>",
"    An enlarged and pulsatile pulmonary artery may be palpated at the second left intercostal space. This impulse is more pronounced in the presence of pulmonary hypertension, when the pulmonic component of the second heart sound may also be palpable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Heart sounds",
"    </span>",
"    &nbsp;&mdash;&nbsp;The characteristic finding in ASDs with large left-to-right shunts and normal pulmonary artery pressure is wide, fixed splitting of the second sound (S2), in contrast to the normal variation in splitting during the respiratory cycle. In one series of school children from Japan with ASDs detected by screening, 90 percent had fixed splitting [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/31\">",
"     31",
"    </a>",
"    ]. The second sound should be evaluated when the patient is sitting or standing, because relatively wide (though not fixed) splitting is common in normal individuals in the supine position. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=see_link\">",
"     \"Auscultation of heart sounds\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The explanation for fixed splitting in patients with ASDs is not definitely established. However, according to one hypothesis, fixed splitting is thought to result from altered characteristics of the pulmonary vascular bed associated with increased pulmonary blood flow. In all individuals, the aortic and pulmonic closure sounds (A2 and P2) occur shortly after (but not instantly after) ventricular pressure falls below arterial pressure. The delay between the ventricular pressure drop and valve closure is referred to as the \"hangout time,\" and is the delay due to pressure recoil from the arterial bed.",
"   </p>",
"   <p>",
"    In the systemic arterial circulation, the hangout time is short because of high aortic impedance and rapid pressure recoil; it does not vary with respiration. In contrast, the pulmonary hangout time is longer, because of the greater compliance of the pulmonary vascular bed, and is prolonged by inspiration, which increases pulmonary capacitance. As a result, P2 normally occurs after A2, and this separation (\"splitting\") of S2 increases with inspiration.",
"   </p>",
"   <p>",
"    With an ASD, the capacitance of the pulmonary bed is increased throughout the respiratory cycle without much respiratory variation. The increased and constant capacitance results in an increased and fixed hangout time, with wide splitting between the first and second components of the S2, and little respiratory variation. Fixed splitting of S2 is rare with ASDs in newborns, in whom the left-to-right shunt is usually small or negligible.",
"   </p>",
"   <p>",
"    The intensities of the pulmonic and aortic components of S2 are equal in most patients with uncomplicated ASDs. Patients with pulmonary hypertension usually have an accentuated pulmonic component of S2. A similar finding is occasionally seen with normal pulmonary pressures, because of the proximity of the dilated pulmonary artery to the chest wall.",
"   </p>",
"   <p>",
"    The first heart sound (S1), which is heard best at the apex and lower left sternal border, is often split, and the second component (tricuspid closure) is intensified in patients with an ASD. One possible explanation for this increase in intensity is that the large volume of diastolic blood flow from right atrium to right ventricle presses the tricuspid leaflets toward the right ventricular wall, and the forceful right ventricular contraction causes the tricuspid leaflets to move abruptly cephalad during systole.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Heart murmurs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The low velocity shunt flow across the ASD produces insufficient turbulence to be audible, although it can be demonstrated by intracardiac phonocardiography. However, several other murmurs may be heard. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link\">",
"     \"Auscultation of cardiac murmurs\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A midsystolic pulmonary flow or ejection murmur, resulting from the increased blood flow across the pulmonic valve, is classically present with moderate to large left-to-right shunts and may be louder than that attributed to the usual functional murmur. In the previously mentioned series of Japanese schoolchildren, an ejection systolic murmur was audible in 94 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/31\">",
"       31",
"      </a>",
"      ]. This murmur is loudest over the second intercostal space and is usually not associated with a thrill. The presence of a thrill typically indicates a very large shunt or pulmonic stenosis.",
"     </li>",
"     <li>",
"      A systolic crescendo-decrescendo murmur audible over the lung fields and not prominent over the second intercostal space results from rapid flow through the peripheral pulmonary arteries.",
"     </li>",
"     <li>",
"      A murmur of mitral regurgitation may accompany these findings due to a cleft mitral valve in ostium primum defects and mitral valve prolapse in secundum defects. In the latter setting, an apical late or holosystolic murmur of mitral regurgitation radiating to the axilla may be heard.",
"     </li>",
"     <li>",
"      A mid-diastolic murmur of low to medium frequency is commonly audible with an ASD and a left-to-right shunt greater than 2:1. It results from high flow across the tricuspid valve and does not increase with inspiration.",
"     </li>",
"     <li>",
"      A low-pitched diastolic murmur of pulmonic regurgitation may result from dilatation of the pulmonary artery.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Pulmonary hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Right-to-left shunting due to pulmonary hypertension in the occasional patient with ASD may be associated with the following auscultatory findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A right ventricular fourth heart sound",
"     </li>",
"     <li>",
"      A midsystolic ejection click",
"     </li>",
"     <li>",
"      A midsystolic pulmonic murmur that is softer and shorter because the ejected stroke volume is less",
"     </li>",
"     <li>",
"      No tricuspid flow murmur",
"     </li>",
"     <li>",
"      Increased intensity of the pulmonic component of S2, but no fixed splitting",
"     </li>",
"     <li>",
"      A pulmonic insufficiency murmur, if present, is high-pitched",
"     </li>",
"     <li>",
"      A holosystolic murmur of tricuspid insufficiency may result from right ventricular and atrial enlargement",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Eisenmenger syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of Eisenmenger physiology is accompanied by signs of right ventricular failure (including elevated jugular venous pressure, hepatic congestion, and pedal edema), cyanosis, and clubbing (",
"    <a class=\"graphic graphic_picture graphicRef55721 \" href=\"UTD.htm?2/37/2640\">",
"     picture 1",
"    </a>",
"    ), in addition to the auscultatory features of pulmonary hypertension described above. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/55/6007?source=see_link\">",
"     \"Evaluation and prognosis of Eisenmenger syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Extracardiac features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with an ASD may also have manifestations of associated syndromes. As an example, abnormalities such as deformities of the radius, carpal bones,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    thumbs occur in Holt-Oram (heart-hand) syndrome. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Genetic disorders'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In addition, there may be an association between migraine headaches with aura and right to left cardiac shunts, particularly patent foramen ovale. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8600?source=see_link&amp;anchor=H8#H8\">",
"     \"Pathophysiology, clinical features, and diagnosis of migraine in children\", section on 'Right to left cardiac shunt'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Paradoxical embolization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Paradoxical embolization of clot from the venous system or right atrium via right-to-left shunting through a PFO or an ASD into the arterial circulation is a rare complication in children but a common cause of cryptogenic stroke in adults. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39689?source=see_link\">",
"     \"Atrial septal abnormalities (PFO, ASD, and ASA) and risk of cerebral emboli in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of the child with a possible ASD begins with an electrocardiogram (ECG) and chest radiograph. This is followed by specific tests, beginning with echocardiography, to both identify and assess the ASD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Electrocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;The electrocardiogram (ECG) may be normal with an uncomplicated ASD and a small shunt. Although most affected children have normal sinus rhythm, sinus node dysfunction often develops in early childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/36\">",
"     36",
"    </a>",
"    ]. In one study of 40 children with ASDs, 33 had a prolonged sinus node recovery time and 10 had an abnormal sinoatrial conduction time [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/37\">",
"     37",
"    </a>",
"    ]. Atrial arrhythmias, especially atrial fibrillation but also atrial flutter and supraventricular tachycardia, often occur beyond the third decade.",
"   </p>",
"   <p>",
"    P waves are typically normal with secundum ASDs. In comparison, sinus venosus ASDs are often associated with a leftward frontal plane P-wave axis (ie, negative in leads III and aVF and positive in lead aVL) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/38\">",
"     38",
"    </a>",
"    ]. This leftward shift is caused by an ectopic pacemaker resulting from an ASD located near the sinus node.",
"   </p>",
"   <p>",
"    The PR interval may be prolonged and increases with increasing age [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    First degree AV block can occur in any type of ASD, but is classically present in ostium primum defects in association with complete right bundle branch block and left anterior fascicular block. The rim of the ostium primum defect is in close spatial relationship to the His bundle accounting for abnormalities of impulse conduction through this area.",
"   </p>",
"   <p>",
"    The frontal plane QRS axis often ranges from +95&ordm; to +135&ordm; (right axis deviation) with a clockwise loop. In the previously mentioned series of Japanese school children, 55 percent had right axis deviation [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/31\">",
"     31",
"    </a>",
"    ]. Left axis deviation of the QRS axis with a counterclockwise frontal plane loop can occur with uncomplicated secundum ASD, although it usually suggests the presence of an AV canal defect.",
"   </p>",
"   <p>",
"    The QRS complex is often slightly prolonged and has a characteristic rSr' or rsR' pattern that is thought to result from disproportionate thickening of the right ventricular outflow tract, which is the last portion of the ventricle to depolarize. This pattern, which is often described as incomplete right bundle branch block, results from hypertrophy rather than a conduction disturbance. In the previously mentioned series of school children from Japan with ASDs detected by screening, this QRS pattern was seen in 79 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/31\">",
"     31",
"    </a>",
"    ]. Patients with increasing pulmonary hypertension tend to lose the rSr' pattern in V1 and develop a tall monophasic R wave with a deeply inverted T wave.",
"   </p>",
"   <p>",
"    Notching of the peak of the R wave in the inferior leads (a pattern called \"crochetage\") has been described in patients with an ASD. In a series of 82 children with secundum ASDs and 244 control children with other congenital heart disease or normal echocardiograms, the presence of crochetage in at least one inferior limb lead had a sensitivity of 32 percent and a specificity of 86 percent for ASD [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Chest radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;The typical chest radiograph in secundum ASD with large left-to-right shunts shows cardiac enlargement and increased pulmonary vascularity. The increase in pulmonary vascularity typically extends to the periphery of the lung fields, and the pulmonary trunk and central branches appear dilated.",
"   </p>",
"   <p>",
"    The heart often has a characteristic triangular appearance because the enlarged pulmonary arteries prevent the normal diameter ascending and transverse aorta from forming the heart border. The right atrium and ventricle are usually enlarged, while the left atrium and left ventricle are normal.",
"   </p>",
"   <p>",
"    In patients with a sinus venosus defect, the insertion of the pulmonary vein into the inferior vena cava can be seen as an abnormal density on the chest radiograph called the \"scimitar sign\" [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/41\">",
"     41",
"    </a>",
"    ]. The scimitar sign is a vertical, gently curved, right-sided paracardiac density that increases in width as it approaches the right cardiophrenic angle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiography is the test of choice for the diagnosis of ASD. Transthoracic echocardiography is usually definitive in ostium secundum defects (",
"    <a class=\"graphic graphic_movie graphicRef80448 \" href=\"UTD.htm?6/56/7040\">",
"     movie 2",
"    </a>",
"    ), while transesophageal echocardiography may aid in the sizing of defects (",
"    <a class=\"graphic graphic_movie graphicRef79348 \" href=\"UTD.htm?22/39/23167\">",
"     movie 3",
"    </a>",
"    ), the diagnosis of sinus venosus defects, and the assessment of associated congenital anomalies or other abnormalities such as mitral valve prolapse [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/42\">",
"     42",
"    </a>",
"    ]. Shunt volume, shunt ratios, and pulmonary artery pressures can be measured with Doppler flow echocardiography. These issues are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/48/5896?source=see_link\">",
"     \"Identification and assessment of atrial septal defects in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance imaging can be helpful in selected cases with suspected associated defects such as partial anomalous pulmonary venous connection. &nbsp;Magnetic resonance imaging can also provide accurate quantitation of ventricular volumes, and pulmonary and systemic flow when this information is required [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26201/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Sinus venosus defects'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/31/6642?source=see_link\">",
"       \"Patient information: Atrial septal defect (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107035794\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital defects of the atrial septum are common, accounting for approximately 13 percent of all congenital heart disorders. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atrial septal defects (ASDs) can be an isolated finding or be associated with other congenital cardiac abnormalities. The sizes of ASDs are variable, and the functional consequences of an ASD are related to the anatomic location of the defect, its size, and the presence or absence of other cardiac anomalies. ASDs are classified based on their different anatomic locations, which generally reflects the abnormality of embryogenesis that led to the anomaly (",
"      <a class=\"graphic graphic_figure graphicRef52106 \" href=\"UTD.htm?7/36/7748\">",
"       figure 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef77749 \" href=\"UTD.htm?2/6/2153\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Classification'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Embryology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pathophysiology of ASDs depends upon the relationship of pulmonary and systemic resistances, the compliance of the right and left ventricles, and the size of the defect. At birth, the blood flow shifts from a right-to-left shunt to the more typical left-to-right shunt through the septal defect as the left atrial pressure rises above the right atrial pressure (",
"      <a class=\"graphic graphic_figure graphicRef72533 \" href=\"UTD.htm?23/17/23826\">",
"       figure 3",
"      </a>",
"      ). This results in increased pulmonary blood flow, which is generally well tolerated for years in patients without correction of their ASDs. However, the incidence of congestive heart failure and atrial arrhythmias increases with advancing age. Occasionally, pulmonary arteriopathy leading to progressive pulmonary hypertension may develop leading to right-to left shunting of blood (ie, Eisenmenger syndrome). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with isolated ASDs are generally asymptomatic and are typically diagnosed by the characteristic physical findings of a midsystolic pulmonary flow or ejection murmur accompanied by a fixed split second heart sound during routine examination. Infants with large ASDs may present with heart failure",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      recurrent respiratory infections. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of ASDs is clinically based on characteristic findings (as noted above) and confirmed by echocardiography. Echocardiography also establishes the specific type of ASD, size of the defect, and if present, detects other cardiac anomalies. (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Echocardiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other tests performed in the evaluation of children with ASDs include electrocardiogram and chest radiography. Magnetic resonance imaging (MRI) may be helpful in selected cases in which ASDs is one component of a more complex cardiac lesion, such as PAPVC. MRI also can provide accurate quantitation of ventricular volume, and pulmonary and systemic flow. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/1\">",
"      van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 2011; 58:2241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/2\">",
"      Riggs T, Sharp SE, Batton D, et al. Spontaneous closure of atrial septal defects in premature vs. full-term neonates. Pediatr Cardiol 2000; 21:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/3\">",
"      Helgason H, Jonsdottir G. Spontaneous closure of atrial septal defects. Pediatr Cardiol 1999; 20:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/4\">",
"      Brassard M, Fouron JC, van Doesburg NH, et al. Outcome of children with atrial septal defect considered too small for surgical closure. Am J Cardiol 1999; 83:1552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/5\">",
"      McMahon CJ, Feltes TF, Fraley JK, et al. Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart 2002; 87:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/6\">",
"      Caputo S, Capozzi G, Russo MG, et al. Familial recurrence of congenital heart disease in patients with ostium secundum atrial septal defect. Eur Heart J 2005; 26:2179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/7\">",
"      Gelernter-Yaniv L, Lorber A. The familial form of atrial septal defect. Acta Paediatr 2007; 96:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/8\">",
"      Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39:1890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/9\">",
"      Sucho�� E, Podolec P, P��azak W, et al. Mitral valve prolapse associated with ostium secundum atrial septal defect--a functional disorder. Acta Cardiol 2004; 59:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/10\">",
"      Joy J, Kartha CC, Balakrishnan KG. Structural basis for mitral valve dysfunction associated with ostium secundum atrial septal defects. Cardiology 1993; 82:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/11\">",
"      Vaughan CJ, Basson CT. Molecular determinants of atrial and ventricular septal defects and patent ductus arteriosus. Am J Med Genet 2000; 97:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/12\">",
"      Basson CT, Cowley GS, Solomon SD, et al. The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med 1994; 330:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/13\">",
"      Newbury-Ecob RA, Leanage R, Raeburn JA, Young ID. Holt-Oram syndrome: a clinical genetic study. J Med Genet 1996; 33:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/14\">",
"      Basson CT, Bachinsky DR, Lin RC, et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 1997; 15:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/15\">",
"      Garg V, Kathiriya IS, Barnes R, et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003; 424:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/16\">",
"      Zeisberg EM, Ma Q, Juraszek AL, et al. Morphogenesis of the right ventricle requires myocardial expression of Gata4. J Clin Invest 2005; 115:1522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/17\">",
"      Terrett JA, Newbury-Ecob R, Cross GS, et al. Holt-Oram syndrome is a genetically heterogeneous disease with one locus mapping to human chromosome 12q. Nat Genet 1994; 6:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/18\">",
"      Ching YH, Ghosh TK, Cross SJ, et al. Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet 2005; 37:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/19\">",
"      Schott JJ, Benson DW, Basson CT, et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998; 281:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/20\">",
"      Liu XY, Wang J, Yang YQ, et al. Novel NKX2-5 mutations in patients with familial atrial septal defects. Pediatr Cardiol 2011; 32:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/21\">",
"      Benson DW, Sharkey A, Fatkin D, et al. Reduced penetrance, variable expressivity, and genetic heterogeneity of familial atrial septal defects. Circulation 1998; 97:2043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/22\">",
"      al Zaghal AM, Li J, Anderson RH, et al. Anatomical criteria for the diagnosis of sinus venosus defects. Heart 1997; 78:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/23\">",
"      Van Praagh S, Geva T, Lock JE, et al. Biatrial or left atrial drainage of the right superior vena cava: anatomic, morphogenetic, and surgical considerations--report of three new cases and literature review. Pediatr Cardiol 2003; 24:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/24\">",
"      Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/25\">",
"      Arquizan C, Coste J, Touboul PJ, Mas JL. Is patent foramen ovale a family trait? A transcranial Doppler sonographic study. Stroke 2001; 32:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/26\">",
"      Steele PM, Fuster V, Cohen M, et al. Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction. Circulation 1987; 76:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/27\">",
"      Langholz D, Louie EK, Konstadt SN, et al. Transesophageal echocardiographic demonstration of distinct mechanisms for right to left shunting across a patent foramen ovale in the absence of pulmonary hypertension. J Am Coll Cardiol 1991; 18:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/28\">",
"      Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318:1148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/29\">",
"      Di Tullio M, Sacco RL, Gopal A, et al. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992; 117:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/30\">",
"      Markhorst DG, Rothuis E, Sobotka-Plojhar M, Moene RJ. Transient foramen ovale incompetence in the normal newborn: an echocardiographic study. Eur J Pediatr 1995; 154:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/31\">",
"      Muta H, Akagi T, Egami K, et al. Incidence and clinical features of asymptomatic atrial septal defect in school children diagnosed by heart disease screening. Circ J 2003; 67:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/32\">",
"      Rostad H, S&ouml;rland S. Atrial septal defect of secundum type in patients under 40 years of age. A review of 481 operated cases. Symptoms, signs, treatment and early results. Scand J Thorac Cardiovasc Surg 1979; 13:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/33\">",
"      Andrews R, Tulloh R, Magee A, Anderson D. Atrial septal defect with failure to thrive in infancy: hidden pulmonary vascular disease? Pediatr Cardiol 2002; 23:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/34\">",
"      Mainwaring RD, Mirali-Akbar H, Lamberti JJ, Moore JW. Secundum-type atrial septal defects with failure to thrive in the first year of life. J Card Surg 1996; 11:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/35\">",
"      Rhee EK, Evangelista JK, Nigrin DJ, Erickson LC. Impact of anatomic closure on somatic growth among small, asymptomatic children with secundum atrial septal defect. Am J Cardiol 2000; 85:1472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/36\">",
"      Ruschhaupt DG, Khoury L, Thilenius OG, et al. Electrophysiologic abnormalities of children with ostium secundum atrial septal defect. Am J Cardiol 1984; 53:1643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/37\">",
"      Bink-Boelkens MT, Bergstra A, Landsman ML. Functional abnormalities of the conduction system in children with an atrial septal defect. Int J Cardiol 1988; 20:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/38\">",
"      Davia JE, Cheitlin MD, Bedynek JL. Sinus venosus atrial septal defect: analysis of fifty cases. Am Heart J 1973; 85:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/39\">",
"      Shiku DJ, Stijns M, Lintermans JP, Vliers A. Influence of age on atrioventricular conduction intervals in children with and without atrial septal defect. J Electrocardiol 1982; 15:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/40\">",
"      Cohen JS, Patton DJ, Giuffre RM. The crochetage pattern in electrocardiograms of pediatric atrial septal defect patients. Can J Cardiol 2000; 16:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/41\">",
"      Cirillo RL Jr. The scimitar sign. Radiology 1998; 206:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/42\">",
"      Ayres NA, Miller-Hance W, Fyfe DA, et al. Indications and guidelines for performance of transesophageal echocardiography in the patient with pediatric acquired or congenital heart disease: report from the task force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr 2005; 18:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26201/abstract/43\">",
"      Beerbaum P, K&ouml;rperich H, Barth P, et al. Noninvasive quantification of left-to-right shunt in pediatric patients: phase-contrast cine magnetic resonance imaging compared with invasive oximetry. Circulation 2001; 103:2476.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5754 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-4554544F47-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26201=[""].join("\n");
var outline_f25_37_26201=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H107035794\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EMBRYOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Secundum defects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Genetic disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Sinus venosus defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Coronary sinus defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Patent foramen ovale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Primum defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Associated cardiovascular defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Perinatal physiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Postnatal physiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Patent foramen ovale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Small size for age",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Precordial palpation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Heart sounds",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Heart murmurs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Pulmonary hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Eisenmenger syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Extracardiac features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Paradoxical embolization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107035794\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5754\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5754|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/6/2153\" title=\"figure 1\">",
"      Atrial septal embryology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/36/7748\" title=\"figure 2\">",
"      Atrial septal defect anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/17/23826\" title=\"figure 3\">",
"      Pathophysiology ASD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5754|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/37/2640\" title=\"picture 1\">",
"      Clubbing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5754|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?12/48/13057\" title=\"movie 1\">",
"      TEE PFO",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?6/56/7040\" title=\"movie 2\">",
"      TTE two ASDs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?22/39/23167\" title=\"movie 3\">",
"      TEE ASD",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39689?source=related_link\">",
"      Atrial septal abnormalities (PFO, ASD, and ASA) and risk of cerebral emboli in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=related_link\">",
"      Auscultation of cardiac murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=related_link\">",
"      Auscultation of heart sounds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/55/6007?source=related_link\">",
"      Evaluation and prognosis of Eisenmenger syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/48/5896?source=related_link\">",
"      Identification and assessment of atrial septal defects in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/1/38936?source=related_link\">",
"      Management and outcome of isolated atrial septal defects in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/36/3656?source=related_link\">",
"      Partial anomalous pulmonary venous connection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/32/3593?source=related_link\">",
"      Patent foramen ovale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16825?source=related_link\">",
"      Pathophysiology and clinical features of atrial septal defects in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4344?source=related_link\">",
"      Pathophysiology of left to right shunts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8600?source=related_link\">",
"      Pathophysiology, clinical features, and diagnosis of migraine in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/31/6642?source=related_link\">",
"      Patient information: Atrial septal defect (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_37_26202="Auscultation of cardiac murmurs";
var content_f25_37_26202=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Auscultation of cardiac murmurs",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26202/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26202/contributors\">",
"     Kanu Chatterjee, MB, FRCP, FCCP, FACC, MACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26202/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26202/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/37/26202/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/37/26202/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/37/26202/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac auscultation is one of the most useful investigative tools that the physician can use at the bedside to detect alterations in cardiovascular anatomy and physiology. Most patients with significant valvular heart disease are first diagnosed based upon the finding of a murmur. Auscultation has a reported sensitivity of 70 percent and a specificity of 98 percent for detection of valvular heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/1\">",
"     1",
"    </a>",
"    ]. However, the sensitivity and specificity vary substantially with the expertise of the examiner.",
"   </p>",
"   <p>",
"    In clinical practice, echocardiography is the standard for establishing the cause of a murmur. The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (ACC/AHA)",
"    </span>",
"    guidelines on the management of patients with valvular heart disease (with 2008 focused update) included recommendations for the use of echocardiography in patients with symptomatic and asymptomatic murmurs (",
"    <a class=\"graphic graphic_table graphicRef50108 graphicRef58419 \" href=\"UTD.htm?39/46/40684\">",
"     table 1A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/2\">",
"     2",
"    </a>",
"    ]. The optimal management of valvular heart disease is based upon early diagnosis before the patient has become symptomatic.",
"   </p>",
"   <p>",
"    This topic will review the auscultation of cardiac murmurs, including the maneuvers (eg, respiration, Valsalva maneuver) that can be used to differentiate one murmur from another. These maneuvers as well as auscultation of other heart sounds are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41876?source=see_link\">",
"     \"Physiologic and pharmacologic maneuvers in the differential diagnosis of heart murmurs and sounds\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=see_link\">",
"     \"Auscultation of heart sounds\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MURMUR DESCRIPTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The character of a murmur is described by a number of features, including intensity (grade), frequency, timing, shape, location, and radiation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Intensity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The intensity of a murmur is primarily determined by the quantity and velocity of blood flow at the site of its origin, the transmission characteristic of the tissues between the blood flow and stethoscope, the site of auscultation or recording, and the distance of transmission. In general, the intensity declines in the presence of obesity, emphysema, and pericardial effusion. Murmurs are usually louder in children and in thin individuals.",
"   </p>",
"   <p>",
"    Six grades are used to classify the intensity of a murmur:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Grade I is the faintest murmur that can be heard (with difficulty)",
"     </li>",
"     <li>",
"      Grade II murmur is also a faint murmur but can be identified immediately",
"     </li>",
"     <li>",
"      Grade III murmur is moderately loud",
"     </li>",
"     <li>",
"      Grade IV murmur is loud and is associated with a palpable thrill",
"     </li>",
"     <li>",
"      Grade V murmur is very loud but cannot be heard without the stethoscope.",
"     </li>",
"     <li>",
"      Grade VI murmur is the loudest and can be heard without a stethoscope",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The gradation of intensity is purely subjective. However, it allows recognition of changes in the intensity of the murmur, which has diagnostic relevance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pitch",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of the murmur determines the pitch, which may be high or low. The quality can be described as harsh, rumbling, scratchy, grunting, blowing, squeaky, and musical. Quality and pitch are closely related.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Configuration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The time course of murmur intensity corresponds to the \"shape\" of a diagram of murmur intensity over time, as in a phonocardiogram. A number of configurations or shapes of murmurs are recognized:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Crescendo (increasing)",
"     </li>",
"     <li>",
"      Decrescendo (diminishing)",
"     </li>",
"     <li>",
"      Crescendo-decrescendo (increasing-decreasing or diamond shaped)",
"     </li>",
"     <li>",
"      Plateau (unchanged in intensity)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Location",
"    </span>",
"    &nbsp;&mdash;&nbsp;The location on the patient's chest where the murmur is loudest is typically described as apical or parasternal. Parasternal murmurs are further described by the intercostal space and right or left side of the sternum [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Timing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duration of a murmur is assessed by determining the length of systole or diastole that the murmur occupies. The murmur can be long (eg, it occupies most of systole or diastole), or it can be brief. The following classification is useful [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    For systolic murmurs:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Midsystolic (or systolic ejection)",
"     </li>",
"     <li>",
"      Holosystolic (or pansystolic)",
"     </li>",
"     <li>",
"      Early systolic",
"     </li>",
"     <li>",
"      Late systolic",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For diastolic murmurs:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Early diastolic",
"     </li>",
"     <li>",
"      Mid-diastolic",
"     </li>",
"     <li>",
"      Late diastolic (or presystolic)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Continuous murmurs",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Systolic murmurs",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systolic murmur starts with or after S1 and terminates before or at S2 (",
"    <a class=\"graphic graphic_figure graphicRef61744 \" href=\"UTD.htm?16/62/17391\">",
"     figure 1",
"    </a>",
"    ). Systolic murmurs are recognized by identifying S1 and S2 and timing them with the carotid pulse. In patients with marked tachycardia, a long diastolic murmur can be occasionally confused with a systolic murmur; timing with the carotid pulse upstroke avoids an incorrect diagnosis.",
"   </p>",
"   <p>",
"    Systolic murmurs are further classified according to the time of onset and termination in systole:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A midsystolic murmur (MSM) begins after S1 and ends before A2 (left sided) or P2 (right sided) (",
"      <a class=\"graphic graphic_table graphicRef65728 \" href=\"UTD.htm?5/28/5581\">",
"       table 2",
"      </a>",
"      ). Both S1 and S2 are audible",
"     </li>",
"     <li>",
"      A holosystolic (or pansystolic) murmur starts with S1 and extends up to A2 (left sided) or P2 (right sided), obscuring both S1 and S2",
"     </li>",
"     <li>",
"      An early systolic murmur obscures S1 and extends for a variable length in systole but does not extend up to S2",
"     </li>",
"     <li>",
"      A late systolic murmur starts after S1 and obscures A2 (left sided) or P2 (right sided)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Diastolic murmurs",
"    </span>",
"    &nbsp;&mdash;&nbsp;A diastolic murmur starts with or after S2 and ends at or before S1. Diastolic murmurs are also classified according to the time of onset and termination of the murmur in diastole:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An early diastolic murmur starts with A2 (left sided) or P2 (right sided) and extends into diastole for a variable duration",
"     </li>",
"     <li>",
"      A mid-diastolic murmur starts after S2 and terminates before S1",
"     </li>",
"     <li>",
"      A late diastolic (presystolic) murmur starts well after S2 and extends up to the mitral component (left sided) or to the tricuspid component (right sided) of S1",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Continuous murmur",
"    </span>",
"    &nbsp;&mdash;&nbsp;A continuous murmur begins in systole and continues to diastole without interruption, encompassing the S2 (",
"    <a class=\"graphic graphic_figure graphicRef54292 \" href=\"UTD.htm?18/5/18526\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef50660 \" href=\"UTD.htm?16/39/17020\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     MIDSYSTOLIC EJECTION MURMURS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ejection or midsystolic murmur (MSM) is related to flow of blood across the semilunar valves; onset of the MSM coincides with the beginning of ejection and termination occurs with the cessation of forward flow. S1 occurs at the onset of isovolumic systole when ventricular pressure rises; ejection, and thus the MSM, begins at the end of isovolumic systole when the ventricular pressures exceed the semilunar valve opening pressure. The onset of a MSM is therefore separated from S1 and the interval between S1 and the onset of the murmur is proportional to the duration of isovolumic systole (",
"    <a class=\"graphic graphic_figure graphicRef61744 \" href=\"UTD.htm?16/62/17391\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The intensity of the MSM increases (crescendo) during acceleration of blood flow early in systole; intensity declines (decrescendo) with the later deceleration of flow, resulting in a crescendo-decrescendo configuration. Forward flow from the ventricle stops when ventricular pressure falls below the aortic or pulmonary artery pressures, before the closure of the semilunar valves. The murmur terminates with cessation of flow, before A2 or P2, depending upon whether the murmur is left or right sided, respectively. The interval between the termination of the murmur and A2 or P2 is proportional to the aortic or pulmonic hangout time, respectively.",
"   </p>",
"   <p>",
"    The most common causes of a MSM are benign (innocent) flow murmurs, an increase in flow rate across a normal semilunar valve, and aortic valve sclerosis. These physiologic murmurs need to be distinguished from the abnormal MSM in patients with fixed or dynamic outflow tract obstruction (",
"    <a class=\"graphic graphic_table graphicRef65728 \" href=\"UTD.htm?5/28/5581\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Innocent midsystolic murmurs",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systolic murmur is present in up to 60 percent of patients, with 90 percent being associated with a normal echocardiogram [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/4\">",
"     4",
"    </a>",
"    ]. These innocent or benign \"flow\" murmurs are typically ejection type and midsystolic in timing (",
"    <a class=\"graphic graphic_table graphicRef65728 \" href=\"UTD.htm?5/28/5581\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/5\">",
"     5",
"    </a>",
"    ]. The \"innocence\" of an MSM should not depend upon the duration or intensity of the murmur, but on the absence of other abnormal findings. Even a short grade",
"    <span class=\"nowrap\">",
"     I/VI",
"    </span>",
"    ejection mid-systolic murmur may not be innocent if there are coexisting findings such as an abnormal S2.",
"   </p>",
"   <p>",
"    A short, vibrating murmur (Still's murmur) can be heard over the mid precordium in children in the absence of any other abnormality. It is thought to arise from vibrations of the attachments of the pulmonic valve leaflets.",
"   </p>",
"   <p>",
"    Another innocent MSM can be heard in children and young adults that has a blowing quality and is best heard over the left second interspace. This murmur is thought to originate from vibrations of the pulmonary trunk.",
"   </p>",
"   <p>",
"    In patients with the straight back syndrome who have a decreased anteroposterior diameter of the chest, a superficial MSM is heard over the left second interspace [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/6\">",
"     6",
"    </a>",
"    ]. The mechanism of the murmur remains unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Increased semilunar blood flow",
"    </span>",
"    &nbsp;&mdash;&nbsp;An MSM also occurs in the presence of normal valves when flow across the semilunar valve is significantly increased, as occurs in the following settings (",
"    <a class=\"graphic graphic_table graphicRef65728 \" href=\"UTD.htm?5/28/5581\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anemia, pregnancy, and thyrotoxicosis. As an example, a pulmonic MSM is present in over 80 percent of normal pregnant women.",
"     </li>",
"     <li>",
"      In patients with pure aortic regurgitation, an ejection mid-systolic murmur may result from markedly increased flow across the aortic valve and should not be considered evidence for aortic stenosis in the absence of other findings.",
"     </li>",
"     <li>",
"      An atrial septal defect with left to right shunting results in an ejection mid-systolic murmur resulting from increased flow across the pulmonic valve. This does not indicate associated pulmonic stenosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Aortic valve sclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The murmur of aortic sclerosis is also a midsystolic ejection murmur (",
"    <a class=\"graphic graphic_figure graphicRef61744 \" href=\"UTD.htm?16/62/17391\">",
"     figure 1",
"    </a>",
"    ). It is not associated with hemodynamic consequences, but it must be considered in the differential diagnosis of aortic stenosis in elderly patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38279?source=see_link\">",
"     \"Aortic valve sclerosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The murmur is usually best heard over the right second interspace. In some patients, a musical high-frequency murmur of brief duration can be heard along the lower left sternal border and cardiac apex. In general, the murmur is brief and not very loud. A normal carotid pulse and normal S2 confirm the absence of significant aortic valve obstruction.",
"   </p>",
"   <p>",
"    The clinical significance of the diagnosis of aortic sclerosis is that it is a risk factor for long-term adverse outcomes due to atherosclerotic heart disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Aortic outflow obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;An MSM associated with fixed aortic obstruction due to valvular, subvalvular, or supravalvular stenosis or hypertrophic cardiomyopathy (HCM) typically is harsh and medium pitch (",
"    <a class=\"graphic graphic_table graphicRef65728 \" href=\"UTD.htm?5/28/5581\">",
"     table 2",
"    </a>",
"    ). The time the murmur peaks after its onset bears some correlation to the severity of the obstruction. In patients with aortic stenosis (AS), the longer- and later-peaking murmur is usually associated with hemodynamically significant obstruction; a brief and early peaking murmur indicates less severe AS (",
"    <a class=\"graphic graphic_figure graphicRef61744 \" href=\"UTD.htm?16/62/17391\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    However, the intensity of the murmur is variable and may not correlate with the severity of stenosis. A grade 4 or greater murmur is specific but not sensitive for the diagnosis of severe AS, as most patients with severe AS have a grade 3 murmur. Furthermore, the presence of heart failure and a reduced stroke volume, the duration, configuration, and intensity bear a poor correlation to the degree of obstruction.",
"   </p>",
"   <p>",
"    An ejection sound at the onset of the murmur suggests congenital aortic stenosis or a bicuspid valve. The ejection sound is usually absent in severe AS.",
"   </p>",
"   <p>",
"    The site of maximum intensity and direction of radiation of the murmur are related to the site of obstruction and the direction of the jet in the aortic root. Nevertheless, echocardiography is required for accurate determination of the site and severity of a fixed obstruction (valvular, supravalvular, or subvalvular).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Valvular aortic stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In valvular AS, the maximum intensity is appreciated over the right second interspace; a thrill may be palpable over the same area. The murmur radiates up into the neck and over both carotid arteries (",
"    <a class=\"graphic graphic_table graphicRef51024 \" href=\"UTD.htm?42/11/43196\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In older patients with calcific trileaflet AS, an MSM with a musical quality is frequently heard over the cardiac apex or along the lower left sternal border, in addition to a harsh murmur over the right second interspace (",
"    <a class=\"graphic graphic_movie graphicRef67896 \" href=\"UTD.htm?13/13/13521\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef56063 \" href=\"UTD.htm?20/22/20832\">",
"     movie 2",
"    </a>",
"    ). A musical murmur appears to originate from the vibration of the valve and subvalvular structures and can be recorded in the left ventricular (LV) cavity (Gallavardin phenomenon); a harsh murmur originates in the aortic root and is related to the high-velocity ejection jet. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=see_link\">",
"     \"Clinical features and evaluation of aortic stenosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A bicuspid aortic valve is another common cause of an MSM, and the murmur may be present before leaflet thickening and calcification result in outflow obstruction (",
"    <a class=\"graphic graphic_table graphicRef65728 \" href=\"UTD.htm?5/28/5581\">",
"     table 2",
"    </a>",
"    ). The murmur is best heard over the right second interspace with little or no radiation (",
"    <a class=\"graphic graphic_movie graphicRef77091 \" href=\"UTD.htm?39/8/40065\">",
"     movie 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef72877 \" href=\"UTD.htm?43/6/44128\">",
"     movie 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The diagnosis of a nonstenotic bicuspid valve is virtually confirmed if it is accompanied by an aortic ejection sound, a short early diastolic murmur, and normal carotid pulse upstroke and S2. However, these findings are not sensitive for the diagnosis and many patients with a bicuspid valve are first diagnosed when echocardiography is performed for other indications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=see_link\">",
"     \"Clinical manifestations and diagnosis of bicuspid aortic valve\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Supravalvular aortic stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In supravalvular AS, the murmur may be loudest at a slightly higher location than in valvular aortic stenosis (",
"    <a class=\"graphic graphic_table graphicRef51024 \" href=\"UTD.htm?42/11/43196\">",
"     table 4",
"    </a>",
"    ). In addition, the intensity of the radiated murmur over the right carotid may be greater than over the left carotid artery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/52/40774?source=see_link\">",
"     \"Supravalvar aortic stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Subvalvular outflow obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;In subvalvular LV outflow obstruction, usually due to hypertrophic cardiomyopathy, the maximum intensity of the murmur is usually located along the lower left sternal border or over the cardiac apex (",
"    <a class=\"graphic graphic_table graphicRef51024 \" href=\"UTD.htm?42/11/43196\">",
"     table 4",
"    </a>",
"    ). It radiates poorly to the base and neck. The site of the LV outflow obstruction cannot be identified with certainty by the location, radiation, and character of the MSM. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Fixed versus dynamic outflow obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is usually not difficult to distinguish between fixed valvular AS and dynamic (obstructive HCM) LV outflow obstruction (",
"    <a class=\"graphic graphic_table graphicRef51024 \" href=\"UTD.htm?42/11/43196\">",
"     table 4",
"    </a>",
"    ). With respect to the carotid pulse:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In fixed valvular AS, the initial upstroke and the peak of the carotid pulse are delayed and the volume may be reduced.",
"     </li>",
"     <li>",
"      In obstructive HCM, the initial upstroke of the carotid pulse is usually sharp and the volume is normal.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The change in intensity of the MSM in response to different maneuvers is also useful diagnostically.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With the patient starting in a squatting position, assuming a standing position increases the intensity of the murmur in HCM; it decreases the murmur of valvular aortic stenosis. This is the most reliable maneuver for evaluation of a MSM.",
"     </li>",
"     <li>",
"      The murmur of HCM increases in intensity with the straining phase of a Valsalva maneuver and the carotid pulse decreases or is unchanged. Both the intensity of the murmur and the carotid pulse volume decline with Valsalva in AS.",
"     </li>",
"     <li>",
"      With amyl nitrate inhalation, the murmur of HCM increases in intensity and the carotid pulse volume decreases or remains unchanged. Heart rate increases and arterial blood pressure falls. In AS, both the intensity of the murmur and carotid pulse volume increase with amyl nitrate inhalation. It is generally more difficult to interpret the responses to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/1/33813?source=see_link\">",
"       amyl nitrite",
"      </a>",
"      than to standing or Valsalva in distinguishing HCM from valvular AS.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These features can also be used to distinguish HCM from fixed subvalvular aortic stenosis (subaortic stenosis), which is seen primarily in children (",
"    <a class=\"graphic graphic_table graphicRef51024 \" href=\"UTD.htm?42/11/43196\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33207?source=see_link\">",
"     \"Subvalvar aortic stenosis (subaortic stenosis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The murmur of dynamic left ventricular outflow obstruction has been observed transiently in patients who develop acquired left ventricular outflow obstruction during acute myocardial infarction or in patients with apical ballooning syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/1\">",
"     1",
"    </a>",
"    ]. However, these complications are distinctly rare. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/1/30745?source=see_link\">",
"     \"Stress-induced (takotsubo) cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Pulmonic outflow obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The murmur of valvular pulmonic stenosis is harsh and best heard over the left second interspace. When the murmur is loud it radiates to the left side of the neck and is frequently accompanied by a palpable thrill. A pulmonic ejection sound at the onset of the murmur may be heard, and S2 is widely split with a decreased intensity of P2. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/62/39910?source=see_link\">",
"     \"Clinical manifestations and diagnosis of pulmonic stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The murmur duration correlates reasonably well with the severity of stenosis. The duration can be determined by timing the termination of the murmur in relation to A2. A murmur terminating before A2 (relatively short) is usually associated with mild to moderate stenosis. Stenosis is likely to be more severe if the murmur drowns A2 (terminating after A2) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Occasionally, the long, harsh MSM of pulmonic stenosis can be confused with the holosystolic murmur of a ventricular septal defect. This is more likely to occur with infundibular than valvular stenosis because of the lower location of the murmur. Careful attention to the behavior of S2 helps in the differential diagnosis: S2 is usually normal in VSD, while in pulmonic stenosis it is widely split and the intensity of P2 is decreased.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/1/33813?source=see_link\">",
"     Amyl nitrite",
"    </a>",
"    inhalation is sometimes helpful; it usually decreases the intensity of the VSD murmur but not that of the pulmonic stenosis (which may be accentuated).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Dilation of the aortic root or pulmonary artery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortic root dilatation or dilatation of the proximal pulmonary artery may be associated with an MSM. The usual findings of idiopathic dilatation of the pulmonary artery are a pulmonary ejection sound, a short midsystolic murmur, a relatively widely split S2 with normal intensity of P2, and occasionally a short pulmonic regurgitant murmur. There is no hemodynamic abnormality. The auscultatory findings are very similar in pulmonary hypertension, except S2 is narrowly split with P2 markedly accentuated, the pulmonic ejection sound is relatively late, and hemodynamic abnormalities are always evident.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1552257\">",
"    <span class=\"h2\">",
"     Mid-systolic versus holosystolic murmurs",
"    </span>",
"    &nbsp;&mdash;&nbsp;It can be difficult to distinguish between a long MSM and a holosystolic regurgitant murmur in certain situations. The MSM transmitted to the cardiac apex in dynamic or fixed LV outflow obstruction may sound similar to the murmur of mitral regurgitation (MR) or ventricular septal defect (VSD). It is often difficult to appreciate the onset of the murmur when S1 is soft, which can occur in AS or MR. When A2 is soft, determining the timing of murmur termination may also be difficult. Although the etiology of the murmur will be readily established by echocardiography [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/3\">",
"     3",
"    </a>",
"    ], a number of helpful distinguishing features can be elicited by auscultation (",
"    <a class=\"graphic graphic_figure graphicRef61744 \" href=\"UTD.htm?16/62/17391\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The murmur is likely to be mid-systolic if A2 is clearly audible over the cardiac apex. If A2 is heard over the right and left second interspaces but not over the apex, it is likely that A2 is \"drowned\" by the holosystolic murmur of MR.",
"     </li>",
"     <li>",
"      The intensity of an MSM increases with a longer RR cycle (eg, in patients with atrial fibrillation and varying RR cycles) and with a post ectopic beat (in patients with premature beats); the intensity of a regurgitant murmur usually remains unchanged in these situations.",
"     </li>",
"     <li>",
"      Changes in the intensity of the murmur may occur in response to hand grip; it increases the intensity of an MR murmur (increased afterload effect) and usually decreases the intensity of an AS murmur. However, the physiologic responses to hand grip are complex; in addition to an increase in systemic vascular tone and arterial pressure, a reflex increase in contractility may occur, which may increase, rather than decrease, the intensity of the stenotic murmur.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     HOLOSYSTOLIC MURMURS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Holosystolic murmurs are usually regurgitant murmurs and occur when blood flows from a chamber whose pressure throughout systole is higher than pressure in the chamber receiving the flow. There are three causes of holosystolic murmurs:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      MR",
"     </li>",
"     <li>",
"      Tricuspid regurgitation",
"     </li>",
"     <li>",
"      VSD",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The timing and duration of holosystolic murmurs are best explained by the hemodynamic changes of MR. In hemodynamically significant MR, regurgitant flow from the left ventricle to the left atrium begins with the onset of isovolumic systole when pressure in the left ventricle just exceeds pressure in the left atrium. This pressure crossover point also marks S1, explaining the onset of the holosystolic murmur with S1. Throughout systole and extending to the early part of the isovolumic relaxation phase, the left ventricular pressure remains higher than the left atrial pressure. Thus, the regurgitant flow continues throughout systole, and even after aortic valve closure, explaining the holosystolic character of the regurgitant murmur. This also explains why A2 is often drowned by the murmur over the cardiac apex.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Mitral regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The holosystolic murmur of MR is high pitched and best heard with the diaphragm of the stethoscope and the patient in the left lateral decubitus position (",
"    <a class=\"graphic graphic_movie graphicRef56783 \" href=\"UTD.htm?15/24/15744\">",
"     movie 5",
"    </a>",
"    ). Radiation depends upon the murmur intensity, which may be variable. The direction of radiation follows the direction of the regurgitant jet into the left atrium.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When the jet is directed posterolaterally, the apical holosystolic murmur radiates toward the left axilla, inferior angle of the left scapula, and over the thoracic spine [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/8\">",
"       8",
"      </a>",
"      ]. In some patients, a loud murmur may be transmitted up the spine to the top of the head.",
"     </li>",
"     <li>",
"      The murmur radiates toward the base and root of the neck if the regurgitant stream is directed anteromedially against the interatrial septum near the base of the aorta. Thus, it can be confused with the murmur of AS or obstructive HCM. The character of the carotid pulse and the behavior of S2 provide important clues to the diagnosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Associated physical findings may help to characterize the nature and severity of MR, although with significant limitations. A more benign overall examination is suggestive of less severe MR and primary valve disease. Abnormalities (eg, S3, an accentuated P2, or a displaced apical impulse) are less helpful, since they can occur with primary valve disease, secondary MR, or a separate cardiac or pulmonary abnormality. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/30/9705?source=see_link\">",
"     \"Etiology, clinical features, and evaluation of chronic mitral regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The value and limitations of associated physical findings in a patient with MR is illustrated by the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The absence of an S3 and cardiac enlargement suggest hemodynamically insignificant chronic MR. In contrast, clinical evidence of pulmonary hypertension (accentuated P2, right ventricular systolic hypertension) and right-sided heart failure are almost always associated with significant MR, provided no other cause of pulmonary hypertension coexists.",
"     </li>",
"     <li>",
"      A normal or hyperdynamic LV apical impulse suggests normal LV systolic function, and therefore primary MR. However, a displaced or sustained apical impulse may occur with either primary or secondary MR.",
"     </li>",
"     <li>",
"      In patients with either severe primary MR or a dilated cardiomyopathy with secondary (functional) MR, there may be an S3 gallop due to the high antegrade flow across the mitral valve, and findings of pulmonary hypertension and right heart failure. However, in dilated cardiomyopathy, S3 and findings of pulmonary hypertension may be present with mild or insignificant MR.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, physical examination cannot reliably distinguish chronic severe MR due to primary valve disease from secondary MR due to dilated cardiomyopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9909?source=see_link\">",
"     \"Examination of the precordial pulsation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Tricuspid regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The holosystolic murmur of tricuspid regurgitation is best heard with the diaphragm of the stethoscope over the lower left second and third interspaces and along the left sternal border. The location of maximum intensity may be shifted toward the cardiac apex when the right ventricle is dilated and the murmur can be misdiagnosed as MR. Radiation and respiratory changes in the intensity of the murmur are two important distinguishing features.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With tricuspid regurgitation, the murmur is heard along the left or right sternal border and may radiate to the epigastrium.",
"     </li>",
"     <li>",
"      During the inspiratory phase of respiration, the intensity of the murmur of tricuspid regurgitation increases (Carvallo's sign, sometimes spelled Carvello's) if severe right ventricular failure is not present. The increase in intensity does not occur immediately with the onset of inspiration, but after one or two cardiac cycles. The mechanism for the increase in intensity appears to be augmented regurgitant flow following the inspiratory increase in right ventricular volume. A right ventricular S3 gallop and a mid-diastolic flow murmur, which also increase in intensity with inspiration, suggest more severe tricuspid regurgitation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Murmur intensity does not change in the presence of severe right ventricular failure when right ventricular volume may not change appreciably. With severe right-sided heart failure, the murmur can be absent, or only an early systolic murmur may be recognized. In these circumstances, the bedside diagnosis of tricuspid regurgitation relies upon the presence of other physical findings, such as a prominent v wave in the jugular venous pulse and systolic hepatic pulsation.",
"   </p>",
"   <p>",
"    Tricuspid regurgitation is most often secondary to pulmonary arterial hypertension. Thus, a prominent left parasternal impulse and narrow splitting of S2 with an accentuated P2 suggest secondary tricuspid regurgitation. Theoretically, severe tricuspid regurgitation may produce reversed splitting of S2 due to shortened right ventricular ejection time; however, this is a rare finding.",
"   </p>",
"   <p>",
"    Primary tricuspid regurgitation is much less common but can occur following bacterial endocarditis (eg, with intravenous drug abuse) or in patients with Ebstein's anomaly, carcinoid heart disease, or prior right ventricular infarction. A hyperdynamic left parasternal impulse and normal or only slightly accentuated P2 suggest primary tricuspid regurgitation, but its diagnosis primarily depends upon the elimination of pulmonary hypertension and left-sided disorders such as mitral and aortic valve disease and cardiomyopathy. In primary tricuspid regurgitation, the murmur may be early systolic rather than holosystolic, and have a decrescendo shape. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/9/149?source=see_link\">",
"     \"Etiology, clinical features, and evaluation of tricuspid regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Ventricular septal defect",
"    </span>",
"    &nbsp;&mdash;&nbsp;VSDs cause a holosystolic murmur if pressure in the right ventricle is lower than the left ventricle throughout systole, resulting in a continuous left-to-right shunt [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. This hemodynamic profile is present in small VSDs and is associated with normal pulmonary artery pressure and pulmonary vascular resistance. Thus, S2 is normal and pulmonary hypertension is absent.",
"   </p>",
"   <p>",
"    The murmur is usually loud and may be accompanied by a thrill. The left-to-right shunt is directed toward the right ventricular cavity. The murmur is maximal over the third and fourth interspaces along the sternal border when the VSD is below the crista supraventricularis. When the defect is above the crista, the shunt is directed toward the pulmonary trunk; the maximal intensity of the murmur may be in the left second interspace in this case, and it can be confused with the murmur of pulmonary valve stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Changes in S2 help in the differential diagnosis. A wide splitting of S2 with reduced intensity of P2 is present in pulmonary stenosis; a normal S2 favors VSD.",
"   </p>",
"   <p>",
"    The character and timing of the systolic murmur change with large VSDs due to increased right ventricular and pulmonary artery pressure and an elevated pulmonary vascular resistance. Instead of being holosystolic, it becomes early systolic and the peak of the murmur occurs earlier. The physical findings of pulmonary arterial hypertension and right ventricular hypertrophy are present.",
"   </p>",
"   <p>",
"    When ventricular pressures are equal in Eisenmenger complex, there is no murmur across the VSD; instead a mid-systolic murmur due to dilatation of the pulmonary trunk appears. S2 is markedly accentuated and single [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, a loud holosystolic murmur in a patient with a VSD indicates favorable hemodynamics (eg, relatively normal right-sided pressures). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=see_link\">",
"     \"Pathophysiology and clinical features of isolated ventricular septal defects in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     EARLY SYSTOLIC MURMURS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early systolic murmurs begin with S1, do not extend to S2, and generally have a decrescendo configuration. Early systolic murmurs may result from MR, tricuspid regurgitation, or VSD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Mitral regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Either acute severe or mild chronic MR can be associated with an early systolic murmur. Acute severe mitral regurgitation causes a rapid increase in left atrial pressure and a giant regurgitant wave (v wave) during the latter part of ventricular systole. An equalization of left atrial and left ventricular pressure may occur, preventing the regurgitant flow during this part of systole. Thus, the regurgitant murmur terminates before A2. Since the regurgitant flow is maximal at the beginning of systole and decreases with increasing left atrial pressure, a decrescendo configuration of this early systolic murmur is common [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. Associated clinical findings include pulmonary hypertension, hyperdynamic apical impulse, a late systolic left parasternal impulse, and atrial and ventricular gallops. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/45/28376?source=see_link\">",
"     \"Pathophysiology, clinical features, evaluation, and management of acute mitral regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In some patients with mitral stenosis, an early systolic murmur is heard and probably represents mild mitral regurgitation. Secondary mitral regurgitation in dilated cardiomyopathy is usually mild and may be early systolic in timing. Mitral annular calcification can be associated with an early systolic murmur and suggests trivial MR. Ineffective reduction of the circumference of the annulus at the beginning of systole, due to calcification, is probably the underlying mechanism for mild MR and the early systolic murmur [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Tricuspid regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary tricuspid regurgitation with normal right ventricular systolic pressure, as seen with infective endocarditis in drug addicts, may be associated with an early systolic murmur with a decrescendo configuration. The mechanism is similar to that in acute, severe MR. A rapid increase in right atrial pressure and an accentuated v wave in the later part of systole decreases the regurgitant flow. The frequency of these murmurs is usually lower than the murmurs associated with an elevated right ventricular systolic pressure, presumably due to a lower rate of regurgitation. In addition to a relatively normal S2, palpating and recording the left parasternal impulse may reveal a systolic inward movement and a diastolic outward movement, reflecting right ventricular volume changes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Ventricular septal defect",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a large VSD with pulmonary hypertension, the murmur may be early systolic in timing, since the increasing right ventricular pressure during late systole decreases the left-to-right shunt. Findings of pulmonary hypertension are always present. An early systolic murmur may also occur in some patients with a VSD in the absence of pulmonary hypertension or increased pulmonary vascular resistance; these murmurs are more frequently localized and of shorter duration. They tend to occur with VSDs that later close spontaneously [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Small muscular VSDs may also cause an early systolic murmur, since the defect closes soon after the onset of systole. Evidence of pulmonary hypertension is absent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/52/14154?source=see_link&amp;anchor=H26371633#H26371633\">",
"     \"Ventricular septal defect in adults\", section on 'Physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     LATE SYSTOLIC MURMURS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A late systolic murmur starts after S1 and, if left-sided, extends to A2, usually in a crescendo manner (",
"    <a class=\"graphic graphic_figure graphicRef54292 \" href=\"UTD.htm?18/5/18526\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Mitral valve prolapse",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitral valve prolapse is the most common cause of a late systolic murmur. It is best heard with the diaphragm of the stethoscope, over or just medial to the cardiac apex. It is usually preceded by single or multiple clicks [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/16\">",
"     16",
"    </a>",
"    ]. Mitral valve prolapse can occur from disorders of the mitral annulus, redundancy of the leaflets, abnormalities of the chordae, or contraction abnormalities of the left ventricular wall. Mitral regurgitation occurs when prolapse is sufficient to cause a lack of apposition of the leaflets. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13705?source=see_link\">",
"     \"Definition and diagnosis of mitral valve prolapse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most common etiology for mitral valve prolapse is redundancy of valve tissue with respect to the valve ring (\"floppy\" valve or Barlow's syndrome). This disparity increases with a decreased left ventricular volume, which is associated with an earlier onset of prolapse and, therefore, the late systolic murmur occupies a relatively greater portion of systole. Standing, sitting, Valsalva's maneuver (phase 2), and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/1/33813?source=see_link\">",
"     amyl nitrite",
"    </a>",
"    inhalation all decrease left ventricular volume and cause an earlier onset of the click and murmur, which also appear long (",
"    <a class=\"graphic graphic_table graphicRef75155 \" href=\"UTD.htm?11/1/11292\">",
"     table 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef57858 \" href=\"UTD.htm?7/55/8051\">",
"     movie 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef80360 \" href=\"UTD.htm?15/40/16004\">",
"     movie 7",
"    </a>",
"    ). The intensity, however, becomes softer.",
"   </p>",
"   <p>",
"    Conversely, squatting, elevation of the legs, or isometric exercise (hand grip), which increases left ventricular volume, delay the onset of the click and murmur, the intensity of which may increase. A \"whoop\" or \"honk,\" which is a high-frequency, musical, loud, and widely transmitted murmur, can appear intermittently in some patients with mitral valve prolapse and may be precipitated by a change of posture.",
"   </p>",
"   <p>",
"    In general, mitral valve prolapse with a late systolic murmur is associated with mild mitral regurgitation and is not accompanied by an S3 or signs of pulmonary hypertension. Left ventricular function is normal.",
"   </p>",
"   <p>",
"    In patients with pseudohypertrophic muscular dystrophy, mitral valve prolapse and a late systolic murmur are manifestations of cardiac involvement. These may or may not be associated with midsystolic clicks. The electrocardiogram almost always demonstrates a relatively tall R wave in leads V1 and V2, simulating true posterior myocardial infarction. The mechanism of mitral valve prolapse and its electrocardiographic changes is fibrosis of the posterior left ventricular wall.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Tricuspid valve prolapse",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tricuspid valve prolapse is uncommon in the absence of mitral valve prolapse. It causes a late systolic murmur that extends up to P2. It is best heard over the left lower sternal border. Onset of the murmur may be delayed during inspiration due to an increase in right ventricular volume.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Ischemic mitral regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A late systolic murmur may occur with mild mitral regurgitation due to papillary muscle displacement (previously known as papillary muscle dysfunction) in patients with &ldquo;ischemic mitral regurgitation&rdquo; due to acute or chronic myocardial infarction. It can also occur in patients with chronic coronary artery disease during an episode of myocardial ischemia, presumably due to ischemic papillary muscle displacement. In these patients, isometric exercise or maneuvers that increase ventricular volume may precipitate mitral regurgitation and a late systolic murmur because of increased myocardial oxygen requirements, which may induce myocardial ischemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18297?source=see_link\">",
"     \"Ischemic mitral regurgitation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/6/11369?source=see_link\">",
"     \"Role of echocardiography in acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     EARLY DIASTOLIC MURMURS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early diastolic murmurs, most often due to aortic or pulmonary regurgitation, typically start at the time of semilunar valve closure and their onset coincides with S2. An aortic regurgitation murmur begins with A2; pulmonary regurgitation begins with P2.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Aortic regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Discovery of a diastolic murmur is essential for the diagnosis of aortic regurgitation. In a review of the literature, the presence of an early diastolic murmur was the most useful finding for establishing the presence of aortic regurgitation (positive likelihood ratio 8.8 [ie, the odds of aortic regurgitation are increased 8.8-fold]) and its absence the most useful finding for eliminating the presence of aortic regurgitation (negative likelihood ratio 0.2 to 0.3 [ie, the odds of disease are reduced by a factor of 0.2 to 0.3]) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/17\">",
"     17",
"    </a>",
"    ]. Among patients with end-stage renal disease, a transient murmur of aortic regurgitation may be induced by the effects of volume overload; thus, such patients should be reexamined after dialysis, when the excess fluid has been removed [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The murmur of aortic regurgitation is best heard with the diaphragm of the stethoscope. Low-intensity, high-pitched aortic regurgitation murmurs may not be heard unless firm pressure is applied with the diaphragm of the stethoscope over the left sternal border or over the right second interspace, while the patient sits and leans forward with the breath held in full expiration (",
"    <a class=\"graphic graphic_movie graphicRef77962 \" href=\"UTD.htm?0/12/195\">",
"     movie 8",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef76340 \" href=\"UTD.htm?39/27/40368\">",
"     movie 9",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The radiation of an aortic regurgitation murmur is toward the cardiac apex and the location of maximum intensity may vary considerably. It can be best heard in some patients over the mid precordium, along the lower left sternal border, or even over the cardiac apex (",
"    <a class=\"graphic graphic_movie graphicRef56371 \" href=\"UTD.htm?41/61/42960\">",
"     movie 10",
"    </a>",
"    ). Radiation of the murmur to the right sternal border is more common in aortic regurgitation caused by aortic root or aortic cusp anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The configuration of the aortic regurgitation murmur is usually decrescendo because the magnitude of regurgitation progressively declines. The murmur is high-frequency and has a \"blowing\" character. Occasionally the murmur can be musical in quality (diastolic whoop); this has been attributed to a flail everted aortic cusp. The \"whoop\" can be mid, late, or pansystolic [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The duration of the murmur is variable but usually terminates before S1. The duration of the murmur does not always correlate with the severity of aortic regurgitation, although mild aortic regurgitation is usually associated with a murmur of brief duration. The murmur may also be short with acute severe aortic regurgitation because of a rapid increase in left ventricular diastolic pressure, which equalizes with aortic diastolic pressure soon after the onset of diastole. If the aortic pressure remains higher than left ventricular pressure throughout diastole, a pandiastolic murmur may be present, even when the severity of aortic regurgitation is only moderate. Bedside evaluation of the severity of aortic regurgitation should be primarily based upon a determination of the hemodynamic consequences. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33013?source=see_link\">",
"     \"Examination of the arterial pulse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An Austin Flint murmur is usually associated with significant aortic regurgitation (see",
"    <a class=\"local\" href=\"#H44\">",
"     'Austin Flint murmur'",
"    </a>",
"    below). A decreased intensity of S2 does not necessarily suggest significant aortic regurgitation; however, reversed splitting of S2, which in the absence of left bundle branch block results from increased left ventricular forward stroke volume, indirectly suggests significant aortic regurgitation. Changes in the intensity of S1 should be noted, since a reduced intensity is usually associated with an elevated left ventricular end-diastolic pressure, which is more likely to occur in severe aortic regurgitation. Physical findings of pulmonary venous, arterial hypertension, and right-sided heart failure indicate hemodynamically significant aortic regurgitation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38039?source=see_link\">",
"     \"Pathophysiology, clinical features, and evaluation of chronic aortic regurgitation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Assessment of left ventricular function is important, particularly with respect to the timing of surgery. A hyperdynamic left ventricular impulse is associated with a relatively normal ejection fraction. On the other hand, a sustained impulse and S3 gallop may indicate a reduced ejection fraction; further evaluation to assess left ventricular function is indicated in this circumstance.",
"   </p>",
"   <p>",
"    The onset of heart failure can modify many of the physical findings that suggest significant aortic regurgitation. The pulse pressure that was initially high may decrease, and the arterial diastolic pressure that was low may increase. The duration of the regurgitant murmur may decrease as the left ventricular diastolic pressure increases.",
"   </p>",
"   <p>",
"    The hemodynamic consequences of acute, severe aortic regurgitation differ considerably from those of chronic aortic regurgitation, explaining the differences in physical findings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/35/20022?source=see_link\">",
"     \"Acute aortic regurgitation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sudden severe volume overload in a nondilated left ventricle causes a rapid increase in diastolic pressure and often equalization of left ventricular and aortic root pressures in mid-diastole. Thus, the regurgitant murmur can be of short duration.",
"     </li>",
"     <li>",
"      S1 is soft or absent due to a reduced intensity of the mitral component of S1 and premature closure of the mitral valve [",
"      <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The P2 of S2 is frequently accentuated due to postcapillary pulmonary hypertension.",
"     </li>",
"     <li>",
"      A marked increase in left ventricular end-diastolic pressure may prevent effective left ventricular filling during left atrial systole; an atrial gallop may therefore be absent.",
"     </li>",
"     <li>",
"      The carotid pulse can appear small since left ventricular forward stroke volume may not increase or may even decrease, although the character remains normal.",
"     </li>",
"     <li>",
"      The pulse pressure may become narrow as the systemic vascular resistance either increases or remains normal and the arterial diastolic pressure does not fall, if the forward stroke volume declines concomitantly.",
"     </li>",
"     <li>",
"      A lack of left ventricular dilation and hypertrophy is recognized by the relatively normal position of the left ventricular impulse.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Pulmonic regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small amount of pulmonic regurgitation is normal and occasionally can be heard in thin subjects.",
"   </p>",
"   <p>",
"    Pathologic pulmonic regurgitation is most frequently a result of pulmonic hypertension (Graham-Steell murmur) or residual after Tetralogy of Fallot repair in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/21\">",
"     21",
"    </a>",
"    ]. The murmur of pulmonic regurgitation associated with hypertension is high-pitched and \"blowing.\" It begins with an accentuated P2 of S2 and can be of variable duration. It may occupy all of diastole if there is a pandiastolic gradient between the pulmonary artery and the right ventricular diastolic pressure. The murmur has a decrescendo configuration like that of aortic regurgitation; differentiation is difficult if not impossible by auscultation alone. The murmur may increase in intensity during inspiration and can be more localized. It is best heard over the left second and third interspaces.",
"   </p>",
"   <p>",
"    In contrast, the murmur of residual pulmonic regurgitation after Tetralogy of Fallot repair typically is low pitched and soft because pulmonary pressures are normal, so there is only a small diastolic pressure difference between the pulmonary artery and right ventricle. A to-and-fro murmur over the left second intercostal space may be noted or there may be no audible murmur with severe pulmonic regurgitation.",
"   </p>",
"   <p>",
"    Pulmonic regurgitation can occur in the absence of pulmonary hypertension, as in patients with idiopathic dilatation of the pulmonary artery, after pulmonic valvulotomy, with right-sided endocarditis, and with congenital absence of the pulmonic valve. In these conditions, the pulmonary artery diastolic pressure is normal or low and there is a lower rate of regurgitant flow; the regurgitant murmur is of low to medium pitch.",
"   </p>",
"   <p>",
"    In congenital absence of the pulmonic valve, P2 is absent and there is a silent interval between A2 and the onset of the regurgitant murmur. A loud to-and-fro murmur may be heard in these patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1552310\">",
"    <span class=\"h2\">",
"     Left anterior descending artery stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Left anterior descending coronary artery stenosis very rarely causes a diastolic murmur similar to AR (Dock's murmur) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/22\">",
"     22",
"    </a>",
"    ]. The murmur is not widespread like that of aortic regurgitation and usually is best heard over the left second or third interspace, a little lateral to the left sternal border. The murmur may be long or short. It is caused by turbulent flow across the coronary artery stenosis and usually indicates moderately severe stenosis. Coronary artery bypass surgery or percutaneous coronary intervention abolishes the murmur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h1\">",
"     MID-DIASTOLIC MURMURS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mid-diastolic murmurs result from turbulent flow across the atrioventricular valves during the rapid filling phase because of mitral or tricuspid valve stenosis and an abnormal pattern of flow across these valves.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Mitral stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mid-diastolic murmur of mitral stenosis has a rumbling character and is best heard with the bell of the stethoscope over the left ventricular impulse with the patient in the left lateral decubitus position (",
"    <a class=\"graphic graphic_movie graphicRef55136 \" href=\"UTD.htm?7/25/7571\">",
"     movie 11",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef66921 \" href=\"UTD.htm?28/24/29057\">",
"     movie 12",
"    </a>",
"    ). The murmur originates in the left ventricular cavity, explaining its location of maximum intensity.",
"   </p>",
"   <p>",
"    The murmur is present both in sinus rhythm and in atrial fibrillation. It characteristically starts with an opening snap. Its duration, which correlates with the duration of the diastolic pressure gradient across the mitral valve, is a reasonably good guide to assess the severity of mitral stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/23\">",
"     23",
"    </a>",
"    ]. The longer the duration of the murmur, the more severe is the mitral stenosis, provided the diastolic interval is not too short (absence of tachycardia). If the murmur extends up to S1 during a longer diastolic interval, it can be assumed that the pressure gradient is still present at end-diastole, which implies severe mitral stenosis.",
"   </p>",
"   <p>",
"    When the flow across the mitral valve is markedly reduced, which may result from associated right-sided heart failure and pulmonary hypertension, the murmur may be of very brief duration or even absent (so-called silent mitral stenosis), even in the presence of severe mitral stenosis. Conversely, with enhanced flow across the valve, as in the high-output state of pregnancy, the intensity and duration of the murmur increase even with less severe stenosis. In these circumstances, one cannot rely on the duration of the murmur to assess the severity of mitral stenosis; other ancillary investigations, particularly echocardiographic studies, are necessary. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/18/13610?source=see_link\">",
"     \"Pathophysiology, clinical features, and evaluation of mitral stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h2\">",
"     Tricuspid stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tricuspid stenosis may be associated with a mid-diastolic rumble that is best heard along the left sternal border. The most characteristic feature is the increase in intensity of the murmur with inspiration (Carvallo's sign) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/24\">",
"     24",
"    </a>",
"    ]. The mid-diastolic rumble may be associated with a tricuspid opening snap and wide splitting of S1 due to delayed closure of the tricuspid valve. Most patients with tricuspid stenosis are in atrial fibrillation and the murmur is mid-diastolic when the transvalvular pressure gradient is maximum. In sinus rhythm, the murmur may occur only in late diastole, resulting from an increased flow due to right atrial systole.",
"   </p>",
"   <p>",
"    Tricuspid stenosis most frequently occurs in association with mitral stenosis. Isolated tricuspid stenosis is uncommon; when suspected, carcinoid heart disease and right atrial myxoma should be investigated as possible etiologies. A prominent a wave and a relatively slow y descent in the jugular venous pulse, presystolic hepatic pulsation, and the absence of a right atrial gallop should strengthen the suspicion of tricuspid stenosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h2\">",
"     Atrial myxoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial myxoma may cause obstruction of the atrioventricular valves and a mid-diastolic murmur. In left atrial myxoma, the auscultatory findings can be similar to those of mitral stenosis. The murmur is frequently presystolic and crescendo in configuration; it appears to occur with the onset of ventricular systole when the tumor is moved toward the left atrium through the mitral orifice, and when the flow across the valve is still continuing.",
"   </p>",
"   <p>",
"    It is difficult to distinguish between a left atrial myxoma and mitral stenosis at the bedside. However, the character and intensity of the murmur due to an atrial myxoma may change with alterations of position [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/25\">",
"     25",
"    </a>",
"    ]. Sinus rhythm, changing intensity and character of the murmur, and a \"tumor plop\" sound favor the diagnosis of left atrial myxoma. Nevertheless, echocardiographic evaluation is necessary and is always recommended in a patient with suspected mitral stenosis.",
"   </p>",
"   <p>",
"    Right atrial myxoma is far less common than left atrial myxoma. Auscultatory findings may be similar to those of tricuspid stenosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/32/17930?source=see_link\">",
"     \"Cardiac tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h2\">",
"     Increased flow across the atrioventricular valve",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mid-diastolic murmurs may occur in the presence of normal atrioventricular valves when the flow across the valve is markedly increased in mid-diastole (flow murmurs). In pure severe mitral regurgitation, a larger volume of blood (due to the regurgitant volume) moves from the left atrium to the left ventricle during diastole; the etiology is a partial closing movement of the mitral valve, which occurs after it opens widely at the beginning of diastole. The rapid flow to the left ventricle continues, and thus \"functional mitral stenosis\" occurs, explaining the mid-diastolic rumble. In some patients a mid-diastolic pressure gradient has been demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/26-28\">",
"     26-28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a left-to-right shunt, antegrade blood flow across the mitral valve increases during diastole, which may be associated with a mid-diastolic murmur. The mechanism may be similar to that seen in mitral regurgitation. When the etiology is an atrial septal defect or anomalous pulmonary venous drainage, a tricuspid flow murmur can also be heard along the lower left sternal border; this is due to a partial closing movement of the tricuspid valve after its full opening in early diastole and functional tricuspid stenosis at mid-diastole [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/29\">",
"     29",
"    </a>",
"    ]. The intensity of the tricuspid flow murmur tends to increase during inspiration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44\">",
"    <span class=\"h2\">",
"     Austin Flint murmur",
"    </span>",
"    &nbsp;&mdash;&nbsp;An apical diastolic rumbling murmur has been described in patients with pure aortic regurgitation [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Several mechanisms have been proposed to explain the genesis of this murmur, including fluttering of the mitral valve from the impingement by the aortic regurgitant jet, relative (functional) mitral stenosis, and regurgitant jets directed against the left ventricular free wall [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/30-32\">",
"     30-32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mitral fluttering is not the mechanism of the Austin Flint murmur, since fluttering occurs in early diastole with the onset of regurgitation, while the rumble occurs in mid or late diastole. A second proposed mechanism was premature partial closing movement of the mitral valve at mid-diastole due to the regurgitant flow, leading to functional mitral stenosis. However, use of M-mode and two-dimensional echocardiography, color flow Doppler, and cine magnetic resonance imaging has shown that the murmur arises from the regurgitant jets that are directed at the left ventricular free wall, not functional mitral stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If the Austin Flint murmur is not recognized, a mistaken diagnosis of organic mitral stenosis can occur. The presence of an opening snap suggests organic mitral stenosis.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/1/33813?source=see_link\">",
"     Amyl nitrite",
"    </a>",
"    inhalation is also a helpful method of differentiation. An Austin Flint murmur tends to decrease in intensity and duration as the severity of the aortic regurgitation decreases with decreased left ventricular afterload. In contrast, the murmur of mitral stenosis increases in intensity and duration with an increased heart rate and increased antegrade flow across the mitral valve.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H45\">",
"    <span class=\"h2\">",
"     Carey-Coombs murmur",
"    </span>",
"    &nbsp;&mdash;&nbsp;In acute rheumatic fever, a mid-diastolic murmur over the left ventricular impulse, a Carey-Coombs murmur, has been attributed to acute mitral valvulitis. However, first-degree atrioventricular block (prolonged PR interval) is common in rheumatic carditis and an increased flow due to earlier atrial systole coinciding with the rapid filling phase may contribute to a Carey-Coombs murmur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1552367\">",
"    <span class=\"h2\">",
"     Left-to-right shunts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Flow murmurs due to a large left-to-right shunt are usually mid-diastolic in timing. Occasionally, they can extend to late diastole.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H46\">",
"    <span class=\"h1\">",
"     LATE DIASTOLIC (PRESYSTOLIC) MURMURS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Presystolic murmurs occur in late diastole and extend up to S1. They usually have a crescendo configuration. The murmurs result from increased flow across the mitral or tricuspid valve and are most frequently observed in the presence of normal sinus rhythm. However, crescendo presystolic murmurs can occur in the presence of atrial fibrillation in the absence of atrial systole; mitral valve closure, resulting in a reduction of an effective mitral orifice, begins before the onset of isovolumic systole and S1 and during this period antegrade flow across the mitral valve continues [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H47\">",
"    <span class=\"h2\">",
"     Mitral stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial contraction increases the pressure gradient and flow at end-diastole when mitral stenosis is present, generating the presystolic murmur. When a mid-diastolic rumble accompanies a presystolic murmur, the intensity of the mid-diastolic murmur frequently decreases before the onset of the presystolic murmur. The presence of only a presystolic murmur associated with increased intensity of S1 suggests mild mitral stenosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H48\">",
"    <span class=\"h2\">",
"     Tricuspid stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In tricuspid stenosis with sinus rhythm, the murmur is usually presystolic because the transvalvular gradient is maximum during this period [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/24\">",
"     24",
"    </a>",
"    ]. The intensity of the presystolic murmur of tricuspid stenosis also increases during inspiration, which is associated with an increased venous return to the right atrium. Increased right atrial volume is associated with more forceful right atrial contraction and, therefore, an increased pressure gradient during this interval and accentuation of the murmur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49\">",
"    <span class=\"h2\">",
"     Myxoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Presystolic murmurs may occur with left or right atrial myxomas. This is due to obstruction of the atrioventricular valves.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H51\">",
"    <span class=\"h2\">",
"     Complete heart block",
"    </span>",
"    &nbsp;&mdash;&nbsp;In complete atrioventricular block with a slow idioventricular rhythm, a short late diastolic murmur can occasionally be heard and recorded (Rytand's murmur). The precise mechanism of Rytand's murmur has not been elucidated; diastolic mitral regurgitation has been postulated [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Diastolic mitral regurgitation appears to depend upon the position of the P wave and atrial systole in ventricular diastole. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15285?source=see_link\">",
"     \"Third degree (complete) atrioventricular block\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H52\">",
"    <span class=\"h1\">",
"     CONTINUOUS MURMURS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Continuous murmurs are defined as murmurs that begin in systole and extend up to diastole without interruption. They do not necessarily need to occupy the total duration of systole and diastole. Continuous murmurs result from blood flow from a higher pressure chamber or vessel to a lower system associated with a persistent pressure gradient between these areas during systole and diastole. These murmurs may occur due to aortopulmonary connections, arteriovenous communication, and disturbances in the flow patterns in the arteries or veins (",
"    <a class=\"graphic graphic_figure graphicRef54292 \" href=\"UTD.htm?18/5/18526\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef50660 \" href=\"UTD.htm?16/39/17020\">",
"     table 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/36-39\">",
"     36-39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H53\">",
"    <span class=\"h2\">",
"     Patent ductus arteriosus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patent ductus arteriosus is a relatively common cause of a continuous murmur in adults. Aortic pressure is higher than pulmonary artery pressure during both systole and diastole; blood flow from the high pressure descending thoracic aorta to the low pressure pulmonary artery causes the continuous murmur (Gibson's murmur or machinery murmur).",
"   </p>",
"   <p>",
"    The maximum intensity of the murmur usually occurs at S2. The duration of the murmur depends upon the pressure difference between aorta and pulmonary artery. With pulmonary hypertension, pulmonary artery diastolic pressure increases; when it approaches systemic level, the diastolic portion of the continuous murmur becomes shorter and ultimately absent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/40\">",
"     40",
"    </a>",
"    ]. With more severe pulmonary hypertension, pulmonary artery systolic pressure can equalize with aortic systolic pressure and the systolic component of the murmur may also be absent (silent ductus). Differential cyanosis due to the reversal of the shunt and signs of pulmonary hypertension with or without evidence of right-sided heart failure are the only physical findings that are recognizable at the bedside in these circumstances.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H54\">",
"    <span class=\"h2\">",
"     Aortopulmonary window",
"    </span>",
"    &nbsp;&mdash;&nbsp;Continuous murmurs may be present with an aortopulmonary window. However, because of the large size of the communication, pulmonary vascular resistance, and pulmonary artery diastolic pressure tend to be higher, which is associated with a shorter duration of the diastolic component of the continuous murmur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H55\">",
"    <span class=\"h2\">",
"     Shunts",
"    </span>",
"    &nbsp;&mdash;&nbsp;A left-to-right shunt through a small atrial septal defect in the presence of mitral valve obstruction, known as Lutembacher syndrome, may occasionally cause a continuous murmur [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/41\">",
"     41",
"    </a>",
"    ]. Total anomalous pulmonary venous drainage, a small atrial septal defect without mitral valve obstruction, and mitral stenosis with a persistent left superior vena cava are very rare causes of continuous murmurs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H56\">",
"    <span class=\"h2\">",
"     Arteriovenous fistulas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital or acquired arteriovenous fistulas also cause continuous murmurs.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Coronary arteriovenous fistulas may produce a continuous murmur; the location, duration, and character of the murmur depend upon the anatomical type of fistulas. As an example, the right coronary and right atrial, or coronary sinus, communication produces continuous murmurs that are usually located along the parasternal areas. The murmur of a circumflex coronary artery and coronary sinus communication are usually located in the left axilla. The configuration of the murmur and the intensity of the systolic and diastolic components are variable. Marked systolic compression of the abnormal vessels reduces the systolic flow; thus, the systolic component of the murmur may be very soft. On the other hand, an increased systolic gradient may result from the partial compression of the intramural communication, which will tend to increase the intensity of the systolic portion of the murmur.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Fistulous connection between an internal mammary graft and the pulmonary vasculature or left anterior descending vein are rare causes of continuous murmurs [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A communication between the sinus of Valsalva and the right atrium or right ventricle produces continuous murmurs that may appear as to-and-fro murmurs due to the increased intensity of both the systolic and diastolic components and a softer intensity around S2.",
"     </li>",
"     <li>",
"      Systemic and pulmonary arteriovenous fistulas are also associated with continuous murmurs. Although a systemic arteriovenous communication usually produces a loud murmur, the murmur of pulmonary arteriovenous fistulas is softer and may be primarily systolic. The major pressure gradient occurs in systole, and the diastolic gradient is usually very small. Pulmonary arteriovenous fistulas usually involve the lower left or right middle lobe; the location of the murmurs is also over these areas. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27656?source=see_link\">",
"       \"Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical features\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H57\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Constriction in the systemic or pulmonary arteries can be associated with continuous murmurs due to a persistent pressure gradient across the narrowed segment of the vessel.",
"   </p>",
"   <p>",
"    In coarctation of the aorta, a continuous murmur can be heard in the back overlying the area of constriction. Continuous murmurs may originate in large tortuous collateral arteries in coarctation of the aorta, which are also heard in the back over the interscapular regions. Sometimes large, tortuous intercostal vessels are visible when the shoulders are rotated medially and forward to separate the scapulas (Suzman's sign) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/37/26202/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=see_link\">",
"     \"Clinical manifestations and diagnosis of coarctation of the aorta\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pulmonary artery branch stenosis and a partial occlusion of the pulmonary artery due to pulmonary embolism may also cause continuous murmurs.",
"   </p>",
"   <p>",
"    Rapid flow through tortuous collateral vessels, as in coarctation of the aorta, may cause a continuous murmur. Bronchial arterial collateral vessels develop in certain types of cyanotic congenital heart disease (tricuspid atresia, pulmonary atresia with ventricular septal defect) and loud continuous murmurs may be heard along the parasternal area.",
"   </p>",
"   <p>",
"    In dialysis patients, a large dialysis fistula can be associated with a continuous murmur that can radiate to the infraclavicular area.",
"   </p>",
"   <p>",
"    The \"mammary souffle\" associated with pregnancy may be systolic or continuous. These innocent murmurs are usually of higher frequency (high pitched) and louder in systole.",
"   </p>",
"   <p>",
"    A venous hum, which results from altered flow in the veins, can also cause an innocent continuous murmur. The venous hum is heard with the patient in the sitting position (usually in the supraclavicular fossa) and frequently disappears when the patient moves to the supine position. The hum tends to be louder in diastole and can be completely abolished by compression of the ipsilateral internal jugular vein. A loud, left-sided venous hum transmitted below the clavicle should not be mistaken for the murmur of patent ductus arteriosus. Venous hum is not heard in the supine position, and pressure on the internal jugular vein abolishes the venous hum. In contrast, the murmur of patent ductus arteriosus persists in the supine position and despite pressure on the internal jugular vein.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/42/36514?source=see_link\">",
"       \"Patient information: Heart murmurs (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1552124\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A murmur is characterized by its intensity (grade), timing, configuration (time course), frequency (pitch), and location.",
"     </li>",
"     <li>",
"      The most common causes of a mid-systolic murmur are benign (innocent) flow murmurs, an increase in flow rate across a normal semilunar valve, and aortic valve sclerosis. These physiologic murmurs need to be distinguished from the abnormal mid-systolic murmur in patients with fixed or dynamic outflow tract obstruction (",
"      <a class=\"graphic graphic_table graphicRef65728 \" href=\"UTD.htm?5/28/5581\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Midsystolic ejection murmurs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Aortic valve stenosis causes an abnormal mid-systolic murmur that typically is loudest over the right second intercostal space and radiates to the carotids. A mid-systolic murmur associated with a single S2 suggests severe aortic stenosis.",
"     </li>",
"     <li>",
"      Fixed aortic valve obstruction is distinguished from dynamic subaortic outflow tract obstruction by changes in the murmur with maneuvers (",
"      <a class=\"graphic graphic_table graphicRef65728 \" href=\"UTD.htm?5/28/5581\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Midsystolic ejection murmurs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A holosystolic murmur is caused by mitral regurgitation, tricuspid regurgitation, or a small ventricular septal defect (except for some small muscular ventricular septal defects). (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Holosystolic murmurs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An early systolic murmur is caused by acute severe or mild chronic mitral regurgitation, primary tricuspid regurgitation with normal right ventricular pressures, a large ventricular septal defect, or a small muscular ventricular septal defect. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Early systolic murmurs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Late systolic murmurs are most commonly caused by mitral valve prolapse, which may be accompanied by a late systolic murmur of tricuspid valve prolapse. The murmur of ischemic mitral regurgitation (caused by infarction or ischemia) is frequently late systolic. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Late systolic murmurs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An early diastolic murmur is usually due to aortic or pulmonic regurgitation. (See",
"      <a class=\"local\" href=\"#H35\">",
"       'Early diastolic murmurs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mitral stenosis causes a mid-diastolic murmur, a late diastolic murmur, or both. (See",
"      <a class=\"local\" href=\"#H40\">",
"       'Mitral stenosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H47\">",
"       'Mitral stenosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tricuspid stenosis with sinus rhythm causes a late diastolic murmur while tricuspid stenosis with atrial fibrillation causes a mid-diastolic murmur. (See",
"      <a class=\"local\" href=\"#H41\">",
"       'Tricuspid stenosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H48\">",
"       'Tricuspid stenosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A myxoma causes a mid- or late-diastolic murmur. (See",
"      <a class=\"local\" href=\"#H42\">",
"       'Atrial myxoma'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H49\">",
"       'Myxoma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Causes of a continuous murmur include patent ductus arteriosus, aortopulmonary window, some shunts, arteriovenous fistulas, and coarctation of the aorta. (See",
"      <a class=\"local\" href=\"#H52\">",
"       'Continuous murmurs'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/1\">",
"      Mineo K, Cummings J, Josephson R, Nanda NC. Acquired left ventricular outflow tract obstruction during acute myocardial infarction: diagnosis of a new cardiac murmur. Am J Geriatr Cardiol 2001; 10:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/2\">",
"      Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/3\">",
"      Attenhofer Jost CH, Turina J, Mayer K, et al. Echocardiography in the evaluation of systolic murmurs of unknown cause. Am J Med 2000; 108:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/4\">",
"      Etchells E, Bell C, Robb K. Does this patient have an abnormal systolic murmur? JAMA 1997; 277:564.",
"     </a>",
"    </li>",
"    <li>",
"     Perloff JK. Innocent or normal murmurs. In: Cardiovascular Problems: Perspectives and Progress, Russek H (Ed), University Park Press, Baltimore  p.1976.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/6\">",
"      DELEON AC Jr, PERLOFF JK, TWIGG H, MAJD M. THE STRAIGHT BACK SYNDROME: CLINICAL CARDIOVASCULAR MANIFESTATIONS. Circulation 1965; 32:193.",
"     </a>",
"    </li>",
"    <li>",
"     Perloff JK. The Clinical Recognition of Congenital Heart Disease, WB Saunders, Philadelphia 1970.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/8\">",
"      PERLOFF JK, HARVEY WP. Auscultatory and phonocardiographic manifestations of pure mitral regurgitation. Prog Cardiovasc Dis 1962; 5:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/9\">",
"      CRAIGE E. Phonocardiography in interventricular septal defects. Am Heart J 1960; 60:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/10\">",
"      HOLLMAN A, MORGAN JJ, GOODWIN JF, FIELDS H. Auscultatory and phonocardiographic findings in ventricular septal defect. A study of 93 surgically treated patients. Circulation 1963; 28:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/11\">",
"      Sutton G, Harris A, Leatham A. Second heart sound in pulmonary hypertension. Br Heart J 1968; 30:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/12\">",
"      Cheng TO. Some new observations on the syndrome of papillary muscle dysfunction. Am J Med 1969; 47:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/13\">",
"      Roberts WC, Perloff JK. Mitral valvular disease. A clinicopathologic survey of the conditions causing the mitral valve to function abnormally. Ann Intern Med 1972; 77:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/14\">",
"      Ronan JA Jr, Steelman RB, DeLeon AC Jr, et al. The clinical diagnosis of acute severe mitral insufficiency. Am J Cardiol 1971; 27:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/15\">",
"      Perloff JK. Therapeutics of nature--the invisible sutures of \"spontaneous closure\". Am Heart J 1971; 82:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/16\">",
"      Hutter AM Jr, Dinsmore RE, Willerson JT, DeSanctis RW. Early systolic clicks due to mitral valve prolapse. Circulation 1971; 44:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/17\">",
"      Choudhry NK, Etchells EE. The rational clinical examination. Does this patient have aortic regurgitation? JAMA 1999; 281:2231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/18\">",
"      HARVEY WP, CORRADO MA, PERLOFF JK. \"Right-sided\" murmurs of aortic insufficiency (diastolic murmurs better heard to the right of the sternum rather than to the left). Am J Med Sci 1963; 245:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/19\">",
"      Suwa M, Hirota Y, Kino M, et al. Late diastolic whoop in severe aortic regurgitation. Am J Cardiol 1986; 57:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/20\">",
"      Mann T, McLaurin L, Grossman W, Craige E. Assessing the hemodynamic severity of acute aortic regurgitation due to infective endocarditis. N Engl J Med 1975; 293:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/21\">",
"      Perloff JK. Auscultatory and phonocardiographic manifestations of pulmonary hypertension. Prog Cardiovasc Dis 1967; 9:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/22\">",
"      Dock W, Zoneraich S. A diastolic murmur arising in a stenosed coronary artery. Am J Med 1967; 42:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/23\">",
"      WOOD P. An appreciation of mitral stenosis. I. Clinical features. Br Med J 1954; 1:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/24\">",
"      PERLOFF JK, HARVEY WP. Clinical recognition of tricusoid stenosis. Circulation 1960; 22:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/25\">",
"      Nasser WK, Davis RH, Dillon JC, et al. Atrial myxoma. I. Clinical and pathologic features in nine cases. Am Heart J 1972; 83:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/26\">",
"      Fortuin NJ, Craige E. Echocardiographic studies of genesis of mitral diastolic murmurs. Br Heart J 1973; 35:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/27\">",
"      HUBBARD TF, DUNN FL, NEIS DD. A phonocardiographic study of the apical diastolic murmurs in pure mitral insufficiency. Am Heart J 1959; 57:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/28\">",
"      Nixon PG, Wooler GH. LEFT VENTRICULAR FILLING PRESSURE GRADIENT IN MITRAL INCOMPETENCE. Br Heart J 1963; 25:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/29\">",
"      Wooley CF, Levin HS, Leighton RF, et al. Intracardiac sound and pressure events in man. Am J Med 1967; 42:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/30\">",
"      Fortuin NJ, Craige E. On the mechanism of the Austin Flint murmur. Circulation 1972; 45:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/31\">",
"      Reddy PS, Curtiss EI, Salerni R, et al. Sound pressure correlates of the Austin Flint murmur. An intracardiac sound study. Circulation 1976; 53:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/32\">",
"      Landzberg JS, Pflugfelder PW, Cassidy MM, et al. Etiology of the Austin Flint murmur. J Am Coll Cardiol 1992; 20:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/33\">",
"      Criley JM, Hermer AJ. The crescendo presystolic murmur of mitral stenosis with atrial fibrillation. N Engl J Med 1971; 285:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/34\">",
"      Rutishauser W, Wirz P, Gander M, L&uuml;thy E. Atriogenic diastoliceflux in patients with atrioventricular block. Circulation 1966; 34:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/35\">",
"      Panidis IP, Ross J, Munley B, et al. Diastolic mitral regurgitation in patients with atrioventricular conduction abnormalities: a common finding by Doppler echocardiography. J Am Coll Cardiol 1986; 7:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/36\">",
"      Craige E, Milward DK. Diastolic and continuous murmurs. Prog Cardiovasc Dis 1971; 14: 38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/37\">",
"      NEILL C, MOUNSEY P. Auscultation in patent ductus arteriosus; with a description of two fistulae simulating patent ductus. Br Heart J 1958; 20:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/38\">",
"      GASUL BM, ARCILLA RA, FELL EH, et al. Congenital coronary arteriovenous fistula. Clinical, phonocardiographic, angiocardiographic and hemodynamic studies in five patients. Pediatrics 1960; 25:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/39\">",
"      Harris A, Jefferson K, Chatterjee K. Coronary arteriovenous fistula with aneurysm of coronary sinus. Br Heart J 1969; 31:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/40\">",
"      MYERS GS, SCANNELL JG, WYMAN SM, et al. Atypical patent ductus arteriosus with absence of the usual aortic-pulmonary pressure gradient and of the characteristic murmur. Am Heart J 1951; 41:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/41\">",
"      Steinbrunn W, Cohn KE, Selzer A. Atrial septal defect associated with mitral stenosis. The Lutembacher syndrome revisited. Am J Med 1970; 48:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/42\">",
"      Guray U, Guray Y, Ozbakir C, et al. Fistulous connection between internal mammary graft and pulmonary vasculature after coronary artery bypass grafting: a rare cause of continuous murmur. Int J Cardiol 2004; 96:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/37/26202/abstract/43\">",
"      Campbell M, Suzman S. COARCTATION OF THE AORTA. Br Heart J 1947; 9:185.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1078 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-FC5DC09734-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26202=[""].join("\n");
var outline_f25_37_26202=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1552124\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MURMUR DESCRIPTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Intensity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pitch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Configuration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Location",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Timing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Systolic murmurs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Diastolic murmurs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Continuous murmur",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      MIDSYSTOLIC EJECTION MURMURS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Innocent midsystolic murmurs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Increased semilunar blood flow",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Aortic valve sclerosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Aortic outflow obstruction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Valvular aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Supravalvular aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Subvalvular outflow obstruction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Fixed versus dynamic outflow obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Pulmonic outflow obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Dilation of the aortic root or pulmonary artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1552257\">",
"      Mid-systolic versus holosystolic murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      HOLOSYSTOLIC MURMURS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Tricuspid regurgitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Ventricular septal defect",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      EARLY SYSTOLIC MURMURS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Tricuspid regurgitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Ventricular septal defect",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      LATE SYSTOLIC MURMURS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Mitral valve prolapse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Tricuspid valve prolapse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Ischemic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      EARLY DIASTOLIC MURMURS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Aortic regurgitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Pulmonic regurgitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1552310\">",
"      Left anterior descending artery stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      MID-DIASTOLIC MURMURS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      Tricuspid stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      Atrial myxoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      Increased flow across the atrioventricular valve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H44\">",
"      Austin Flint murmur",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H45\">",
"      Carey-Coombs murmur",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1552367\">",
"      Left-to-right shunts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46\">",
"      LATE DIASTOLIC (PRESYSTOLIC) MURMURS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H47\">",
"      Mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H48\">",
"      Tricuspid stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H49\">",
"      Myxoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H51\">",
"      Complete heart block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H52\">",
"      CONTINUOUS MURMURS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H53\">",
"      Patent ductus arteriosus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H54\">",
"      Aortopulmonary window",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H55\">",
"      Shunts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H56\">",
"      Arteriovenous fistulas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H57\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1552124\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1078\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1078|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/62/17391\" title=\"figure 1\">",
"      Systolic murmurs and S2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/5/18526\" title=\"figure 2\">",
"      Schematic continuous murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1078|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?13/13/13521\" title=\"movie 1\">",
"      Phonocardiogram calcific AS 3rd left ICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?20/22/20832\" title=\"movie 2\">",
"      Phonocardiogram calcific AS at 2nd right intercostal space",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?39/8/40065\" title=\"movie 3\">",
"      Phonocardiogram bicusid AS at 2nd R ICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?43/6/44128\" title=\"movie 4\">",
"      Phonocardiogram of bicuspid AS at apex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?15/24/15744\" title=\"movie 5\">",
"      MR in atrial fibrillation as heard at the apex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?7/55/8051\" title=\"movie 6\">",
"      Mitral valve prolapse with patient standing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?15/40/16004\" title=\"movie 7\">",
"      Mitral valve prolapse with patient squatting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?0/12/195\" title=\"movie 8\">",
"      Aortic regurgitation as heard at the lower left sternal border",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?39/27/40368\" title=\"movie 9\">",
"      AR as heard at the second right intercostal space",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?41/61/42960\" title=\"movie 10\">",
"      Aortic regurgitation as heard at the apex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?7/25/7571\" title=\"movie 11\">",
"      Mitral stenosis as heard at the apex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?28/24/29057\" title=\"movie 12\">",
"      Mitral stenosis as heard at the base",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1078|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/4/36939\" title=\"table 1A\">",
"      Echo asymptomatic murmurs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/35/17979\" title=\"table 1B\">",
"      Echo symptomatic murmurs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/28/5581\" title=\"table 2\">",
"      Causes systolic ejection murmur",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/39/17020\" title=\"table 3\">",
"      Continuous thoracic murmurs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/11/43196\" title=\"table 4\">",
"      Causes LV outflow obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/1/11292\" title=\"table 5\">",
"      Maneuvers mitral valve prolapse",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/35/20022?source=related_link\">",
"      Acute aortic regurgitation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38279?source=related_link\">",
"      Aortic valve sclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=related_link\">",
"      Auscultation of heart sounds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/32/17930?source=related_link\">",
"      Cardiac tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=related_link\">",
"      Clinical features and evaluation of aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=related_link\">",
"      Clinical manifestations and diagnosis of bicuspid aortic valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=related_link\">",
"      Clinical manifestations and diagnosis of coarctation of the aorta",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/62/39910?source=related_link\">",
"      Clinical manifestations and diagnosis of pulmonic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13705?source=related_link\">",
"      Definition and diagnosis of mitral valve prolapse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/30/9705?source=related_link\">",
"      Etiology, clinical features, and evaluation of chronic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/9/149?source=related_link\">",
"      Etiology, clinical features, and evaluation of tricuspid regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33013?source=related_link\">",
"      Examination of the arterial pulse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9909?source=related_link\">",
"      Examination of the precordial pulsation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18297?source=related_link\">",
"      Ischemic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=related_link\">",
"      Pathophysiology and clinical features of isolated ventricular septal defects in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38039?source=related_link\">",
"      Pathophysiology, clinical features, and evaluation of chronic aortic regurgitation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/18/13610?source=related_link\">",
"      Pathophysiology, clinical features, and evaluation of mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/45/28376?source=related_link\">",
"      Pathophysiology, clinical features, evaluation, and management of acute mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/42/36514?source=related_link\">",
"      Patient information: Heart murmurs (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41876?source=related_link\">",
"      Physiologic and pharmacologic maneuvers in the differential diagnosis of heart murmurs and sounds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27656?source=related_link\">",
"      Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/6/11369?source=related_link\">",
"      Role of echocardiography in acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/1/30745?source=related_link\">",
"      Stress-induced (takotsubo) cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33207?source=related_link\">",
"      Subvalvar aortic stenosis (subaortic stenosis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/52/40774?source=related_link\">",
"      Supravalvar aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15285?source=related_link\">",
"      Third degree (complete) atrioventricular block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/52/14154?source=related_link\">",
"      Ventricular septal defect in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_37_26203="Sx GI endocrine neoplasms";
var content_f25_37_26203=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F71093&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F71093&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Symptoms of gastrointestinal endocrine neoplasms",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Syndrome",
"       </td>",
"       <td class=\"subtitle1\">",
"        Peptide",
"       </td>",
"       <td class=\"subtitle1\">",
"        Symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zollinger-Ellison",
"       </td>",
"       <td>",
"        Gastrin",
"       </td>",
"       <td>",
"        Ulcers, diarrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carcinoid",
"       </td>",
"       <td>",
"        Serotonin",
"       </td>",
"       <td>",
"        Flushing, diarrhea, bronchospasm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Verner-Morrison (VIPoma)",
"       </td>",
"       <td>",
"        Vasoactive intestinal peptide",
"       </td>",
"       <td>",
"        Voluminous watery diarrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Insulinoma",
"       </td>",
"       <td>",
"        Insulin",
"       </td>",
"       <td>",
"        Hypoglycemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glucagonoma",
"       </td>",
"       <td>",
"        Glucagon",
"       </td>",
"       <td>",
"        Diabetes, migratory necrolytic erythema",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Somatostatinoma",
"       </td>",
"       <td>",
"        Somatostatin",
"       </td>",
"       <td>",
"        Cholelithiasis, diabetes, steatorrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PP-oma",
"       </td>",
"       <td>",
"        Pancreatic polypeptide",
"       </td>",
"       <td>",
"        No significant phenotype other than mass effect",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26203=[""].join("\n");
var outline_f25_37_26203=null;
var title_f25_37_26204="Benef chemo SB adenoCA";
var content_f25_37_26204=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F53789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F53789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Retrospective reviews suggesting benefit for palliative chemotherapy in small bowel adenocarcinoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Author, year",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Disease status",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Number of patients",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Chemotherapy",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        RR, percent",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Median OS, months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Total",
"       </td>",
"       <td class=\"subtitle2\">",
"        Chemo",
"       </td>",
"       <td class=\"subtitle2\">",
"        No chemo",
"       </td>",
"       <td class=\"subtitle2\">",
"        Chemotherapy",
"       </td>",
"       <td class=\"subtitle2\">",
"        No chemotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Halfdanarson T; 2010",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        163",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        Various agents",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        15.5",
"       </td>",
"       <td>",
"        3.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fishman P; 2006",
"       </td>",
"       <td>",
"        Metastatic, LAD",
"       </td>",
"       <td>",
"        113",
"       </td>",
"       <td>",
"        44",
"       </td>",
"       <td>",
"        69",
"       </td>",
"       <td>",
"        Various agents",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        18.6",
"       </td>",
"       <td>",
"        13.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Czaykowski P; 2007",
"       </td>",
"       <td>",
"        Metastatic, LAD",
"       </td>",
"       <td>",
"        37",
"       </td>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        21",
"       </td>",
"       <td>",
"        5-FU based",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        15.6",
"       </td>",
"       <td>",
"        7.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dabaja B; 2004",
"       </td>",
"       <td>",
"        Metastatic",
"       </td>",
"       <td>",
"        49",
"       </td>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ouriel K; 1984",
"       </td>",
"       <td>",
"        Metastatic",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        5-FU based",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        10.7",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     NR: not reported; 5-FU: 5-fluorouracil; LAD: locally advanced, unresectable, disease; RR: response rate; OS: overall survival.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26204=[""].join("\n");
var outline_f25_37_26204=null;
var title_f25_37_26205="Cirrhosis in hep C";
var content_f25_37_26205=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F79193&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F79193&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 536px\">",
"   <div class=\"ttl\">",
"    Decompensation with cirrhosis due to hepatitis C infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 516px; height: 320px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In this study of 384 patients with compensated cirrhosis due to hepatitis C virus infection, the risk of developing hepatic decompensation was 3.9 percent per year.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Fattovich, G, Giustina, G, Degos, F, et al, Gastroenterology 1997; 112:463.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26205=[""].join("\n");
var outline_f25_37_26205=null;
var title_f25_37_26206="CNS tumor type child rates";
var content_f25_37_26206=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F61480&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F61480&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 503px\">",
"   <div class=\"ttl\">",
"    Age-specific incidence of childhood primary brain and CNS tumors by selected histologies CBTRUS 2000-2004",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 483px; height: 401px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: CBTRUS (2008) Statistical Report: Primary Brain Tumors in the United States, 2000-2004. Published by the Central Brain Tumor Registry of the United States.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26206=[""].join("\n");
var outline_f25_37_26206=null;
var title_f25_37_26207="Mucogingivitis";
var content_f25_37_26207=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F56573&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F56573&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mucogingivitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 237px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mucogingivitis in relation to the maxillary permanent incisors in a child with Crohn disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Hardy S, Fleming P, Rowland M, et al. A prospective study of the oral manefestations of Crohn's disease. Clin Gastroenterol Hepatol 2005; 3:886. Copyright &copy; 2005 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_37_26207=[""].join("\n");
var outline_f25_37_26207=null;
